https://www.lmi.no/2022/06/07/asco-oppsummert/ 2022-06-07T09:07:48+00:00 https://www.lmi.no/wp-content/uploads/2022/06/IMG_3526-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/IMG_3526-scaled.jpg https://www.lmi.no/2022/06/07/presentasjoner-fra-dra-forums-medlemsmote/ 2022-06-07T10:01:24+00:00 https://www.lmi.no/wp-content/uploads/2022/06/chris-montgomery-smgTvepind4-unsplash-2-scaled.jpg https://www.lmi.no/2022/06/06/targovax-viste-frem-sterke-resultater-pa-asco/ 2022-06-07T15:19:37+00:00 https://www.lmi.no/wp-content/uploads/2022/06/IMG_3508-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/IMG_3508-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/IMG_3493-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/IMG_3503-scaled.jpg https://www.lmi.no/2022/06/08/vil-at-stortinget-setter-maksgrense-for-hvor-lenge-legemiddelverket-kan-vente-for-de-starter-metodevurderingene/ 2022-06-08T08:46:23+00:00 https://www.lmi.no/2022/06/08/gravide-som-gar-pa-epilepsimedisiner-har-okt-risiko-for-a-fa-barn-med-autisme/ 2022-06-08T09:56:33+00:00 https://www.lmi.no/2022/05/31/meld-deg-pa-lmis-fagdag-om-anskaffelser-av-legemidler-fremtidig-utvikling-og-losninger/ 2022-06-08T10:36:58+00:00 https://www.lmi.no/wp-content/uploads/2021/02/PP-presentasjon_stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/05/fagdag-22.-juni-22.jpg https://www.lmi.no/2022/06/08/lmi-soker-medlemmer-som-kan-bista-ukrainsk-kompetanse/ 2022-06-08T11:21:56+00:00 https://www.lmi.no/wp-content/uploads/2022/03/Ukraina-scaled.jpeg https://www.lmi.no/2022/06/09/ny-immunterapi-mot-blodkreft-godkjent-i-europa/ 2022-06-09T07:28:59+00:00 https://www.lmi.no/2022/06/09/lovende-resultater-av-nytt-vektreduserende-legemiddel/ 2022-06-09T07:30:11+00:00 https://www.lmi.no/2022/06/10/nye-metoder-ber-om-gjennomgang-av-unntaksordning/ 2022-06-10T06:32:51+00:00 https://www.lmi.no/2022/06/10/ny-rapport-norden-bor-styrke-felles-vaksineproduksjon/ 2022-06-10T06:34:56+00:00 https://www.lmi.no/2022/06/10/frp-vil-innfore-right-to-try/ 2022-06-10T06:36:36+00:00 https://www.lmi.no/2022/06/10/helsenaeringens-verdi-2022-samarbeid-er-nokkelen-for-a-lose-utfordringene/ 2022-06-10T12:12:54+00:00 https://www.lmi.no/wp-content/uploads/2022/06/DSC_3054-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSC_3054-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/Nicolai.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSC_2935-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSC_2986-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSC_3086-scaled.jpg https://www.lmi.no/2022/06/13/vi-kan-rett-og-slett-bli-en-av-norges-storste-naeringer/ 2022-06-13T08:02:56+00:00 https://www.lmi.no/2022/06/13/helsenaeringen-kan-bli-norges-viktigste-naering-i-fremtiden/ 2022-06-13T08:04:40+00:00 https://www.lmi.no/2022/06/13/pa-sporet-av-medisin-mot-flere-sykdommer/ 2022-06-13T08:06:36+00:00 https://www.lmi.no/2022/06/13/eu-covid-19-vaksiner-forer-ikke-til-at-menstruasjonen-forsvinner/ 2022-06-13T08:19:31+00:00 https://www.lmi.no/2022/06/13/nye-brystkreft-funn-gir-hap-men-norske-kvinner-ma-fortsatt-vente/ 2022-06-13T08:20:46+00:00 https://www.lmi.no/2022/06/13/far-flere-millioner-kroner-til-kreftforskning-kjempeviktig/ 2022-06-13T08:23:57+00:00 https://www.lmi.no/2022/06/13/alle-vaksinene-voksne-bor-ta-men-som-mange-ikke-vet-om/ 2022-06-13T08:26:09+00:00 https://www.lmi.no/2022/06/13/helsenaeringens-verdi-2022-de-ansatte-skal-rette-seg-opp-i-ryggen-og-vaere-stolt-over-arbeidsplassen-sin/ 2022-06-13T10:35:34+00:00 https://www.lmi.no/wp-content/uploads/2022/06/karita-og-borhaug.png https://www.lmi.no/2022/06/14/opptak-fra-frokostmote-om-avanserte-terapier-13-juni/ 2022-06-14T07:31:53+00:00 https://www.lmi.no/wp-content/uploads/2022/06/frokostmote-13.juni_.jpg https://www.lmi.no/2022/06/14/forventer-faerre-forstadier-til-livmorhalskreft-det-blir-en-gledelig-nedgang/ 2022-06-14T08:26:02+00:00 https://www.lmi.no/2022/06/14/fem-millioner-til-kreftforskning/ 2022-06-14T08:28:17+00:00 https://www.lmi.no/2022/06/14/epcoritamab-lovende-mot-den-vanligste-formen-for-lymfekreft/ 2022-06-14T08:32:10+00:00 https://www.lmi.no/2022/06/14/immunterapi-godkjent-i-europa-for-pasienter-med-tidlig-ikke-smacellet-lungekreft/ 2022-06-14T08:33:08+00:00 https://www.lmi.no/2022/06/14/kampen-mot-antibiotikaresistens-kan-laere-av-pandemien/ 2022-06-14T08:35:08+00:00 https://www.lmi.no/2022/06/14/amerikanske-myndigheter-pfizer-trygt-for-de-minste/ 2022-06-14T08:36:40+00:00 https://www.lmi.no/2022/06/15/vil-gjore-dyr-vaksine-gratis-for-barn-astrid-10-matte-legges-inn-pa-sykehus/ 2022-06-15T09:23:39+00:00 https://www.lmi.no/2022/06/15/lar-brukere-skal-fa-bestemme-mer-selv/ 2022-06-15T09:24:38+00:00 https://www.lmi.no/2022/06/14/diabetes-type-2-myter-fordommer-og-fasitsvar/ 2022-06-15T10:37:21+00:00 https://www.lmi.no/wp-content/uploads/2022/06/Diabetes-type-2-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/06/Diabetes-type-2-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/06/diabetespodkast-scaled.jpg https://www.lmi.no/2022/06/15/melanor-blir-en-del-av-nho-geneo/ 2022-06-15T14:16:50+00:00 https://www.lmi.no/wp-content/uploads/2022/06/melanor-geneo-2.png https://www.lmi.no/wp-content/uploads/2022/06/melanor-geneo-2.png https://www.lmi.no/2022/06/16/tungvekter-inn-i-ny-landsforening/ 2022-06-16T07:36:56+00:00 https://www.lmi.no/2022/06/16/presisjonsmedisin-oppdagelsen-endret-livet-til-helen-13-en-fantastisk-nyhet/ 2022-06-16T07:38:02+00:00 https://www.lmi.no/2022/06/16/hjertemedisinen-vyndaqel-skal-opp-i-beslutningsforum-for-fjerde-gang/ 2022-06-16T07:44:23+00:00 https://www.lmi.no/2022/06/16/disse-sakene-star-pa-agendaen-pa-beslutningsforum-sitt-junimote/ 2022-06-16T07:49:32+00:00 https://www.lmi.no/2022/06/16/ny-immunterapi-mot-lymfekreft-godkjent-i-europa-er-et-alternativ-til-car-t-behandling/ 2022-06-16T07:51:08+00:00 https://www.lmi.no/2022/06/16/skal-bekjempe-sykdom-i-planter-og-dyr-med-naturlige-bakterier/ 2022-06-16T07:59:45+00:00 https://www.lmi.no/2022/06/16/nordisk-studie-bekrefter-alvorlig-bivirkning-etter-koronavaksinasjon-med-vaxzevria/ 2022-06-16T08:10:43+00:00 https://www.lmi.no/2022/06/16/satsar-stort-pa-nytt-diabetes-senter/ 2022-06-16T08:11:56+00:00 https://www.lmi.no/2022/06/16/horingssvar-prinsipper-for-bruk-av-markedet-pa-e-helseomradet/ 2022-06-16T08:58:32+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2022/06/17/uenige-i-at-norge-ligger-foran-nar-det-gjelder-nye-medisiner/ 2022-06-17T07:27:24+00:00 https://www.lmi.no/2022/06/17/tidligere-ungdomspolitiker-bjorn-kristian-svendsrud-gar-til-sanofi/ 2022-06-17T07:30:13+00:00 https://www.lmi.no/2022/06/17/privat-helse-naering-med-rekordtall-etter-korona/ 2022-06-17T07:38:49+00:00 https://www.lmi.no/2022/06/17/helsenaeringen-kan-bli-norges-viktigste-naering-i-fremtiden-2/ 2022-06-17T08:09:48+00:00 https://www.lmi.no/2022/06/13/de-siste-plassene-gar-na-meld-deg-pa-fagdagen/ 2022-06-17T10:27:46+00:00 https://www.lmi.no/wp-content/uploads/2022/06/KKBeskjaert.jpg https://www.lmi.no/2022/06/17/hvis-vi-ikke-samarbeider-sa-oppnar-vi-ikke-suksess/ 2022-06-17T11:24:17+00:00 https://www.lmi.no/wp-content/uploads/2022/06/DSCF3510-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3480-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3510-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3527-scaled.jpg https://www.lmi.no/wp-content/uploads/2017/02/portrett_monica2.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3475-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3477-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3492-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3489-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3503-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3517-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3542-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3552-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3557-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3560-scaled.jpg https://www.lmi.no/2022/06/17/regulatorisk-hostmote-2022-hold-av-datoen/ 2022-06-17T18:39:26+00:00 https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/2022/06/20/mandag-avgjor-beslutningsforum-om-400-norske-pasienter-med-lungefibrose-skal-fa-ny-medisin/ 2022-06-20T07:28:41+00:00 https://www.lmi.no/2022/06/20/usa-coronavaksiner-godkjent-for-babyer-ned-til-seks-maneder/ 2022-06-20T07:29:42+00:00 https://www.lmi.no/2022/06/20/legemiddel-mot-fedme-oppsiktsvekkende-gode-resultater/ 2022-06-20T07:32:12+00:00 https://www.lmi.no/2022/06/20/nytt-forskningssenter-far-52-millioner-kroner-for-a-gi-diabetespasienter-mer-presis-diagnose-og-behandling/ 2022-06-20T07:35:58+00:00 https://www.lmi.no/2022/06/20/efpia-dypt-skuffet-over-wtos-avgjorelse-pa-mc12/ 2022-06-20T11:37:54+00:00 https://www.lmi.no/wp-content/uploads/2020/04/Efpia.jpg https://www.lmi.no/2022/06/20/ema-skal-vurdere-tilpasset-versjon-av-koronavaksinen-comirnaty/ 2022-06-20T11:56:52+00:00 https://www.lmi.no/2022/06/17/eu4health-produksjon-av-legemidler-vil-ikke-innga-under-eu-fab-nettverket/ 2022-06-20T12:49:01+00:00 https://www.lmi.no/wp-content/uploads/2019/04/christian-wiediger-735834-unsplash-2.jpg https://www.lmi.no/2022/06/21/dette-ble-konklusjonene-etter-beslutningsforum-sitt-junimote/ 2022-06-21T07:09:08+00:00 https://www.lmi.no/2022/06/21/beslutningsforum-sier-ja-til-livsforlengende-hjertemedisin-etter-tre-avslag/ 2022-06-21T07:12:05+00:00 https://www.lmi.no/2022/06/21/strategien-skal-gi-konkrete-resultater/ 2022-06-21T07:21:43+00:00 https://www.lmi.no/2022/06/21/nordmenn-har-liten-kunnskap-om-tbe-smitte/ 2022-06-21T07:23:26+00:00 https://www.lmi.no/2022/06/21/skal-lage-nye-medisiner-for-a-stoppe-antibiotikaresistente-bakterier/ 2022-06-21T07:31:25+00:00 https://www.lmi.no/2022/06/10/helsenaeringens-verdi-se-lanseringsarrangementet-her/ 2022-06-21T12:58:10+00:00 https://www.lmi.no/wp-content/uploads/2022/06/menon1.jpg https://www.lmi.no/wp-content/uploads/2022/06/menon1.jpg https://www.lmi.no/2022/06/22/dette-er-trendene-for-kunstig-intelligens-i-helse-norge/ 2022-06-22T07:23:38+00:00 https://www.lmi.no/2022/06/22/biologi-i-hoyere-opplosning/ 2022-06-22T07:27:01+00:00 https://www.lmi.no/2022/06/22/345-millioner-til-innovasjon-i-naeringslivet/ 2022-06-22T07:28:52+00:00 https://www.lmi.no/2022/06/22/funn-fra-undersokelse-om-nye-pris-og-betalingsmodeller/ 2022-06-22T11:59:03+00:00 https://www.lmi.no/wp-content/uploads/2022/06/shubham-dhage-pb5w9WU1goA-unsplash-scaled.jpg https://www.lmi.no/2022/06/23/flere-pasienter-skal-fa-sin-sak-vurdert-av-ekspert-panelet/ 2022-06-23T07:03:49+00:00 https://www.lmi.no/2022/06/23/ny-avansert-kolesterolsenkende-medisin-kan-tas-i-bruk-i-norge/ 2022-06-23T07:05:11+00:00 https://www.lmi.no/2022/06/23/targovax-amerikanske-myndigheter-med-godkjennelse-av-kreftvaksine-til-bruk-i-kliniske-studier-i-usa/ 2022-06-23T08:01:52+00:00 https://www.lmi.no/2022/06/23/samarbeid-og-dialog-er-nokkelen-til-innkjopssuksess/ 2022-06-23T11:03:54+00:00 https://www.lmi.no/wp-content/uploads/2022/06/DSC_3371-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSC_3371-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSC_3292-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSC_3255-scaled.jpg https://www.lmi.no/2022/06/23/lmi-og-atrium-arrangerte-cra-kurs-for-forste-gang-pa-mer-enn-ti-ar/ 2022-06-23T13:38:06+00:00 https://www.lmi.no/wp-content/uploads/2022/06/DSCF3585-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/DSCF3585-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/anna-byfuglien-scaled.jpg https://www.lmi.no/2022/06/24/har-studert-lukket-legemiddelsloyfe-ved-sykehuset-ostfold-kalnes/ 2022-06-24T07:06:54+00:00 https://www.lmi.no/2022/06/24/pasientoppropet-overleverte-102-000-underskrifter-til-helseministeren/ 2022-06-24T07:08:03+00:00 https://www.lmi.no/2022/06/24/koronapillen-kommer-snart-til-norge-disse-vil-fa-tilbud/ 2022-06-24T07:09:09+00:00 https://www.lmi.no/2022/06/24/gir-helseregionene-i-oppdrag-a-gjennomga-unntaksordningen/ 2022-06-24T07:11:17+00:00 https://www.lmi.no/2022/06/24/forskere-og-studenter-ved-uio-far-21-millioner-kroner-i-stotte-fra-veksthuset-for-livsvitenskap/ 2022-06-24T07:13:04+00:00 https://www.lmi.no/2022/06/24/koronavaksinen-fra-valneva-er-godkjent-i-europa/ 2022-06-24T07:22:55+00:00 https://www.lmi.no/2022/06/24/tidligere-ungdomspolitiker-bjorn-kristian-svendsrud-gar-til-legemiddelselskapet-sanofi/ 2022-06-24T08:40:06+00:00 https://www.lmi.no/2022/06/24/direktoratet-for-e-helse-vurderer-konsekvenser-av-et-felles-europeisk-helsedataomrade-ehds/ 2022-06-24T09:41:33+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Kliniske-studier-helsedata.jpg https://www.lmi.no/wp-content/uploads/2019/04/DSC_5556.jpg https://www.lmi.no/2022/06/24/om-du-ikke-fikk-med-deg-lmis-statusmote-for-daglig-ledere-kan-du-se-opptaket-her/ 2022-06-24T11:43:32+00:00 https://www.lmi.no/wp-content/uploads/2022/06/Skjermbilde-2022-06-24-134216.png https://www.lmi.no/2022/06/27/anbudspilot-apner-for-at-flere-pasienter-kan-fa-behandling-med-pcsk9-hemmere-pa-bla-resept/ 2022-06-27T07:48:28+00:00 https://www.lmi.no/2022/06/27/kan-bli-konsekvens-av-flystreiken-pasienter-far-ikke-kreftmedisin/ 2022-06-27T07:50:06+00:00 https://www.lmi.no/2022/06/27/slar-alarm-frykter-at-ny-kreftbehandling-bare-blir-for-de-rikeste/ 2022-06-27T07:53:15+00:00 https://www.lmi.no/2022/06/27/norske-targovax-med-fda-godkjenning-i-usa/ 2022-06-27T09:38:30+00:00 https://www.lmi.no/wp-content/uploads/2022/06/IMG_3508-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/IMG_3508-1-scaled.jpg https://www.lmi.no/2022/06/27/innblikk-fra-danmark-og-sverige-pa-alternative-pris-og-betalingslosninger-hold-det-enkelt-og-ha-tett-dialog/ 2022-06-27T09:53:53+00:00 https://www.lmi.no/wp-content/uploads/2022/06/amgros.jpg https://www.lmi.no/wp-content/uploads/2022/06/amgros.jpg https://www.lmi.no/2022/06/27/ledige-utvalgsplasser-innen-enkelte-kompetanseomrader-obs-kort-soknadsfrist-30-juni/ 2022-06-27T10:40:08+00:00 https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/wp-content/uploads/2022/05/tilgjeng4.jpg https://www.lmi.no/wp-content/uploads/2022/05/inno4.jpg https://www.lmi.no/wp-content/uploads/2022/05/naering-endelig.jpg https://www.lmi.no/2022/06/27/regulatorisk-hostmote-2022-hold-av-datoen-2/ 2022-06-27T10:40:16+00:00 https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/2022/06/27/referat-8-juni-2022/ 2022-06-27T11:29:45+00:00 https://www.lmi.no/2022/06/28/flere-pasienter-skal-fa-sin-sak-vurdert-av-ekspertpanelet/ 2022-06-28T07:43:07+00:00 https://www.lmi.no/2022/06/28/ingvild-kjerkol-ap-svarer-bard-hoksrud-frp-om-dansk-modell/ 2022-06-28T09:24:27+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Kjerkol.jpg https://www.lmi.no/wp-content/uploads/2022/06/BAH_full-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/INK_full-scaled.jpg https://www.lmi.no/2022/06/28/pharmaq-analytiq-har-spesialbygget-nye-laboratorier-for-prosessering-av-histopatologiprover/ 2022-06-28T14:01:06+00:00 https://www.lmi.no/wp-content/uploads/2022/06/Analytiq-lab-Oslo-8.jpg https://www.lmi.no/wp-content/uploads/2022/06/Analytiq-lab-Oslo-9.jpg https://www.lmi.no/wp-content/uploads/2022/06/Analytiq-lab-Oslo-8.jpg https://www.lmi.no/2022/06/29/norsk-studie-lynparza-som-monoterapi-er-lovende-mot-trippel-negativ-brystkreft/ 2022-06-29T07:17:24+00:00 https://www.lmi.no/2022/06/29/enhertu-naermere-eu-godkjennelse-mot-metastatisk-brystkreft-i-andre-linje/ 2022-06-29T07:46:33+00:00 https://www.lmi.no/2022/06/29/lege-ber-om-avklaring-i-lys-av-forskningsfunn-om-endetarmskreft/ 2022-06-29T07:52:54+00:00 https://www.lmi.no/2022/06/29/chmp-anbefaler-parp-inhibitor-til-adjuverende-behandling-av-tidlig-brystkreft/ 2022-06-29T07:54:09+00:00 https://www.lmi.no/2022/06/29/ny-malrettet-terapi-mot-sjelden-hematologisk-syndrom-har-god-effekt/ 2022-06-29T07:55:45+00:00 https://www.lmi.no/2022/06/30/nye-legemidler-kan-bli-gode-alternativer-til-fedmeoperasjon/ 2022-06-30T07:16:30+00:00 https://www.lmi.no/2022/06/30/legemiddelgigant-passerte-milliardstreken/ 2022-06-30T07:55:31+00:00 https://www.lmi.no/2022/06/30/meld-deg-pa-spesialistkurs-10-til-11-november/ 2022-06-30T08:55:52+00:00 https://www.lmi.no/wp-content/uploads/2021/02/PP-presentasjon_stock-scaled.jpeg https://www.lmi.no/2022/06/30/horing-koronakommisjonens-rapport-nr-2/ 2022-06-30T09:07:56+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2022/06/30/de-forste-utlysningene-for-ihi-partnerskapet-er-na-publisert/ 2022-06-30T09:15:13+00:00 https://www.lmi.no/wp-content/uploads/2021/06/kliniske-studier-naeringsutvikling-scaled.jpeg https://www.lmi.no/2022/06/30/kontaktmote-med-departementet/ 2022-06-30T09:32:58+00:00 https://www.lmi.no/wp-content/uploads/2022/06/IMG_3592-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/IMG_3592-scaled.jpg https://www.lmi.no/2022/06/30/aesgp-euro-otc-nyhetsbrev-juni-2022/ 2022-06-30T09:54:59+00:00 https://www.lmi.no/wp-content/uploads/2022/03/AESGP.jpg https://www.lmi.no/2022/06/30/lmi-signerer-ny-og-oppdatert-samarbeidsavtale-med-legeforeningen/ 2022-06-30T11:47:30+00:00 https://www.lmi.no/wp-content/uploads/2022/06/IMG_3703-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/IMG_3698-scaled.jpg https://www.lmi.no/wp-content/uploads/2016/08/Lars.jpg https://www.lmi.no/2022/07/01/nordmenn-er-blitt-mye-mer-skeptiske-til-naturmedisin/ 2022-07-01T07:41:25+00:00 https://www.lmi.no/2022/07/01/derfor-hamstrer-kvinner-angrepiller/ 2022-07-01T07:56:17+00:00 https://www.lmi.no/2022/07/01/de-undersoker-hele-landskap-av-bakterier-for-a-finne-resistens/ 2022-07-01T07:58:10+00:00 https://www.lmi.no/2022/07/01/novartis-omorganiserer-og-sier-opp-8-000-ansatte-usikkert-hva-det-betyr-for-novartis-norge/ 2022-07-01T08:04:40+00:00 https://www.lmi.no/2022/07/01/vaksine-mot-apekopper-i-godkjenningsprosess/ 2022-07-01T08:05:52+00:00 https://www.lmi.no/2022/07/01/enorm-okning-i-bruk-av-vitamin-d-tilskudd/ 2022-07-01T08:10:06+00:00 https://www.lmi.no/2022/07/01/ultralyd-og-bobler-hjelper-medisiner-inn-i-hjernen/ 2022-07-01T08:15:49+00:00 https://www.lmi.no/2022/07/01/behov-for-et-nasjonalt-senter-for-krise-pandemi-og-legemiddelberedskap/ 2022-07-01T08:18:09+00:00 https://www.lmi.no/2022/07/01/humbug-i-apotek-vekker-mange-folelser/ 2022-07-01T08:22:41+00:00 https://www.lmi.no/2022/07/01/mattilsynet-overveier-tilsyn-av-helsekost-i-apotek/ 2022-07-01T08:24:26+00:00 https://www.lmi.no/2022/07/01/ultimovacs-fullforer-rekruttering-til-studie-pa-foflekkreft/ 2022-07-01T09:07:33+00:00 https://www.lmi.no/2022/07/04/vi-vil-gjerne-bidra-til-at-utprovende-behandling-kommer-flere-pasienter-til-gode/ 2022-07-04T07:41:04+00:00 https://www.lmi.no/2022/07/04/ingen-endringer-i-lua-listen-i-2022/ 2022-07-04T07:42:07+00:00 https://www.lmi.no/2022/07/04/flere-endringer-pa-helsefeltet-fra-1-juli/ 2022-07-04T07:43:15+00:00 https://www.lmi.no/2022/07/04/hod-vil-se-pa-behovet-for-okt-regulering-av-helprivate-helsetjenester/ 2022-07-04T07:44:28+00:00 https://www.lmi.no/2022/07/04/slik-kan-vi-bremse-neste-epidemi/ 2022-07-04T07:45:56+00:00 https://www.lmi.no/2022/07/04/coronapillen-snart-i-norge-stor-fordel-for-enkelte/ 2022-07-04T07:50:07+00:00 https://www.lmi.no/2022/07/04/na-starter-det-aller-forste-anbudet-pa-blareseptlegemidler/ 2022-07-04T07:50:54+00:00 https://www.lmi.no/2022/07/04/revidert-retningslinje-for-ms-behandling-pa-horing/ 2022-07-04T08:08:53+00:00 https://www.lmi.no/2022/07/04/salgstall-fra-farmastat-for-juni-2022/ 2022-07-04T08:09:23+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2022/07/04/rapport-fra-skandinaviske-summit-2022-hvordan-mote-behovene-til-fremtidens-kreftpasienter-i-skandinavia/ 2022-07-04T12:39:56+00:00 https://www.lmi.no/wp-content/uploads/2022/07/Skjermbilde-2022-07-04-135902.png https://www.lmi.no/wp-content/uploads/2022/07/DSC_3311-scaled.jpg https://www.lmi.no/2022/07/05/melanor-ma-skifte-fokus-fra-a-problematisere-til-a-anerkjenne-ny-helseteknologi/ 2022-07-05T07:28:35+00:00 https://www.lmi.no/2022/07/06/dobling-av-tbe-vaksinering-fra-i-fjor/ 2022-07-06T07:45:08+00:00 https://www.lmi.no/2022/07/06/studie-reiser-sporsmal-om-paracetamol-og-immunterapi/ 2022-07-06T07:46:27+00:00 https://www.lmi.no/2022/07/07/ansattflukt-i-legemiddelverket-lokkes-av-millionlonninger/ 2022-07-07T07:26:32+00:00 https://www.lmi.no/2022/07/07/gratkvalt-nanovector-sjef-vi-gar-ikke-konkurs/ 2022-07-07T08:02:06+00:00 https://www.lmi.no/2022/07/07/legemiddelselskaper-frikjent-for-ansvar-for-opioid-krisen-i-amerikansk-delstat/ 2022-07-07T08:03:03+00:00 https://www.lmi.no/2022/07/07/mer-apenhet-pa-genteknologiomradet/ 2022-07-07T08:04:40+00:00 https://www.lmi.no/2022/07/07/lmi-arrangerte-introduksjonsmote-med-legemiddelindustrien/ 2022-07-07T08:12:08+00:00 https://www.lmi.no/wp-content/uploads/2022/07/monica1.jpg https://www.lmi.no/wp-content/uploads/2022/07/veronica-2-.jpg https://www.lmi.no/wp-content/uploads/2022/07/monica1.jpg https://www.lmi.no/wp-content/uploads/2022/07/hyllin1.jpg https://www.lmi.no/wp-content/uploads/2022/07/Magnus1.jpg https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/2022/07/06/sommerhilsen-fra-karita/ 2022-07-07T08:19:42+00:00 https://www.lmi.no/wp-content/uploads/2022/07/karita-skjermbilde.png https://www.lmi.no/2022/07/07/horingssvar-revidert-retningslinje-for-ms/ 2022-07-07T11:47:44+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2022/07/11/genterapi-det-mest-uetiske-er-kanskje-a-ikke-gjore-noe/ 2022-07-11T08:20:48+00:00 https://www.lmi.no/2022/07/11/trabecta-godkjent-av-ec-til-behandling-av-avansert-nsclc/ 2022-07-11T08:23:29+00:00 https://www.lmi.no/2022/07/11/norsk-tilgang-til-parp-hemmere-ved-brca-negativ-eggstokkreft-sikret-af-dansk-test/ 2022-07-11T08:28:26+00:00 https://www.lmi.no/2022/07/11/tavinlar-mekinist-kombinasjon-far-tidlig-godkjennelse-av-fda/ 2022-07-11T08:30:40+00:00 https://www.lmi.no/2022/07/11/hoy-utskiftning-av-ansatte-i-legemiddelverket-bekymrer-ledelsen-koen-av-legemidler-som-skal-metodervurderes-vokser/ 2022-07-11T10:20:41+00:00 https://www.lmi.no/2022/07/11/gsk-investerer-12-milliarder-pa-forskning-pa-legemidler-mot-sykdommer-i-lavinntektsland/ 2022-07-11T10:29:01+00:00 https://www.lmi.no/wp-content/uploads/2022/07/Malaria_adobe-stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/07/Malaria_adobe-stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2019/04/christian-probst.jpg https://www.lmi.no/2022/07/12/referat-lbu-1-2-2022/ 2022-07-12T13:00:24+00:00 https://www.lmi.no/2022/07/13/a-tilby-helsehjelp-er-ikke-det-samme-som-a-selge-kaffe/ 2022-07-13T08:21:27+00:00 https://www.lmi.no/2022/07/13/kreftrisiko-kan-i-framtiden-vurderes-av-blodprove-og-kunstig-intelligens/ 2022-07-13T08:22:59+00:00 https://www.lmi.no/2022/07/13/private-aktorer-har-en-rolle/ 2022-07-13T08:36:13+00:00 https://www.lmi.no/2022/04/28/kronikk-voksenvaksinasjonsprogram-pa-overtid/ 2022-07-14T09:24:28+00:00 https://www.lmi.no/wp-content/uploads/2022/04/Collage-kronikk-vaksine.jpg https://www.lmi.no/wp-content/uploads/2022/04/kronikk-skjermdump.png https://www.lmi.no/wp-content/uploads/2022/04/Collage-kronikk-vaksine.jpg https://www.lmi.no/2021/02/11/enige-om-voksenvaksinasjonsprogram-men-uenige-om-nar/ 2022-07-14T09:24:39+00:00 https://www.lmi.no/wp-content/uploads/2017/03/Stortinget.jpg https://www.lmi.no/wp-content/uploads/2017/03/Stortinget.jpg https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/2021/01/07/voksenvaksinasjonsprogram-venter-pa-politisk-beslutning/ 2022-07-14T09:24:47+00:00 https://www.lmi.no/wp-content/uploads/2021/01/VV_alle3.jpg https://www.lmi.no/wp-content/uploads/2021/01/VV_alle3.jpg https://www.lmi.no/wp-content/uploads/2021/01/VV_inge-og-per.jpg https://www.lmi.no/2020/04/01/voksenvaksinasjonsprogram-pa-overtid/ 2022-07-14T09:24:59+00:00 https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/2019/12/12/voksenvaksinasjonsprogram-skrider-sakte-frem/ 2022-07-14T09:25:06+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Voksen-f%C3%A5r-vaksine.jpeg https://www.lmi.no/wp-content/uploads/2019/12/Voksen-f%C3%A5r-vaksine.jpeg https://www.lmi.no/wp-content/uploads/2019/02/Inge-Bredde.jpg https://www.lmi.no/2021/01/07/horing-ja-takk-til-sv-forslag-om-vaksinasjonsprogram/ 2022-07-14T09:25:15+00:00 https://www.lmi.no/wp-content/uploads/2021/01/Inge-og-Per_horing.jpg https://www.lmi.no/wp-content/uploads/2021/01/Inge-og-Per_horing.jpg https://www.lmi.no/2020/04/27/produserer-vaksiner-pa-harde-livet/ 2022-07-14T10:32:09+00:00 https://www.lmi.no/wp-content/uploads/2020/04/Ans-Heirman_hjemmekontor_crop.jpg https://www.lmi.no/wp-content/uploads/2020/04/Ans-Heirman_hjemmekontor_crop2.jpg https://www.lmi.no/2019/12/03/helse-og-omsorgskomiteen-har-lagt-frem-sin-innstilling-til-statsbudsjettet-for-2020/ 2022-07-14T10:33:08+00:00 https://www.lmi.no/wp-content/uploads/2016/10/ErlingUlltveit_portrett.jpg https://www.lmi.no/2019/05/10/horing-om-folkehelsemeldingen/ 2022-07-14T10:33:59+00:00 https://www.lmi.no/wp-content/uploads/2019/05/H%C3%B8ring-Stortinget-folkehelse-Inge-og-Elen2.jpg https://www.lmi.no/wp-content/uploads/2019/05/H%C3%B8ring-Stortinget-folkehelse-Inge-og-Elen.jpg https://www.lmi.no/2022/04/28/vaksineutvalgets-innspill-til-folkehelsemeldingen/ 2022-07-14T10:34:22+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2020/10/23/webinar-kampen-om-voksenvaksinasjon/ 2022-07-14T10:45:33+00:00 https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/2020/12/18/kampen-om-voksenvaksinasjon/ 2022-07-14T10:46:02+00:00 https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/2020/10/07/lmi-om-statsbudsjettet-regjeringen-har-truffet-med-det-viktigste-tiltaket-2/ 2022-07-14T10:47:51+00:00 https://www.lmi.no/wp-content/uploads/2020/10/karita_play_0054-scaled.jpg https://www.lmi.no/wp-content/uploads/2020/10/karita_play_0054-scaled.jpg https://www.lmi.no/2020/10/07/statsbudsjettet-38-milliarder-til-covid-19-vaksine/ 2022-07-14T10:48:25+00:00 https://www.lmi.no/wp-content/uploads/2019/02/Inge-Bredde.jpg https://www.lmi.no/wp-content/uploads/2020/09/koronavirusvaksine-scaled.jpeg https://www.lmi.no/wp-content/uploads/2019/02/Inge-Bredde.jpg https://www.lmi.no/2017/06/07/vaksiner-ogsa-forebyggende-helse/ 2022-07-14T10:49:15+00:00 https://www.lmi.no/wp-content/uploads/2016/12/SteffenRistun.jpg https://www.lmi.no/2022/07/14/referat-otc-utvalg/ 2022-07-14T11:32:38+00:00 https://www.lmi.no/2022/07/14/referat-otc-utvalg-04-03-22/ 2022-07-14T11:34:12+00:00 https://www.lmi.no/2022/07/14/referat-otc-utvalg-04-04-22/ 2022-07-14T11:44:09+00:00 https://www.lmi.no/2022/07/14/referat-otc-utvalg-25-05-22/ 2022-07-14T11:45:55+00:00 https://www.lmi.no/2022/07/14/referat-otc-utvalg-21-06-22/ 2022-07-14T11:47:00+00:00 https://www.lmi.no/2022/07/15/fda-gir-gront-lys-til-novavax-vaksinen/ 2022-07-15T08:51:44+00:00 https://www.lmi.no/2022/07/15/eu-anbefaler-fjerde-dose-til-60-aringer-fhi-vurderer-a-folge-etter/ 2022-07-15T08:56:07+00:00 https://www.lmi.no/2022/07/15/systemet-for-nye-metoder-fungerer-ikke-etter-hensikten-ifolge-helsejurist/ 2022-07-15T08:56:40+00:00 https://www.lmi.no/2022/07/15/referat-lbu-22-04-22/ 2022-07-15T10:50:42+00:00 https://www.lmi.no/2022/07/15/referat-lbu-01-06-22/ 2022-07-15T10:52:11+00:00 https://www.lmi.no/2022/07/18/stor-svensk-ms-studie-faerre-attakker-med-rituksimab/ 2022-07-18T08:45:23+00:00 https://www.lmi.no/2022/07/18/kunstig-intelligens-kan-fa-fart-pa-utviklingen-av-legemidler-men-bransjen-mangler-spesialistene/ 2022-07-18T09:01:53+00:00 https://www.lmi.no/2022/07/20/impress-studien-apner-for-blodkreftpasienter/ 2022-07-20T06:23:06+00:00 https://www.lmi.no/2022/07/20/ville-stoppe-betennelse-fant-mate-a-reparere-skader-pa-i-stedet/ 2022-07-20T06:24:44+00:00 https://www.lmi.no/2022/07/21/beslutningsforum-legger-feilaktige-premisser-til-grunn-for-avgjorelsene/ 2022-07-21T08:45:18+00:00 https://www.lmi.no/2022/07/21/skal-teste-blandingsvaksinasjon-mot-covid-19-hos-mennesker-med-og-uten-hiv/ 2022-07-21T08:46:29+00:00 https://www.lmi.no/2022/07/22/mangel-pa-hostemiksturer/ 2022-07-22T08:02:22+00:00 https://www.lmi.no/2022/07/22/ferske-farmasoyter-forteller-kristine-ricaud/ 2022-07-22T08:03:48+00:00 https://www.lmi.no/2022/07/25/legemidlene-vi-bruker-mest/ 2022-07-25T09:54:46+00:00 https://www.lmi.no/2022/07/25/enhertu-med-ny-brystkreftindikasjon-sier-beslutningsforum-ja-denne-gangen/ 2022-07-25T09:56:02+00:00 https://www.lmi.no/2022/07/25/dansk-apekopp-vaksine-er-eu-godkjent/ 2022-07-25T10:58:39+00:00 https://www.lmi.no/2022/07/26/fhi-norge-far-trolig-vaksine-mot-apekopper/ 2022-07-26T08:39:58+00:00 https://www.lmi.no/2022/07/26/blodkreftforeningen-vil-skifte-ut-ledelsen-i-slv/ 2022-07-26T09:18:57+00:00 https://www.lmi.no/wp-content/uploads/2022/07/Blodkreftforeningen-logo.jpg https://www.lmi.no/2022/07/27/norge-far-eu-skryt-for-arbeid-med-legemiddelinformasjon/ 2022-07-27T09:12:45+00:00 https://www.lmi.no/2022/07/28/det-gar-tregt-med-a-gi-eldre-over-75-ar-en-fjerde-dose-koronavaksine/ 2022-07-28T10:52:55+00:00 https://www.lmi.no/2022/07/28/ny-studie-slik-kan-covid-vaksinen-pavirke-mensen/ 2022-07-28T10:57:15+00:00 https://www.lmi.no/2022/07/29/statens-legemiddelverk-kritiseres-for-lange-koer-bor-ringe-noen-bjeller/ 2022-07-29T09:05:30+00:00 https://www.lmi.no/2022/07/29/avtale-apner-for-distribusjon-av-hiv-medisin/ 2022-07-29T09:06:33+00:00 https://www.lmi.no/2022/07/29/forskere-etterlyser-belegg-for-bruk-av-aluminium-i-vaksiner/ 2022-07-29T09:08:24+00:00 https://www.lmi.no/2022/08/01/slvs-prisrevideringsforslag-for-2023/ 2022-08-01T08:24:26+00:00 https://www.lmi.no/wp-content/uploads/2018/10/LOGO-SLV-1.jpg https://www.lmi.no/2022/08/01/salgstall-fra-farmastat-for-juli-2022/ 2022-08-01T12:33:41+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2022/08/03/ema-vurderer-ny-mulig-medisin-mot-covid-19/ 2022-08-03T12:24:36+00:00 https://www.lmi.no/2022/08/03/legemiddelverket-endrer-paracetamol-anbefalinger/ 2022-08-03T12:25:16+00:00 https://www.lmi.no/2022/08/04/klarsignal-for-ny-type-immunterapi-studie-pagar-i-norge/ 2022-08-04T08:03:56+00:00 https://www.lmi.no/2022/08/04/onsker-flere-pasienter-til-impress-studien/ 2022-08-04T08:04:38+00:00 https://www.lmi.no/2022/08/04/insulife-vil-folkefinansiere-studie-pa-insulinspray/ 2022-08-04T08:05:18+00:00 https://www.lmi.no/2022/08/08/helse-bergen-inviterer-til-dialogkonferanse-23-august-2022/ 2022-08-08T11:00:10+00:00 https://www.lmi.no/wp-content/uploads/2022/08/national-cancer-institute-egT3xtDu9DQ-unsplash-scaled.jpg https://www.lmi.no/2022/08/12/navamedic-okte-resultatet-og-inntektene/ 2022-08-12T10:39:44+00:00 https://www.lmi.no/2022/08/12/studier-legemidler-viser-ikke-effekt-mot-mulig-arsak-til-parkinsons-sykdom/ 2022-08-12T10:43:04+00:00 https://www.lmi.no/2022/08/12/ny-studie-kan-ha-kronisk-nyresykdom-uten-a-vite-det/ 2022-08-12T10:48:24+00:00 https://www.lmi.no/2022/08/12/bruker-kunstig-intelligens-som-forutsier-hvordan-tarmkreftceller-reagerer-pa-presisjonsmedisin/ 2022-08-12T10:49:45+00:00 https://www.lmi.no/2022/08/12/enhertu-far-historisk-fda-ja-til-behandling-av-her2-lav-brystkreft/ 2022-08-12T10:50:48+00:00 https://www.lmi.no/2022/08/12/her-vil-ge-healthcare-investere-et-par-milliarder/ 2022-08-12T10:53:05+00:00 https://www.lmi.no/2022/08/15/karita-bekkemellem-blir-administrerende-direktor-i-nho-geneo/ 2022-08-15T09:23:37+00:00 https://www.lmi.no/wp-content/uploads/2022/02/Karita_podkastporrtrett-5-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/02/Karita_podkastporrtrett-5-scaled.jpg https://www.lmi.no/2022/08/15/ett-av-fire-barn-mellom-10-og-12-ar-bruker-smertestillende-tabletter-ukentlig/ 2022-08-15T10:40:37+00:00 https://www.lmi.no/2022/08/15/tilsetningsstoffet-er-na-forbudt-i-mat-men-fortsatt-tillatt-i-paracet-og-ibux/ 2022-08-15T10:43:37+00:00 https://www.lmi.no/2022/08/15/lena-32-blir-kommunikasjonsdirektor-i-nho-geneo/ 2022-08-15T10:45:45+00:00 https://www.lmi.no/2022/08/15/kronikk-vi-ma-satse-der-vi-har-fortrinn/ 2022-08-15T10:47:44+00:00 https://www.lmi.no/wp-content/uploads/2016/11/Forskning.jpg https://www.lmi.no/2022/08/15/kronikk-se-til-helsenaeringen/ 2022-08-15T10:57:10+00:00 https://www.lmi.no/wp-content/uploads/2020/11/karita-play-4-scaled.jpg https://www.lmi.no/2022/08/15/norge-er-som-skapt-for-helsenaering/ 2022-08-15T15:36:42+00:00 https://www.lmi.no/wp-content/uploads/2022/08/helsenaering-mandagauka2022-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/helsenaering-mandagauka2022-scaled.jpg https://www.lmi.no/2022/08/16/fa-ned-tidsbruken-okt-kliniker-og-brukermedvirkning-og-kontinuerlig-arbeid-for-a-forbedre-systemet-for-nye-metoder/ 2022-08-16T09:33:47+00:00 https://www.lmi.no/wp-content/uploads/2022/08/image00001-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/image00001-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/image00047-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/image00023-scaled.jpeg https://www.lmi.no/2022/08/16/politikerne-om-tilgang-pa-legemidler-ma-diskutere-betalingsviljen-krever-innlogging/ 2022-08-16T09:41:48+00:00 https://www.lmi.no/2022/08/16/debatt-om-raskere-tilgang-pa-legemidler-ma-fjerne-tidstyvene-krever-innlogging/ 2022-08-16T09:42:40+00:00 https://www.lmi.no/2022/08/16/beslutningsforum-sjefen-inviterer-til-samarbeid-for-a-innfore-legemidler-raskere/ 2022-08-16T09:43:17+00:00 https://www.lmi.no/2022/08/16/stor-enighet-om-program-for-voksenvaksinasjon-vi-er-utalmodige-krever-innlogging/ 2022-08-16T09:43:59+00:00 https://www.lmi.no/2022/08/16/moderna-vaksine-mot-omikron-godkjent-i-storbritannia/ 2022-08-16T09:44:35+00:00 https://www.lmi.no/2022/08/17/involvering-av-pasienten-for-en-baerekraftig-helsetjeneste-pa-tvers-av-norden/ 2022-08-17T09:31:30+00:00 https://www.lmi.no/wp-content/uploads/2022/08/image00015-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/image00015-scaled.jpeg https://www.lmi.no/2022/08/16/vi-er-ivrige-pa-a-fa-landet-et-voksenvaksinasjonsprogram/ 2022-08-17T10:46:09+00:00 https://www.lmi.no/wp-content/uploads/2022/08/statssekretaer-vaks-2.png https://www.lmi.no/wp-content/uploads/2022/08/statssekretaer-vaks-2.png https://www.lmi.no/2022/08/17/lmi-i-debatt-om-antibiotikaresistens/ 2022-08-17T11:38:45+00:00 https://www.lmi.no/wp-content/uploads/2022/08/SMB-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/SMB-scaled.jpg https://www.lmi.no/2022/08/17/lmi-soker-administrerende-direktor/ 2022-08-17T12:18:49+00:00 https://www.lmi.no/wp-content/uploads/2020/09/scott-graham-5fNmWej4tAA-unsplash-scaled.jpg https://www.lmi.no/2022/08/17/regjeringen-gar-til-angrep-pa-svake-pasienter-og-brukergrupper-et-ideologisk-og-politisk-angrep-vi-ikke-tidligere-har-opplevd-i-norge/ 2022-08-17T12:25:32+00:00 https://www.lmi.no/2022/08/17/ny-menon-rapport-sjeldne-sykdommer-er-sjeldent-dyrt/ 2022-08-17T12:32:56+00:00 https://www.lmi.no/2022/08/17/na-starter-hod-arbeidet-med-a-vurdere-om-det-skal-innfores-en-voksevaksinasjonsprogram/ 2022-08-17T12:33:58+00:00 https://www.lmi.no/2022/08/17/hvordan-kan-verdens-beste-helsevesen-bli-verdens-beste-til-a-ta-i-bruk-innovasjon/ 2022-08-17T12:47:00+00:00 https://www.lmi.no/wp-content/uploads/2022/08/bekeng-arendalsuka-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Radforsk-panel-4-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Radforsk-panel-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Radforsk-panel-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Radforsk-panel-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/BekengArendalsuka-scaled.jpg https://www.lmi.no/2022/08/18/vil-oke-tilliten-til-systemet-for-nye-metoder-leverer-tiltakspakke-til-helseministeren-i-oktober/ 2022-08-18T10:31:28+00:00 https://www.lmi.no/2022/08/18/helseministeren-for-tidlig-a-spekulere-om-hvilke-konsekvenser-nullprofittutvalget-vil-fa-for-private-helseaktorer/ 2022-08-18T10:45:21+00:00 https://www.lmi.no/2022/08/18/vi-ma-stille-sporsmal-om-norge-skal-kreve-legemiddelpriser-pa-niva-med-fattigere-land-i-sor-europa/ 2022-08-18T10:46:56+00:00 https://www.lmi.no/2022/08/18/apotek-kjeder-ma-betale-for-pillemisbruk/ 2022-08-18T10:49:00+00:00 https://www.lmi.no/2022/08/18/lynparza-er-forste-parp-hemmer-godkjent-i-eu-mot-tidlig-brystkreft/ 2022-08-18T10:54:20+00:00 https://www.lmi.no/2022/08/18/nye-data-bekrefter-effekten-av-adjuverende-keytruda-mot-melanom/ 2022-08-18T10:55:52+00:00 https://www.lmi.no/2022/08/18/lmi-i-debatt-om-blarseptanbud-og-migrenebehandlinger/ 2022-08-18T11:47:42+00:00 https://www.lmi.no/wp-content/uploads/2022/08/HE-blaresept-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/HE-blaresept-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/VB_blaresept-scaled.jpg https://www.lmi.no/2022/08/18/industrien-ma-med-for-a-realisere-verdiskaping/ 2022-08-18T12:15:33+00:00 https://www.lmi.no/wp-content/uploads/2022/08/lm-biotek-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/lm-biotek-scaled.jpg https://www.lmi.no/2022/08/19/norge-et-hjem-for-helsenaeringen/ 2022-08-19T08:30:08+00:00 https://www.lmi.no/wp-content/uploads/2022/08/helsenaering-fredag-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/helsenaering-fredag-scaled.jpg https://www.lmi.no/2022/08/19/viktigheten-av-a-oppdage-prostatakreft-tidlig/ 2022-08-19T08:48:41+00:00 https://www.lmi.no/wp-content/uploads/2022/08/image00007-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/image00007-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/image00016-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/Prost3.jpg https://www.lmi.no/2022/08/22/fedme-og-overvekt-hvordan-moter-vi-disse-utfordringene-i-den-nye-folkehelsemeldingen/ 2022-08-22T11:01:07+00:00 https://www.lmi.no/wp-content/uploads/2022/08/IMG_4230-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/IMG_4230-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/IMG_4238-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/IMG_4234-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/IMG_4236-scaled.jpg https://www.lmi.no/2022/08/22/forskningen-ser-mot-private-for-a-lose-finansieringsbehov/ 2022-08-22T11:08:17+00:00 https://www.lmi.no/2022/08/22/slik-kan-norge-blir-et-fyrtarn-for-a-tiltrekke-seg-flere-pasientstudier-og-samtidig-spare-helsevesenet-for-millionbelop/ 2022-08-22T11:09:35+00:00 https://www.lmi.no/2022/08/22/folte-meg-sa-verdilos/ 2022-08-22T11:11:34+00:00 https://www.lmi.no/2022/08/22/arendalsuka-2022-oppsummert/ 2022-08-22T12:57:45+00:00 https://www.lmi.no/wp-content/uploads/2022/08/Arendalsuka-ute-1-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Arendalsuka-ute-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Arendalsuka-ute-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/ARndalsuka-ute-4.jpg https://www.lmi.no/wp-content/uploads/2022/08/Arendalsuka-ute-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Hva-bor-vi-laere-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/Helseindustri-og-globale-markeder_Mandag_KB-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/statssekretaer-vaks-2.png https://www.lmi.no/wp-content/uploads/2022/08/hege-diabetes-arendal.jpg https://www.lmi.no/wp-content/uploads/2022/08/Gi-gass_tirsdag-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Hege-Inven2_tirsdag-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Vondt-i-Hue_tirsdag_Abbvie-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Den-involverte-pasient-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/Sjeldenkoalisjonen_tirsdag.png https://www.lmi.no/wp-content/uploads/2022/08/Hvorfor-krever-norge-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/Sosial-ulikhet-i-helse_onsdag-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/BMS-motet-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Radforskpodden_onsdag-1.jpg https://www.lmi.no/wp-content/uploads/2022/08/BMS-motet-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Alternativebetalingsmodeller_onsdag_VB-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/prostatakreft.jpg https://www.lmi.no/wp-content/uploads/2022/08/image00007-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/Blaresept-ett-ar-etter_onsdag_HE-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Geir-Lippestad-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/steinar-og-co-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Innovasjon-i-bioteknologi_torsdag_ML-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Hvordan-kan-innovasjon_torsdag-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Hva-har-vi-laert-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/08/lungekreft.png https://www.lmi.no/wp-content/uploads/2022/08/Fedmemote-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Fra-forskning-til-prod_torsdag_VB-scaled.jpg https://www.lmi.no/2022/08/24/slv-onsker-svar-pa-sporreundersokelse-om-legemidler-til-barn/ 2022-08-24T07:41:54+00:00 https://www.lmi.no/wp-content/uploads/2017/05/legemidler-til-barn2.jpg https://www.lmi.no/wp-content/uploads/2017/05/legemidler-til-barn2.jpg https://www.lmi.no/2022/08/24/kan-bli-milliardomsetning/ 2022-08-24T09:16:21+00:00 https://www.lmi.no/2022/08/24/er-ydmyk-stolt-og-utrolig-glad/ 2022-08-24T09:19:01+00:00 https://www.lmi.no/2022/08/24/starten-pa-slutten-for-velferds-profitt/ 2022-08-24T09:24:24+00:00 https://www.lmi.no/2022/08/24/insulife-hentet-25-millioner-kroner-over-all-forventning/ 2022-08-24T09:25:42+00:00 https://www.lmi.no/2022/08/24/bor-arbeidsevne-vektlegges-i-metodevurderinger/ 2022-08-24T09:35:46+00:00 https://www.lmi.no/2022/08/24/stortinget-venter-utalmodig-pa-voksenvaksinasjon/ 2022-08-24T09:38:55+00:00 https://www.lmi.no/2022/08/24/apotekene-kan-fa-flere-til-a-ta-koronavaksine/ 2022-08-24T09:40:08+00:00 https://www.lmi.no/2022/08/24/sterk-mistanke-om-juks-i-alzheimers-forskning-tragisk-om-noen-misbruker-tilliten-ved-a-jukse/ 2022-08-24T09:42:12+00:00 https://www.lmi.no/2022/08/25/lmi-radgiver-i-nasjonal-referansegruppe-for-horisont-europa/ 2022-08-25T10:55:18+00:00 https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2019/07/christian-wiediger-735834-unsplash-2.jpg https://www.lmi.no/2022/08/18/juridisk-problematisk-at-kreftpasienter-behandles-som-en-gruppe/ 2022-08-26T09:10:38+00:00 https://www.lmi.no/wp-content/uploads/2022/08/Geir-Lippestad-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Geir-Lippestad-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Pasient-silje-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/steinar-og-co-scaled.jpg https://www.lmi.no/2022/08/16/naeringen-bor-ha-en-storre-rolle/ 2022-08-29T11:19:53+00:00 https://www.lmi.no/wp-content/uploads/2022/08/hege-diabetes-arendal.jpg https://www.lmi.no/wp-content/uploads/2022/08/hege-diabetes-arendal.jpg https://www.lmi.no/2022/08/31/endelig-prisrevurderingsrekkefolge-2023/ 2022-08-31T07:56:22+00:00 https://www.lmi.no/wp-content/uploads/2018/10/LOGO-SLV-1.jpg https://www.lmi.no/2022/08/31/henriette-ellefsen-jovik-forlater-melanor/ 2022-08-31T08:16:19+00:00 https://www.lmi.no/2022/08/31/ett-ar-med-nytt-lakselusmiddel34-millioner-laks-har-sa-langt-blitt-behandlet/ 2022-08-31T08:18:09+00:00 https://www.lmi.no/2022/08/31/det-er-na-mulig-a-soke-om-a-bli-eu-referanselaboratorium-for-in-vitro-diagnostisk-medisinsk-utstyr/ 2022-08-31T08:19:28+00:00 https://www.lmi.no/2022/08/31/studie-18-prosent-reduksjon-av-forverret-hjertesvikt-og-kardiovaskulaer-dod/ 2022-08-31T08:20:39+00:00 https://www.lmi.no/2022/08/31/den-forste-genterapien-for-behandling-av-hemofili-er-godkjent-i-europa/ 2022-08-31T08:22:11+00:00 https://www.lmi.no/2022/08/31/christian-kan-sitte-pa-losningen-for-a-slippe-a-ta-insulinsproyter/ 2022-08-31T08:26:35+00:00 https://www.lmi.no/2022/08/31/svak-nedgang-i-pasientskader/ 2022-08-31T08:59:01+00:00 https://www.lmi.no/2022/08/31/atte-metoder-fikk-ja-til-innforing-i-sykehusene/ 2022-08-31T09:02:48+00:00 https://www.lmi.no/2022/08/31/hold-av-dato-market-access-kurs-2022/ 2022-08-31T09:23:53+00:00 https://www.lmi.no/wp-content/uploads/2021/02/PP-presentasjon_stock-scaled.jpeg https://www.lmi.no/2022/07/08/her-er-de-nye-utvalgene-i-lmi/ 2022-08-31T10:08:21+00:00 https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/wp-content/uploads/2022/02/Karita_podkastporrtrett-5-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/07/LMIs-strategi.png https://www.lmi.no/2022/09/01/nytt-senter-for-forskning-pa-medisinsk-utstyr-i-trondheim/ 2022-09-01T09:51:16+00:00 https://www.lmi.no/2022/09/01/fda-godkjenner-videreutviklede-koronavaksiner-rettet-mot-omikron-varianter/ 2022-09-01T09:52:39+00:00 https://www.lmi.no/2022/09/01/ny-medisin-mot-psoriasis-overlegen/ 2022-09-01T09:53:41+00:00 https://www.lmi.no/2022/09/01/nordre-follo-satser-pa-mer-naeringsvekst-i-arene-fremover/ 2022-09-01T09:56:24+00:00 https://www.lmi.no/2022/09/01/ekspert-kommer-med-klar-vaksineoppfordring/ 2022-09-01T09:59:32+00:00 https://www.lmi.no/2022/09/01/lmis-nye-utvalg-faggrupper-og-prosjektgrupper/ 2022-09-01T10:16:26+00:00 https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/2022/09/01/salgstall-fra-farmastat-for-august-2022/ 2022-09-01T13:42:45+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2022/09/02/bent-hoies-politiske-radgiver-til-lmi/ 2022-09-02T08:25:43+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Thordis-2.jpg https://www.lmi.no/wp-content/uploads/2022/09/Thordis-2.jpg https://www.lmi.no/2022/09/02/vinneren-av-uios-forskningspris-vi-vet-mer-om-coliaki/ 2022-09-02T08:56:58+00:00 https://www.lmi.no/2022/09/02/45-millioner-forskningskroner-til-a-redusere-ulikhet-i-helse/ 2022-09-02T08:58:40+00:00 https://www.lmi.no/2022/09/02/hoyre-gar-til-kamp-mot-overmedisinering/ 2022-09-02T09:00:46+00:00 https://www.lmi.no/2022/09/02/har-undersokt-norsk-oppdrettsfisk-for-uonskede-stoffer/ 2022-09-02T09:02:36+00:00 https://www.lmi.no/2022/09/02/nor-ms-studien-er-fullinkludert/ 2022-09-02T09:03:29+00:00 https://www.lmi.no/2022/09/02/nar-huden-svir-noe-sa-inn-i-h/ 2022-09-02T09:09:03+00:00 https://www.lmi.no/2022/09/02/ema-anbefaler-godkjenning-av-omikronvaksiner/ 2022-09-02T09:14:44+00:00 https://www.lmi.no/2022/09/02/norsk-senter-for-hodepineforskning-apnet-fremdeles-svaert-mange-som-ikke-far-tilstrekkelig-hjelp/ 2022-09-02T09:16:53+00:00 https://www.lmi.no/2022/09/07/jan-petter-55-nektes-medisin-som-andre-pasienter-far/ 2022-09-07T08:58:56+00:00 https://www.lmi.no/2022/09/07/forskning-en-av-to-bruker-medisiner-feil/ 2022-09-07T09:02:43+00:00 https://www.lmi.no/2022/09/07/helsevesenet-er-helt-avhengig-av-at-vi-har-kontroll-pa-kostnadene/ 2022-09-07T09:04:23+00:00 https://www.lmi.no/2022/09/07/alvorlig-hodebry-for-hele-samfunnet/ 2022-09-07T09:07:02+00:00 https://www.lmi.no/2022/09/07/det-handler-om-menneskeliv/ 2022-09-07T09:11:22+00:00 https://www.lmi.no/2022/09/07/meld-deg-pa-hostens-digitale-reklamekurs/ 2022-09-07T11:16:18+00:00 https://www.lmi.no/wp-content/uploads/2022/06/chris-montgomery-smgTvepind4-unsplash-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/reklame-host-22.jpg https://www.lmi.no/2022/08/15/ny-iqvia-rapport-forverring-fra-i-fjor/ 2022-09-08T09:44:45+00:00 https://www.lmi.no/wp-content/uploads/2021/08/KK.png https://www.lmi.no/wp-content/uploads/2022/08/IQVIA-rapport-2022.png https://www.lmi.no/2022/09/08/motereferat-5-september-22/ 2022-09-08T11:37:18+00:00 https://www.lmi.no/2022/09/09/esmo-paris-i-kveld-presenteres-norge-som-studieland/ 2022-09-09T08:16:44+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Paris_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/09/Signe-Oien-Fretland-HIGHRES-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/Catherine-Capdeville3-scaled.jpg https://www.lmi.no/2022/09/09/velkommen-til-regulatorisk-hostmote-2022/ 2022-09-09T08:25:09+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Regulatorisk-hostmote-2022.png https://www.lmi.no/wp-content/uploads/2022/09/Regulatorisk-hostmote-2022.png https://www.lmi.no/2022/09/09/denne-immunterapien-har-flest-godkjenninger-i-beslutningsforum-pa-esmo-kommer-5-ars-overlevelsesdata/ 2022-09-09T08:44:17+00:00 https://www.lmi.no/2022/09/09/en-av-fem-med-hjertesvikt-unngar-forverring-med-nytt-legemiddel/ 2022-09-09T08:44:56+00:00 https://www.lmi.no/2022/09/09/staten-vil-ikke-betale-for-medisinen-henrik-18-trenger-%e2%88%92-ironisk/ 2022-09-09T08:45:34+00:00 https://www.lmi.no/2022/09/12/nortrials-samlet-klinikere-og-industri-under-esmo/ 2022-09-12T08:23:59+00:00 https://www.lmi.no/2022/09/12/slik-skal-vi-fa-flere-legemiddelstudier-til-hele-norge/ 2022-09-12T08:24:36+00:00 https://www.lmi.no/2022/09/12/spetalen-frykter-at-kragero-bedriften-ma-legge-ned-produksjonen-stromregningen-gar-fra-tre-millioner-til-50-millioner/ 2022-09-12T08:25:11+00:00 https://www.lmi.no/2022/09/12/studie-presisjonsmedisin-dobbelt-sa-dyr-som-annen-behandling-av-kreftpasienter-i-siste-fase/ 2022-09-12T08:25:54+00:00 https://www.lmi.no/2022/09/12/impress-studien-over-halvparten-har-fatt-tilbud-om-ny-behandling/ 2022-09-12T08:26:33+00:00 https://www.lmi.no/2022/09/12/astrid-36-har-kreft-med-spredning-hun-far-ikke-ny-medisin-i-tide/ 2022-09-12T08:27:43+00:00 https://www.lmi.no/2022/09/13/undersoker-om-registerdata-kan-bli-kontrollarm-i-kliniske-studier/ 2022-09-13T07:31:55+00:00 https://www.lmi.no/2022/09/13/ny-oppdatert-versjon-av-comirnaty-er-godkjent/ 2022-09-13T07:32:47+00:00 https://www.lmi.no/2022/09/13/dette-er-de-viktigste-lungekreftnyhetene-pa-esmo/ 2022-09-13T07:33:25+00:00 https://www.lmi.no/2022/09/14/flere-etater-ovde-pa-krisesituasjon-pa-ge-healthcare/ 2022-09-14T07:49:12+00:00 https://www.lmi.no/2022/09/14/kristin-fikk-en-ny-hverdag-med-migrenemedisin-tvinges-til-pause-etter-18-maneder/ 2022-09-14T07:49:43+00:00 https://www.lmi.no/2022/09/14/nye-funn-om-kras-rettet-legemiddel-mot-lungekreft/ 2022-09-14T07:50:17+00:00 https://www.lmi.no/2022/09/14/abbvie-blant-europas-beste-arbeidsplasser/ 2022-09-14T10:14:35+00:00 https://www.lmi.no/wp-content/uploads/2020/10/AbbVieHQE_004-scaled.jpg https://www.lmi.no/2022/09/15/ferske-real-world-data-fra-abbvie-pa-atopisk-eksem-krever-innlogging/ 2022-09-15T07:28:52+00:00 https://www.lmi.no/2022/09/15/oppsiktsvekkende-tarmskreftstudie-fikk-applaus-pa-esmo/ 2022-09-15T07:29:34+00:00 https://www.lmi.no/2022/09/15/lmi-i-naeringsdepartementet-om-eksport/ 2022-09-15T08:54:41+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen.jpg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen.jpg https://www.lmi.no/2022/09/15/utlysning-prosjektgruppe-for-legemiddelberedskap/ 2022-09-15T08:55:39+00:00 https://www.lmi.no/wp-content/uploads/2018/03/Pris-p%C3%A5-legemidler_illustrasjon.jpeg https://www.lmi.no/2022/09/16/dette-er-lmis-innspill-til-nasjonal-helse-og-samhandlingsplan/ 2022-09-16T09:01:49+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen.jpg https://www.lmi.no/wp-content/uploads/2020/03/helsepersonell-frivillig-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/2022/09/16/norske-forskere-med-ny-kunnskap-om-parkinson/ 2022-09-16T09:09:11+00:00 https://www.lmi.no/2022/09/16/markant-okning-i-salget-av-blodsukkersenkende-medisiner/ 2022-09-16T09:11:43+00:00 https://www.lmi.no/2022/09/19/statusoppdatering-pa-lmis-arbeid-med-nye-metoder/ 2022-09-19T08:28:16+00:00 https://www.lmi.no/wp-content/uploads/2021/08/KK.png https://www.lmi.no/2022/09/19/folk-strommer-til-apotekene-og-setter-seg-pa-venteliste/ 2022-09-19T08:46:45+00:00 https://www.lmi.no/2022/09/19/ny-kras-hemmer-er-bedre-enn-docetaxel-og-gir-mindre-bivirkninger/ 2022-09-19T08:49:26+00:00 https://www.lmi.no/2022/09/16/regjeringen-3-mrd-i-stromstotte-til-naeringslivet/ 2022-09-19T10:26:47+00:00 https://www.lmi.no/wp-content/uploads/2022/02/jan-christian-vestre-ntb-smk-10-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/02/jan-christian-vestre-ntb-smk-10-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/02/Ole-Erik-Almlid.jpg https://www.lmi.no/2022/09/19/innspill-til-stortingsmelding-om-helseberedskap/ 2022-09-19T10:27:24+00:00 https://www.lmi.no/wp-content/uploads/2018/05/Medisiner.jpeg https://www.lmi.no/2022/09/19/nasjonal-faglig-retningslinje-for-multippel-sklerose-er-revidert/ 2022-09-19T10:44:38+00:00 https://www.lmi.no/wp-content/uploads/2022/09/helsedirektoratet_nyhet.jpg https://www.lmi.no/2022/09/20/norsk-aften-pa-ispor/ 2022-09-20T09:04:21+00:00 https://www.lmi.no/wp-content/uploads/2022/09/ISPOR.png https://www.lmi.no/2022/09/20/aftenposten-slik-forklarer-de-ventetiden-pa-viktig-medisin-lmi-kommenterer/ 2022-09-20T09:49:40+00:00 https://www.lmi.no/wp-content/uploads/2022/03/Image-from-iOS-22-scaled.jpg https://www.lmi.no/2022/09/20/watch-media-lanserer-ny-avis-om-den-norske-helsebransjen/ 2022-09-20T10:24:50+00:00 https://www.lmi.no/wp-content/uploads/2022/09/AG.jpg https://www.lmi.no/wp-content/uploads/2022/09/AG.jpg https://www.lmi.no/2022/09/20/solgte-flere-flasker-pa-en-uke-enn-de-gjor-pa-to-ar/ 2022-09-20T10:26:19+00:00 https://www.lmi.no/2022/09/20/legemiddelprodusenter-ma-betale-mange-titalls-millioner-ekstra-i-strom/ 2022-09-20T11:35:43+00:00 https://www.lmi.no/wp-content/uploads/2020/03/Vistin1.jpg https://www.lmi.no/wp-content/uploads/2020/03/Vistin1.jpg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/wp-content/uploads/2015/06/Bj%C3%B8rn.gif https://www.lmi.no/wp-content/uploads/2020/04/Takeda_fabrikken-Asker-scaled.jpg https://www.lmi.no/2022/09/21/bergensere-fikk-utgatt-covidvaksine/ 2022-09-21T07:45:29+00:00 https://www.lmi.no/2022/09/21/siste-nytt-om-diabetesforskning/ 2022-09-21T07:46:17+00:00 https://www.lmi.no/2022/09/21/gentester-er-avgjorende-for-at-riktig-behandling-kan-gis-til-riktig-pasient/ 2022-09-21T14:06:41+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Gentestn-panel-2_crop.png https://www.lmi.no/wp-content/uploads/2022/09/Gentestn-panel-2_crop.png https://www.lmi.no/wp-content/uploads/2022/09/Gentest-panel-1_crop.png https://www.lmi.no/2022/09/21/medlemsmote-for-daglige-ledere/ 2022-09-21T19:24:34+00:00 https://www.lmi.no/wp-content/uploads/2022/09/medlemsmote.jpg https://www.lmi.no/2022/09/19/meld-deg-pa-produksjonsdagen-2022/ 2022-09-22T08:02:10+00:00 https://www.lmi.no/wp-content/uploads/2022/09/PROD.-DAG-22-Hjemside_arrang-scaled.jpg https://www.lmi.no/2022/09/22/curida-kjoper-legemiddelprodusenten-diatec/ 2022-09-22T13:17:22+00:00 https://www.lmi.no/wp-content/uploads/2020/04/leif-rune-skymoen11.jpg https://www.lmi.no/wp-content/uploads/2017/10/Leif-Rune-front.jpg https://www.lmi.no/2022/09/23/stor-entusiasme-over-tarmkreftfunn-pa-esmo/ 2022-09-23T07:50:52+00:00 https://www.lmi.no/2022/09/23/har-fulgt-diabetes-pasienter-i-44-ar-dette-har-de-laert/ 2022-09-23T07:52:18+00:00 https://www.lmi.no/2022/09/23/referat-8-september-2022/ 2022-09-23T09:59:20+00:00 https://www.lmi.no/2022/09/23/lmi-presenterte-til-bade-helse-og-naeringsministeren-pa-toppledermote/ 2022-09-23T10:33:05+00:00 https://www.lmi.no/wp-content/uploads/2022/09/52376171036_30800826d4_c.jpg https://www.lmi.no/wp-content/uploads/2022/09/52376171036_30800826d4_c.jpg https://www.lmi.no/2022/09/26/en-blodprove-som-avslorer-om-vi-har-risiko-for-demens-er-like-om-hjornet/ 2022-09-26T07:30:45+00:00 https://www.lmi.no/2022/09/26/danmarks-forste-kvantedatamaskin-skal-utvikle-nye-typer-legemidler/ 2022-09-26T07:36:12+00:00 https://www.lmi.no/2022/09/26/en-av-ti-nordmenn-bruker-sovemedisin/ 2022-09-26T07:39:34+00:00 https://www.lmi.no/2022/09/26/na-kommer-de-aller-ferskeste-vaksinene-ogsa-til-norge-raskere-enn-forespeilet/ 2022-09-26T07:42:17+00:00 https://www.lmi.no/2022/09/26/ny-veterinaermedisinforordning-her-er-nyttig-informasjon/ 2022-09-26T07:53:02+00:00 https://www.lmi.no/2022/09/26/omstridt-covid-behandling-bygget-pa-jukse-forskning/ 2022-09-26T08:14:03+00:00 https://www.lmi.no/2022/09/26/legemiddelfirma-mulig-medisin-mot-als-variant/ 2022-09-26T08:22:00+00:00 https://www.lmi.no/2022/09/26/studie-viser-okt-risiko-for-type-1-diabetes-hos-barn-etter-koronainfeksjon/ 2022-09-26T08:25:30+00:00 https://www.lmi.no/2022/09/26/disse-metodene-skal-vurderes-pa-beslutningsforums-septembermote/ 2022-09-26T08:26:25+00:00 https://www.lmi.no/2022/09/26/type-1-gaten-vi-har-ikke-kommet-mye-naermere-en-losning-pa-30-ar/ 2022-09-26T08:27:33+00:00 https://www.lmi.no/2022/09/26/155-millioner-til-forskning-pa-immunterapi/ 2022-09-26T08:29:00+00:00 https://www.lmi.no/2022/09/26/ekstraordinaer-generalforsamling-med-valg-av-suppleringsmedlem-til-styret/ 2022-09-26T10:21:23+00:00 https://www.lmi.no/wp-content/uploads/2022/09/element5-digital-T9CXBZLUvic-unsplash-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/element5-digital-T9CXBZLUvic-unsplash-scaled.jpg https://www.lmi.no/2022/09/27/muskelplager-skyldes-sjelden-statiner/ 2022-09-27T10:56:05+00:00 https://www.lmi.no/2022/09/27/forsker-advarer-mot-populaer-reseptfri-sovemedisin/ 2022-09-27T10:57:43+00:00 https://www.lmi.no/2022/09/27/alternativ-medisin-kan-vise-seg-a-vaere-kur-mot-uhelbredelig-hjertesykdom/ 2022-09-27T10:59:27+00:00 https://www.lmi.no/2022/09/27/sykehusinnkjop-hf-brot-anbudsregler/ 2022-09-27T11:03:34+00:00 https://www.lmi.no/2022/09/27/medisinstart-jeg-har-fatt-stor-respekt-for-kunnskapen-til-farmasoyter/ 2022-09-27T11:06:00+00:00 https://www.lmi.no/2022/09/27/atte-metoder-fikk-ja-i-beslutningsforums-septembermote/ 2022-09-27T11:08:15+00:00 https://www.lmi.no/2022/09/27/ser-dramatisk-okning-av-kreft-blant-voksne-under-50-ar/ 2022-09-27T11:09:23+00:00 https://www.lmi.no/2022/09/27/beslutningsforum-sier-ja-til-brystkreftmedisin-og-seks-andre-legemidler/ 2022-09-27T11:10:47+00:00 https://www.lmi.no/2022/09/27/targovax-har-fatt-klarsignal-for-fase-2-studie/ 2022-09-27T11:12:19+00:00 https://www.lmi.no/2022/09/27/temaavis-om-sjeldne-sykdommer/ 2022-09-27T11:21:40+00:00 https://www.lmi.no/wp-content/uploads/2022/09/hege-presisjonsmedisin.png https://www.lmi.no/wp-content/uploads/2022/09/sjeldne-sykdommer-forside.png https://www.lmi.no/wp-content/uploads/2022/09/hege-presisjonsmedisin.png https://www.lmi.no/2022/09/28/forste-immunterapi-regime-mot-galleveiskreft-godkjent-i-usa/ 2022-09-28T07:02:38+00:00 https://www.lmi.no/2022/09/28/nytt-malrettet-medikament-har-effekt-pa-sjelden-tumor/ 2022-09-28T07:12:49+00:00 https://www.lmi.no/2022/09/28/nye-fase-3-data-pa-kombinasjonsterapi-mot-nyrecellekarsinom/ 2022-09-28T07:38:29+00:00 https://www.lmi.no/2022/09/28/siste-frist-utlysning-prosjektgruppe-om-legemiddelberedskap/ 2022-09-28T09:25:23+00:00 https://www.lmi.no/wp-content/uploads/2018/05/Medisiner.jpeg https://www.lmi.no/2022/09/26/utdatert-konklusjon-pa-studie-om-kost-nytte-av-presisjonsmedisin/ 2022-09-28T11:27:04+00:00 https://www.lmi.no/wp-content/uploads/2022/09/DM-Arena-post-ESMO-2022-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/DM-Arena-post-ESMO-2022-scaled.jpg https://www.lmi.no/2022/09/28/fa-med-deg-helseomsorg21-konferansen-om-fremtidens-helsetjeneste/ 2022-09-28T13:11:05+00:00 https://www.lmi.no/wp-content/uploads/2020/03/helsepersonell-frivillig-scaled.jpeg https://www.lmi.no/2022/09/28/kofa-har-behandlet-to-industriklager/ 2022-09-28T13:53:35+00:00 https://www.lmi.no/wp-content/uploads/2016/08/loverregler_mindre_LMI-lilla-mindre.png https://www.lmi.no/2022/09/28/hvordan-bidrar-ditt-selskap-innen-global-helse/ 2022-09-28T14:18:49+00:00 https://www.lmi.no/wp-content/uploads/2020/08/Glad-afrikans-gutt-1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2018/08/ebolavaksine_adobe.jpeg https://www.lmi.no/wp-content/uploads/2017/04/Baby-f%C3%A5r-vaksine.jpg https://www.lmi.no/wp-content/uploads/2016/11/EbolavaksineWHO.jpg https://www.lmi.no/wp-content/uploads/2020/08/Glad-afrikans-gutt-scaled.jpeg https://www.lmi.no/wp-content/uploads/2016/11/Jente-f%C3%A5r-malariamedisin_Novartis.jpg https://www.lmi.no/2022/09/29/digitalt-medlemsmote-i-nho-geneo/ 2022-09-29T09:23:08+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Karita-og-Ole-Erik.jpg https://www.lmi.no/wp-content/uploads/2022/09/Karita-og-Ole-Erik.jpg https://www.lmi.no/2022/09/29/skandaleartiklene-siteres-arevis-etter-at-de-ble-trukket/ 2022-09-29T09:25:50+00:00 https://www.lmi.no/2022/09/29/onkolog-refser-sykehusinnkjop-og-legemiddelselskap-for-prislekkasje-handtering/ 2022-09-29T09:28:32+00:00 https://www.lmi.no/2022/09/29/ny-studie-sammenheng-mellom-koronavaksine-og-mensenforstyrrelser/ 2022-09-29T09:30:53+00:00 https://www.lmi.no/2022/09/29/ny-forsking-klar-samanheng-mellom-einsemd-og-diabetes-2/ 2022-09-29T09:32:07+00:00 https://www.lmi.no/2022/09/29/melanor-formidler-foresporsel-om-medisinsk-utstyr-til-ukraina/ 2022-09-29T09:41:31+00:00 https://www.lmi.no/2022/09/29/unge-farmasoyter-tilbyr-legemiddelgjennomgang/ 2022-09-29T09:43:39+00:00 https://www.lmi.no/2022/09/29/styrk-sekretariatet-i-nye-metoder/ 2022-09-29T09:47:22+00:00 https://www.lmi.no/2022/09/30/tydelig-tilstede-under-nordic-lifescience-days/ 2022-09-30T08:53:32+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Curida-Skymoen-stand-NLS-Days-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/Curida-Skymoen-stand-NLS-Days-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/Norges-stand-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/Link-scenen-scaled.jpg https://www.lmi.no/2022/09/30/dette-er-nho-geneos-fem-prioriterte-fellesprosjekter/ 2022-09-30T09:50:06+00:00 https://www.lmi.no/2022/09/30/onkolog-refser-sykehusinnkjop-og-legemiddelselskap-for-prislekkasje-handtering-2/ 2022-09-30T09:50:36+00:00 https://www.lmi.no/2022/09/30/studie-mulig-a-produsere-antibiotika-i-norge/ 2022-09-30T09:51:07+00:00 https://www.lmi.no/2022/09/30/industrien-er-klar-til-a-bidra/ 2022-09-30T13:06:14+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen.jpg https://www.lmi.no/wp-content/uploads/2015/08/P%C3%A5-Storo-jobber-det-370-ansatte-innen-blant-annet-forskning-utvikling-og-produksjon..jpg https://www.lmi.no/2022/09/30/drug-safety-forum-utsatt-til-januar/ 2022-09-30T13:19:49+00:00 https://www.lmi.no/wp-content/uploads/2019/05/Legemiddelmangel-apotek.jpeg https://www.lmi.no/wp-content/uploads/2019/05/Legemiddelmangel-apotek.jpeg https://www.lmi.no/2022/10/03/kreftmedisin-kan-lages-i-genspleiset-gjaer/ 2022-10-03T09:52:05+00:00 https://www.lmi.no/2022/10/03/nye-rad-om-legemiddelbehandling/ 2022-10-03T09:52:48+00:00 https://www.lmi.no/2022/10/03/ny-norsk-pasientgruppe-rammes-av-opioid-overdoser/ 2022-10-03T09:53:42+00:00 https://www.lmi.no/2022/10/03/et-samfunn-uten-hjerte/ 2022-10-03T09:54:21+00:00 https://www.lmi.no/2022/10/03/salgstall-fra-farmastat-for-september-2022/ 2022-10-03T10:59:09+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2022/10/03/lmis-innspill-til-nasjonal-e-helsestrategi/ 2022-10-03T11:48:38+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/2022/10/04/sparekniven-svinges-over-fhi/ 2022-10-04T10:29:35+00:00 https://www.lmi.no/2022/10/04/nytt-og-raskt-bivirkningssok-hos-felleskatalogen/ 2022-10-04T11:08:27+00:00 https://www.lmi.no/2022/10/04/videreutvikling-av-nye-metoder-dette-er-arbeidsomradene/ 2022-10-04T11:09:26+00:00 https://www.lmi.no/2022/10/04/husk-regulatorisk-hostmote-19-oktober/ 2022-10-04T11:48:06+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Regulatorisk-hostmote-2022.png https://www.lmi.no/wp-content/uploads/2022/09/Regulatorisk-hostmote-2022.png https://www.lmi.no/2022/10/05/horing-innretning-av-legemiddelberedskapslager-for-primaerhelsetjenesten/ 2022-10-05T07:39:51+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-IKON.png https://www.lmi.no/2022/10/05/oppnevnelse-av-lmis-prosjektgruppe-for-legemiddelberedskap/ 2022-10-05T07:54:18+00:00 https://www.lmi.no/wp-content/uploads/2022/08/octavian-dan-b21Ty33CqVs-unsplash-scaled.jpg https://www.lmi.no/2022/10/05/prislekkasjene-burde-vaert-lost-bedre/ 2022-10-05T08:25:25+00:00 https://www.lmi.no/wp-content/uploads/2021/10/Veronika-LMI-tv.jpg https://www.lmi.no/2022/10/05/sykehusene-endrer-system-for-a-innfore-nye-legemidler-raskere/ 2022-10-05T10:57:00+00:00 https://www.lmi.no/2022/10/05/statsbudsjettet-2023-her-er-helseprofilenes-hap-og-bekymringer/ 2022-10-05T10:57:59+00:00 https://www.lmi.no/2022/10/05/horing-innretning-av-legemiddelberedskapslager-for-primaerhelsetjenesten-2/ 2022-10-05T10:58:42+00:00 https://www.lmi.no/2022/10/05/sylvia-brustad-vil-legge-et-nasjonalt-krise-pandemi-og-beredskapssenter-til-elverum-og-rena/ 2022-10-05T11:00:21+00:00 https://www.lmi.no/2022/10/05/vil-gi-immunterapi-fasttrack-i-beslutningsforum/ 2022-10-05T11:01:11+00:00 https://www.lmi.no/2022/10/06/kjenner-oss-ikke-igjen-i-lmis-beskyldninger/ 2022-10-06T06:26:10+00:00 https://www.lmi.no/2022/10/06/haukeland-ma-snu-pa-hver-pille/ 2022-10-06T06:27:26+00:00 https://www.lmi.no/2022/10/06/haper-pa-snarlig-avklaring-om-norske-retningslinjer/ 2022-10-06T06:28:44+00:00 https://www.lmi.no/2022/10/06/tar-farvel-med-den-tra-disjonelle-selgerrollen/ 2022-10-06T07:08:48+00:00 https://www.lmi.no/2022/10/06/berommer-bevilgning-til-metodevurderinger/ 2022-10-06T11:12:31+00:00 https://www.lmi.no/wp-content/uploads/2022/10/KK-cropped-ny.jpg https://www.lmi.no/wp-content/uploads/2022/10/KK-cropped-ny.jpg https://www.lmi.no/2022/10/06/horing-forskrift-om-nasjonal-losning-for-tilgjengeliggjoring-av-helsedata/ 2022-10-06T12:24:18+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2022/09/21/horing-endringer-i-blareseptforskriften/ 2022-10-06T12:24:59+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2022/10/06/sporreundersokelse-om-merkingsveiledningen/ 2022-10-06T12:33:22+00:00 https://www.lmi.no/wp-content/uploads/2021/07/j-kelly-brito-PeUJyoylfe4-unsplash-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/07/j-kelly-brito-PeUJyoylfe4-unsplash-scaled.jpg https://www.lmi.no/2022/10/06/statsbudsjettet-fra-a-til-a/ 2022-10-06T12:48:50+00:00 https://www.lmi.no/wp-content/uploads/2017/12/HOD-symbol-NETT.jpg https://www.lmi.no/2022/10/07/legemiddelindustrien-vi-er-i-hovedsak-tilfredse-med-arets-statsbudsjett/ 2022-10-07T09:17:30+00:00 https://www.lmi.no/2022/10/07/forbrukertilsynet-arrangerer-webinar-knyttet-til-merking-av-retusjert-reklame/ 2022-10-07T09:19:30+00:00 https://www.lmi.no/wp-content/uploads/2020/02/webinar_adobestock.jpeg https://www.lmi.no/wp-content/uploads/2022/10/retusjert.jpg https://www.lmi.no/2022/10/10/nye-internasjonale-rad-om-diabetesbehandling-publisert/ 2022-10-10T08:24:54+00:00 https://www.lmi.no/2022/10/10/vi-har-gjort-oss-sarbare/ 2022-10-10T08:25:32+00:00 https://www.lmi.no/2022/10/10/takedasjef-lav-betalingsvilje-bremser-tilgang-pa-nye-legemidler/ 2022-10-10T08:26:03+00:00 https://www.lmi.no/2022/10/10/nye-metoder-er-tregt-men-trygt/ 2022-10-10T08:26:39+00:00 https://www.lmi.no/2022/10/06/utlysning-ledige-plasser-i-alle-lmis-faggrupper/ 2022-10-10T11:52:47+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Regulatorisk-faggruppe-2022-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/Regulatorisk-faggruppe-2022-scaled.jpg https://www.lmi.no/2022/10/06/lmi-i-hovedsak-tilfredse-med-arets-statsbudsjett/ 2022-10-10T17:21:39+00:00 https://www.lmi.no/wp-content/uploads/2022/10/forsidebilde-2-statsbudsjett.png https://www.lmi.no/wp-content/uploads/2019/04/Veronika-Barrabes-e1559897653464.jpg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/wp-content/uploads/2022/09/Hege-Edvardsen.jpg https://www.lmi.no/wp-content/uploads/2022/09/Katrine-Bryne.jpg https://www.lmi.no/2022/10/11/bergenbio-varsler-oppstart-av-klinisk-studie/ 2022-10-11T07:53:43+00:00 https://www.lmi.no/2022/10/11/internasjonalt-ai-prosjekt-velger-astrazeneca-som-partner/ 2022-10-11T07:54:18+00:00 https://www.lmi.no/2022/10/11/nytt-fda-ja-til-gsk-vaksine-mot-kikhoste-kan-na-gis-til-gravide/ 2022-10-11T07:54:52+00:00 https://www.lmi.no/2022/10/10/hold-av-datoen-for-strategisamling/ 2022-10-11T09:05:54+00:00 https://www.lmi.no/wp-content/uploads/2022/09/hotell-jeloy-radio.jpg https://www.lmi.no/wp-content/uploads/2022/09/hotell-jeloy-radio.jpg https://www.lmi.no/2022/10/10/meld-deg-pa-norsk-aften-pa-ispor/ 2022-10-11T09:52:41+00:00 https://www.lmi.no/wp-content/uploads/2022/10/BPNO_LMI.jpg https://www.lmi.no/2022/10/11/full-sal-pa-produksjonsdagen/ 2022-10-11T13:51:15+00:00 https://www.lmi.no/wp-content/uploads/2022/10/prod4-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/prod4-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/prod6-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/prod1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/prod5-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/prod8-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/prod3-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/prod7-scaled.jpg https://www.lmi.no/2022/10/11/blogg-slik-kan-nye-prioriteringer-gi-mer-helse-for-pengene/ 2022-10-11T18:54:03+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Veronika-Barrabe%E2%95%A0us_portrett-6_Ba%E2%95%A0erd-Gudim-kvadratisk.jpg https://www.lmi.no/2022/10/12/oppdaterte-retningslinjer-for-pneumokokk-vaksine/ 2022-10-12T08:34:54+00:00 https://www.lmi.no/2022/10/12/gar-mot-kofa-avgjorelse-holder-pa-onkologianbud/ 2022-10-12T08:35:40+00:00 https://www.lmi.no/2022/10/12/msd-overrasket-over-at-kofa-uttalelse-ble-tilsidesatt/ 2022-10-12T08:36:15+00:00 https://www.lmi.no/2022/10/13/astrazeneca-skrinlegger-koronavaksine-i-form-av-nesespray%ef%bf%bc/ 2022-10-13T07:36:29+00:00 https://www.lmi.no/2022/10/14/msd-tar-rhf-ene-til-retten-ber-om-midlertidig-forfoyning/ 2022-10-14T07:40:41+00:00 https://www.lmi.no/2022/10/14/gar-mot-rekordar-for-medisinmangel-urovekkande/ 2022-10-14T07:41:27+00:00 https://www.lmi.no/2022/10/14/beslutningsforum-skal-vurdere-to-car-t-celleterapier-for-behandling-av-lymfekreft-pa-nytt/ 2022-10-14T07:42:02+00:00 https://www.lmi.no/2022/10/14/skjerpede-krav-til-kostnadseffektivitet-kan-oke-prisen-pa-nye-legemidler/ 2022-10-14T07:43:35+00:00 https://www.lmi.no/2022/10/14/farmasoyt-og-vm-vinner-blir-ny-radgiver-i-lmi/ 2022-10-14T08:52:37+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Anne-Margrethe-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/Anne-Margrethe-1-scaled.jpg https://www.lmi.no/2022/10/03/meld-deg-pa-hostens-lov-og-bransjekurs-2/ 2022-10-14T10:30:12+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/wp-content/uploads/2022/06/LB-host-22.jpg https://www.lmi.no/2022/09/30/nasjonale-faglige-rad-for-tryggere-legemiddelbehandling/ 2022-10-17T07:35:09+00:00 https://www.lmi.no/wp-content/uploads/2022/09/forside-legemiddelgjennomgang.png https://www.lmi.no/wp-content/uploads/2022/09/rapport-hdir-forside.png https://www.lmi.no/wp-content/uploads/2022/09/Bente-By-Jansen-scaled.jpg https://www.lmi.no/2022/10/17/lmi-vertskap-for-efpias-nordiske-regulatory-nettverk/ 2022-10-17T08:48:17+00:00 https://www.lmi.no/wp-content/uploads/2022/10/EFPIA-Regulatory-Network-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/EFPIA-regulatory-network_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/EFPIA-Bente.jpg https://www.lmi.no/2022/10/17/internasjonalt-ai-prosjekt-velger-astrazeneca-som-partner-2/ 2022-10-17T10:00:14+00:00 https://www.lmi.no/2022/10/17/norge-er-det-eneste-landet-i-norden-som-ikke-vil-tilby-denne-behandlingen-til-pasienter-med-dodelig-lungesykdom/ 2022-10-17T10:01:20+00:00 https://www.lmi.no/2022/10/17/digitalt-medlemsmote-i-nho-geneo-2/ 2022-10-17T11:01:06+00:00 https://www.lmi.no/wp-content/uploads/2022/10/NHO-Geneo-medl.png https://www.lmi.no/wp-content/uploads/2022/10/NHO-Geneo-medl.png https://www.lmi.no/2022/10/17/norge-har-i-dag-et-todelt-helsevesen/ 2022-10-17T11:39:25+00:00 https://www.lmi.no/wp-content/uploads/2022/10/kb-eu-horing.png https://www.lmi.no/wp-content/uploads/2022/10/kb-eu-horing.png https://www.lmi.no/2022/10/17/lmi-etterspor-handling-for-helsenaering/ 2022-10-17T17:24:21+00:00 https://www.lmi.no/wp-content/uploads/2022/10/HP_horing.png https://www.lmi.no/wp-content/uploads/2022/10/HP_horing.png https://www.lmi.no/2022/10/18/legemiddelpodden-18-hvorfor-har-curida-kjopt-diatec/ 2022-10-18T09:17:26+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Podkast_Curida-og-Diatec-scaled.jpg https://www.lmi.no/2022/10/18/studie-antistoffer-virker-ikke-like-godt-pa-ny-omikron-variant/ 2022-10-18T12:17:28+00:00 https://www.lmi.no/2022/10/18/ti-legemidler-anbefalt-godkjent-i-eu-dette-bor-du-vite-om-dem/ 2022-10-18T12:18:25+00:00 https://www.lmi.no/2022/10/19/norges-eneste-fabrikk-for-smertestillende-sender-ut-permitteringsvarsel-til-alle-ansatte/ 2022-10-19T08:55:32+00:00 https://www.lmi.no/2022/10/19/beslutningsforum-innforer-car-t-behandling-veldig-bra-for-norske-lymfekreftpasienter/ 2022-10-19T08:56:24+00:00 https://www.lmi.no/2022/10/19/staten-snur-etter-kreft-nei-gir-nytt-hap-til-nordmenn/ 2022-10-19T08:57:18+00:00 https://www.lmi.no/2022/10/19/programmet-klart-for-arets-strategisamling/ 2022-10-19T13:58:45+00:00 https://www.lmi.no/wp-content/uploads/2022/09/hotell-jeloy-radio.jpg https://www.lmi.no/wp-content/uploads/2022/09/hotell-jeloy-radio.jpg https://www.lmi.no/2022/10/19/uten-regulatory-folk-ingen-legemidler/ 2022-10-19T20:39:46+00:00 https://www.lmi.no/wp-content/uploads/2022/10/image.png https://www.lmi.no/wp-content/uploads/2022/10/image.png https://www.lmi.no/2022/10/20/janssen-norge-fikk-kofa-medhold-etter-klage-pa-anbud/ 2022-10-20T08:05:43+00:00 https://www.lmi.no/2022/10/20/staten-sier-ja-til-ny-kreft-behandling-vi-har-ventet-altfor-lenge/ 2022-10-20T08:06:47+00:00 https://www.lmi.no/2022/10/20/lmi-med-sesjon-om-helsedata-pa-ehin/ 2022-10-20T08:11:03+00:00 https://www.lmi.no/wp-content/uploads/2018/11/Monica.jpg https://www.lmi.no/2022/10/20/lmi-til-healthtalk-mange-legemidler-star-i-ko-for-a-bli-metodevurdert-det-er-en-urovekkende-utvikling/ 2022-10-20T09:04:52+00:00 https://www.lmi.no/wp-content/uploads/2022/10/kk-video-ht.jpg https://www.lmi.no/wp-content/uploads/2022/10/kk-video-ht.jpg https://www.lmi.no/2022/10/21/lmis-innspill-til-helseberedskapsmeldingen/ 2022-10-21T07:52:47+00:00 https://www.lmi.no/wp-content/uploads/2021/09/Erling-Stortinget.jpg https://www.lmi.no/2022/10/21/onkologitildeling-utsettes-na-er-det-rettslig-prosess/ 2022-10-21T08:07:12+00:00 https://www.lmi.no/2022/10/21/norge-stotter-vaksineproduksjon-pa-det-afrikanske-kontinent/ 2022-10-21T08:08:18+00:00 https://www.lmi.no/2022/10/21/enklere-beslutningsgrunnlag-til-nye-metoder/ 2022-10-21T08:09:23+00:00 https://www.lmi.no/2022/10/24/flere-dor-av-en-overdose-sterke-smertestillende-medisiner/ 2022-10-24T08:41:55+00:00 https://www.lmi.no/2022/10/24/denne-dodelige-sykdommen-kan-utslettes/ 2022-10-24T08:47:05+00:00 https://www.lmi.no/2022/10/24/ny-e-helselab-haper-pa-ringvirkninger-regionalt-og-nasjonalt/ 2022-10-24T08:49:04+00:00 https://www.lmi.no/2022/10/24/stor-mangel-pa-legemidler-i-ar-dette-lageret-kan-hjelpe-oss-ut-av-knipen/ 2022-10-24T09:18:51+00:00 https://www.lmi.no/2022/10/24/regjeringen-avvikler-fritt-behandlingsvalg-tidligst-i-januar-2023/ 2022-10-24T09:20:31+00:00 https://www.lmi.no/2022/10/24/ny-omikron-variant-taler-antistoffer-bedre/ 2022-10-24T09:23:07+00:00 https://www.lmi.no/2022/10/24/eksisterende-legemiddel-far-ny-funksjon-hydroxyurea-viser-potensiale-i-aml/ 2022-10-24T09:25:15+00:00 https://www.lmi.no/2022/10/24/industrien-og-sv-vil-ha-apotekene-med-i-voksenvaksinasjon/ 2022-10-24T09:28:40+00:00 https://www.lmi.no/2022/10/24/dystopisk-om-antibiotika-pa-arendalsuka/ 2022-10-24T09:30:26+00:00 https://www.lmi.no/2022/10/24/rekordinnsamling-for-tv-aksjonen/ 2022-10-24T09:34:26+00:00 https://www.lmi.no/2022/10/24/pakningsvedlegg-pa-papir-har-gatt-ut-pa-dato/ 2022-10-24T09:49:31+00:00 https://www.lmi.no/wp-content/uploads/2021/08/Pakningsvedlegg-1-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2021/08/Pakningsvedlegg-1-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/10/Jordbru-regmote-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/Regulatorisk-hostmote-2022_salen.png https://www.lmi.no/2022/10/21/legemiddepodden-19-industriens-bidrag-i-utviklingsland/ 2022-10-24T12:51:53+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Global-helse-ill-scaled.jpeg https://www.lmi.no/2022/10/21/forutsigbarhet-og-god-dialog-sikrer-best-resultat/ 2022-10-25T08:09:41+00:00 https://www.lmi.no/wp-content/uploads/2022/10/ks-debatt.png https://www.lmi.no/wp-content/uploads/2022/10/ks-debatt-1.png https://www.lmi.no/2022/10/25/trond-mohn-laner-100-millioner-kroner-til-bergenbio/ 2022-10-25T10:16:30+00:00 https://www.lmi.no/2022/10/26/sykehusinnkjop-deler-av-onkologianbudet-utsettes/ 2022-10-26T06:56:16+00:00 https://www.lmi.no/2022/10/26/legemiddelverket-vil-styrke-det-nordiske-samarbeidet-for-a-fa-raskere-godkjenning-av-legemidler/ 2022-10-26T06:58:52+00:00 https://www.lmi.no/2022/10/26/hvordan-setter-direktoratet-for-e-helse-sine-mal/ 2022-10-26T07:01:15+00:00 https://www.lmi.no/2022/10/26/norske-legemiddel-og-helseteknologibedrifter-far-midler-fra-eu/ 2022-10-26T07:05:08+00:00 https://www.lmi.no/2022/10/26/kostnadshopp-gir-underskudd-for-vistin-pharma/ 2022-10-26T07:08:42+00:00 https://www.lmi.no/2022/10/26/slv-tar-grep-for-a-fa-ned-koen-pa-metodevurderinger/ 2022-10-26T08:17:03+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Audun-Haga_Regmote22-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/Audun-Haga_Regmote22-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/Oddvar-Solli_regmote22-scaled.jpg https://www.lmi.no/2022/10/27/apotekenes-rolle-kan-bli-enda-storre/ 2022-10-27T07:46:08+00:00 https://www.lmi.no/2022/10/27/lmi-i-farmatid-apotekenes-rolle-i-fremtidens-helsetjeneste/ 2022-10-27T08:01:07+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Veronika-Barrabe%E2%95%A0us_portrett-6_Ba%E2%95%A0erd-Gudim-kvadratisk.jpg https://www.lmi.no/wp-content/uploads/2022/10/Veronika-Barrabe%E2%95%A0us_portrett-6_Ba%E2%95%A0erd-Gudim-kvadratisk.jpg https://www.lmi.no/wp-content/uploads/2018/11/scanning-apotek2.jpg https://www.lmi.no/2022/10/27/ms-pasienter-responderer-bedre-pa-koronavaksine-enn-tidligere-vist/ 2022-10-27T08:02:16+00:00 https://www.lmi.no/2022/10/27/studie-lav-risiko-for-infeksjonsrelaterte-innleggelser-med-rituksimab/ 2022-10-27T08:04:31+00:00 https://www.lmi.no/2022/10/27/takedas-fabrikkansatte-tar-fagbrev-pa-jobben/ 2022-10-27T08:05:34+00:00 https://www.lmi.no/2022/10/27/basf-verdens-storste-kjemiselskap-nedskalerer-permanent-i-europa/ 2022-10-27T08:07:31+00:00 https://www.lmi.no/2022/10/27/hjertesvikt-ny-forskning-gir-behandlingshap/ 2022-10-27T08:09:06+00:00 https://www.lmi.no/2022/10/27/felleskatalogens-bivirkningssok-nominert-til-ehin-awards-2022/ 2022-10-27T12:46:40+00:00 https://www.lmi.no/wp-content/uploads/2022/02/bente-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/bivirkningssok.png https://www.lmi.no/wp-content/uploads/2022/02/bente-scaled.jpg https://www.lmi.no/2022/10/28/flertall-for-a-fjerne-strengere-regler-for-refusjon-pa-medisin-mot-migrene/ 2022-10-28T07:39:20+00:00 https://www.lmi.no/2022/10/28/beslutningsforum-innforer-enhertu-til-pasienter-med-aggressiv-brystkreft/ 2022-10-28T07:40:17+00:00 https://www.lmi.no/2022/10/28/behandlingen-koster-en-halv-million-ingen-reell-effekt/ 2022-10-28T07:42:56+00:00 https://www.lmi.no/2022/10/28/kan-en-enkel-sproyte-behandle-alvorlig-eksem-hos-sma-barn/ 2022-10-28T07:44:50+00:00 https://www.lmi.no/2022/10/28/skal-oppdage-juks-for-publisering/ 2022-10-28T07:46:35+00:00 https://www.lmi.no/2022/10/28/radiologiprofessor-a-kombinere-kunstig-intelligens-og-genanalyse-er-det-neste-store-innen-kreftdiagnostisering/ 2022-10-28T07:52:04+00:00 https://www.lmi.no/2022/10/28/flere-typer-medisinsk-cannabis-blir-tilgjengelig-i-norge/ 2022-10-28T07:59:04+00:00 https://www.lmi.no/2022/10/28/medlemsoppdatering-om-prislekkasjer-og-onkologianbud/ 2022-10-28T10:30:42+00:00 https://www.lmi.no/wp-content/uploads/2022/10/lmi-firkant-farget.png https://www.lmi.no/2022/10/31/meld-deg-pa-market-access-kurs-2022/ 2022-10-31T08:20:46+00:00 https://www.lmi.no/wp-content/uploads/2022/10/KK-cropped-ny.jpg https://www.lmi.no/wp-content/uploads/2022/10/KK-cropped-ny.jpg https://www.lmi.no/wp-content/uploads/2022/10/Pilar-Martin-Vivaldi_-Market-Access-Manager-i-BMS_.jpg https://www.lmi.no/wp-content/uploads/2022/10/ivar-kristiansen.jpg https://www.lmi.no/wp-content/uploads/2022/10/marie-braadland.jpeg https://www.lmi.no/wp-content/uploads/2022/10/silje-grimseth.jpeg https://www.lmi.no/wp-content/uploads/2018/10/LOGO-SLV.jpg https://www.lmi.no/wp-content/uploads/2020/05/sykehusinnkj%C3%B8p.png https://www.lmi.no/wp-content/uploads/2022/10/bugge-Oslo-E.jpg https://www.lmi.no/wp-content/uploads/2022/10/rhfene.png https://www.lmi.no/2022/10/31/laer-av-de-private-helseaktorene/ 2022-10-31T08:37:15+00:00 https://www.lmi.no/2022/10/31/msd-donerer-utprovende-ebolavaksine-grunnet-utbrudd-i-uganda/ 2022-10-31T08:38:41+00:00 https://www.lmi.no/2022/10/31/marie-far-fortsette-med-kostbar-migrenemedisin/ 2022-10-31T08:40:37+00:00 https://www.lmi.no/2022/10/31/beslutningsforum-innforer-enhertu-til-pasienter-med-aggressiv-brystkreft-2/ 2022-10-31T08:43:05+00:00 https://www.lmi.no/2022/10/31/studie-hoyere-attakkrate-med-rituksimab-enn-okrelizumab/ 2022-10-31T08:44:02+00:00 https://www.lmi.no/2022/11/01/vistin-dobler-produksjonskapasiteten/ 2022-11-01T11:51:31+00:00 https://www.lmi.no/wp-content/uploads/2020/03/Vistin1.jpg https://www.lmi.no/wp-content/uploads/2020/03/Vistin1.jpg https://www.lmi.no/wp-content/uploads/2021/10/vistin-2.jpg https://www.lmi.no/2022/11/01/tidligere-lis-leder-mener-man-bor-ga-tilbake-til-apne-priser-lmi-kommenterer/ 2022-11-01T13:06:40+00:00 https://www.lmi.no/2022/11/01/vestre-viken-lanserer-virtuelt-sykehus/ 2022-11-01T13:24:23+00:00 https://www.lmi.no/wp-content/uploads/2022/11/digitalt-sykehus-ill-vestre-viken2.jpg https://www.lmi.no/wp-content/uploads/2022/11/digitalt-sykehus-ill-vestre-viken2.jpg https://www.lmi.no/wp-content/uploads/2022/11/QR-kode-vestre-viken.png https://www.lmi.no/2022/11/01/salgstall-fra-farmastat-for-oktober-2022/ 2022-11-01T15:03:58+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2022/11/02/hold-av-datoen-drug-safety-forum/ 2022-11-02T14:57:34+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Tar-medisin-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/11/Tar-medisin-scaled.jpeg https://www.lmi.no/2022/11/03/medlemsoppsummering-slv-forsinkelser-og-tidsbruk/ 2022-11-03T08:57:03+00:00 https://www.lmi.no/wp-content/uploads/2022/11/aftenposten-forside-dump.png https://www.lmi.no/wp-content/uploads/2022/11/aftenposten-forside-dump.png https://www.lmi.no/2022/11/03/helseokonomi-for-dummies/ 2022-11-03T10:02:21+00:00 https://www.lmi.no/wp-content/uploads/2022/11/bugge-og-kristiansen.png https://www.lmi.no/wp-content/uploads/2022/11/ivar-sonbo-kristiansen_pc-0219.jpg https://www.lmi.no/wp-content/uploads/2022/10/bugge-Oslo-E.jpg https://www.lmi.no/2022/11/03/slik-fungerer-systemet-for-nye-metoder/ 2022-11-03T10:02:24+00:00 https://www.lmi.no/wp-content/uploads/2022/11/nye-metoder1beskjaert.jpg https://www.lmi.no/wp-content/uploads/2022/11/nye-metoder1beskjaert.jpg https://www.lmi.no/wp-content/uploads/2017/08/SLV-1.png https://www.lmi.no/wp-content/uploads/2020/05/sykehusinnkj%C3%B8p.png https://www.lmi.no/2022/11/03/dra-forums-medlemsmote-og-30-arsjubileum/ 2022-11-03T14:35:30+00:00 https://www.lmi.no/wp-content/uploads/2018/04/legemidler-og-milj%C3%B8.jpeg https://www.lmi.no/wp-content/uploads/2018/04/legemidler-og-milj%C3%B8.jpeg https://www.lmi.no/2022/11/04/helseministeren-vil-ikke-svare-pa-hva-hun-synes-om-hemmelige-priser/ 2022-11-04T09:55:45+00:00 https://www.lmi.no/2022/11/04/lmi-i-kontaktmote-med-helse-og-omsorgsdepartementet/ 2022-11-04T15:01:05+00:00 https://www.lmi.no/wp-content/uploads/2022/11/LMI-foran-HOD-november-2022-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/LMI-foran-HOD-november-2022-scaled.jpg https://www.lmi.no/2022/11/03/legemiddelutvikling-usa-og-kina-rykker-fra-europa/ 2022-11-04T15:11:45+00:00 https://www.lmi.no/wp-content/uploads/2022/11/rogdokning.png https://www.lmi.no/wp-content/uploads/2022/11/rogdokning.png https://www.lmi.no/wp-content/uploads/2022/11/rogde-ansatteokning.png https://www.lmi.no/wp-content/uploads/2022/11/hege-i-koben-scaled.jpg https://www.lmi.no/2022/11/07/mange-har-ingen-anelse-om-risikoforskjellene/ 2022-11-07T10:28:39+00:00 https://www.lmi.no/2022/11/07/ny-medisin-mot-fedme-virket-svaert-godt-pa-unge/ 2022-11-07T10:30:55+00:00 https://www.lmi.no/2022/11/07/ny-angrepille-skal-ta-knerten-pa-kjonnssjukdommar/ 2022-11-07T10:48:04+00:00 https://www.lmi.no/2022/11/07/studie-ny-vaksine-mot-helvetesild-gir-minst-10-ars-beskyttelse/ 2022-11-07T10:50:37+00:00 https://www.lmi.no/2022/11/07/like-farlig-som-antibiotikaresistens/ 2022-11-07T10:52:19+00:00 https://www.lmi.no/2022/11/07/blir-ny-forskningssjef-for-sintef/ 2022-11-07T10:56:21+00:00 https://www.lmi.no/2022/11/07/horing-pasientens-provesvar-i-nasjonal-kjernejournal/ 2022-11-07T10:59:33+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2022/11/07/industriproduksjonen-snur-forsiktig-opp-i-september/ 2022-11-07T11:06:19+00:00 https://www.lmi.no/2022/10/28/presentasjoner-fra-regulatorisk-hostmote-2022/ 2022-11-07T12:50:44+00:00 https://www.lmi.no/wp-content/uploads/2022/10/Regulatorisk-hostmote-2022_salen.png https://www.lmi.no/2022/11/07/tar-statistikk-til-nye-hoyder/ 2022-11-07T14:27:53+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Lars-Meringdal-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Lars-Meringdal-scaled.jpg https://www.lmi.no/2022/11/08/hvorfor-spor-apoteket-om-du-vil-bytte-medisin/ 2022-11-08T10:31:59+00:00 https://www.lmi.no/2022/11/08/vi-tar-e-helseutfordringen/ 2022-11-08T10:36:56+00:00 https://www.lmi.no/2022/11/08/lovende-resultater-for-pasienter-med-kronisk-nyresykdom/ 2022-11-08T10:38:01+00:00 https://www.lmi.no/2022/11/08/fiskehelse-sarskader-er-tredoblet-pa-10-ar/ 2022-11-08T10:39:55+00:00 https://www.lmi.no/2022/11/08/gsk-nadde-ikke-malet-i-blodkreft-studie/ 2022-11-08T10:41:08+00:00 https://www.lmi.no/2022/11/09/rekordvekst-for-dansk-slankemedisin/ 2022-11-09T08:16:54+00:00 https://www.lmi.no/2022/11/09/felleskatalogen-tildelt-ehin-awards-2022/ 2022-11-09T09:58:00+00:00 https://www.lmi.no/wp-content/uploads/2022/11/ehin-awards-2.jpg https://www.lmi.no/2022/11/09/pasientforening-vurderer-soksmal-mot-staten/ 2022-11-09T09:59:06+00:00 https://www.lmi.no/2022/11/09/tomt-for-hostesaft-igjen/ 2022-11-09T10:00:33+00:00 https://www.lmi.no/2022/11/09/etter-ti-ars-kamp-sykepleier-far-erstatning-etter-vaksineskade/ 2022-11-09T10:04:37+00:00 https://www.lmi.no/2022/11/10/mange-nordmenn-klarer-seg-ikke-en-dag-uten-na-er-flere-butikker-tomme/ 2022-11-10T09:36:00+00:00 https://www.lmi.no/2022/11/10/nordic-nanovector-slar-seg-sammen-med-apim-therapeutics/ 2022-11-10T09:36:41+00:00 https://www.lmi.no/2022/11/10/kraftig-okning-i-bruk-av-aknemedisin-slv-advarer/ 2022-11-10T09:37:21+00:00 https://www.lmi.no/2022/11/10/lovende-fase-2b-resultater-for-gsk-medisin-mot-kronisk-hepatitt-b/ 2022-11-10T09:38:05+00:00 https://www.lmi.no/2022/11/10/stortinget-overkjorer-regjeringen-migrenepasienter-skal-ikke-tvinges-til-medisinpause/ 2022-11-10T09:38:50+00:00 https://www.lmi.no/2022/11/10/na-kan-barn-fa-nesespray-vaksine-mot-influensa/ 2022-11-10T09:41:47+00:00 https://www.lmi.no/2022/11/09/tydelige-krav-om-helsedata-pa-ehin/ 2022-11-10T12:27:33+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Camilla-Stoltenberg-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Paneldebatt-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Ambassador-helse-Finland-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Camilla-Stoltenberg-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Finne-scaled.jpg https://www.lmi.no/2022/11/11/koronavaksinen-fra-sanofi-pasteur-er-godkjent-i-europa/ 2022-11-11T08:52:06+00:00 https://www.lmi.no/2022/11/11/kjerkol-mener-stortinget-overstyrer-faglige-vurderinger-av-migrenemedisin-krever-abonnement/ 2022-11-11T09:54:38+00:00 https://www.lmi.no/2022/11/14/leif-rune-skymoen-blir-administrerende-direktor-i-lmi/ 2022-11-14T10:17:51+00:00 https://www.lmi.no/wp-content/uploads/2022/11/leif-rune-skymoen-3.jpg https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen-1-scaled.jpg https://www.lmi.no/2022/11/14/god-deltakelse-pa-norsk-aften-i-wien/ 2022-11-14T10:27:06+00:00 https://www.lmi.no/wp-content/uploads/2022/11/ISPOR-gruppe-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/ISPOR-gruppe-scaled.jpg https://www.lmi.no/2022/11/14/nye-vaksiner-burde-fa-alle-nobelpriser/ 2022-11-14T10:51:27+00:00 https://www.lmi.no/2022/11/14/vinner-av-anbud-for-kolesterolsenkende-legemiddel-er-karet/ 2022-11-14T10:52:13+00:00 https://www.lmi.no/2022/11/14/mange-med-diabetes-type-2-far-ikke-medisiner-som-kan-gjore-dem-friskere/ 2022-11-14T10:53:10+00:00 https://www.lmi.no/2022/11/14/skymoen-ny-lmi-sjef-skal-jobbe-videre-med-kursen-som-allerede-er-staket-ut/ 2022-11-14T12:27:18+00:00 https://www.lmi.no/wp-content/uploads/2020/05/Leif-Rune-hjemmekontor-scaled.jpg https://www.lmi.no/wp-content/uploads/2020/05/Leif-Rune-hjemmekontor-scaled.jpg https://www.lmi.no/2022/11/14/ole-dahlberg-ny-curida-sjef/ 2022-11-14T14:03:42+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Ole-Dahlberg-scaled.jpg https://www.lmi.no/wp-content/uploads/2015/04/Holdt-seminar-for-stortingspolitikere-Dahlberg.jpg https://www.lmi.no/wp-content/uploads/2017/02/Dir.-for-Thermo-Fisher-Monica-M%C3%A6land.gif https://www.lmi.no/wp-content/uploads/2017/11/Thermo-Fisher.gif https://www.lmi.no/wp-content/uploads/2022/11/Ole-Dahlberg-scaled.jpg https://www.lmi.no/2022/11/16/legemiddelindustrien-trapper-opp-tilgangen-i-lav-og-mellominntektsland/ 2022-11-16T09:59:54+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Access-to-medicines-2022_topp-10.png https://www.lmi.no/wp-content/uploads/2022/11/Access-to-medicines-2022_topp-10.png https://www.lmi.no/wp-content/uploads/2022/11/Access-to-medicine_alle.jpg https://www.lmi.no/2022/11/16/5-millioner-til-kreftbehandling/ 2022-11-16T11:06:04+00:00 https://www.lmi.no/2022/11/16/slik-skal-anbudspiloten-evalueres/ 2022-11-16T11:07:01+00:00 https://www.lmi.no/2022/11/16/ny-medisin-pa-bla-resept-viktig-for-pasienter-med-kronisk-nyresykdom/ 2022-11-16T11:08:02+00:00 https://www.lmi.no/2022/11/16/lmi-om-utvidelsen-av-innovasjonsparken-vil-bety-arbeidsplasser-og-eksportinntekter/ 2022-11-16T11:10:51+00:00 https://www.lmi.no/2022/11/17/ge-healthcare-investerer-800-millioner-kroner-i-lindesnes-fabrikken-skaper-100-nye-arbeidsplasser/ 2022-11-17T12:22:51+00:00 https://www.lmi.no/2022/11/18/mote-om-kliniske-studier-og-kontrakter/ 2022-11-18T13:56:05+00:00 https://www.lmi.no/wp-content/uploads/2020/11/Kliniske-studier-i-norge-scaled.jpg https://www.lmi.no/wp-content/uploads/2020/11/Kliniske-studier-i-norge-scaled.jpg https://www.lmi.no/2022/11/21/viser-at-storskala-helseindustri-er-mulig-i-norge/ 2022-11-21T09:15:49+00:00 https://www.lmi.no/wp-content/uploads/2022/11/thomassen-ge.png https://www.lmi.no/2022/11/21/hva-skjedde-med-stamcelle-behandlingen-som-skulle-kurere-alt/ 2022-11-21T09:58:44+00:00 https://www.lmi.no/2022/11/21/sykehus-og-kommuner-vil-samarbeide-med-fhi-om-mini-metodevurdering/ 2022-11-21T10:00:07+00:00 https://www.lmi.no/2022/11/21/ny-behandling-oker-overlevelsen-for-pasienter-med-hjertesvikt/ 2022-11-21T10:02:32+00:00 https://www.lmi.no/2022/11/21/sykehus-og-kommuner-vil-samarbeide-med-fhi-om-mini-metodevurdering-2/ 2022-11-21T10:06:32+00:00 https://www.lmi.no/2022/11/21/ny-als-medisin-kan-gi-ti-maneder-lenger-levetid/ 2022-11-21T10:07:21+00:00 https://www.lmi.no/2022/11/21/stig-ditlefsen-53-betaler-kreftmedisinen-sin-selv/ 2022-11-21T10:08:05+00:00 https://www.lmi.no/2022/11/21/na-skal-fremtiden-for-onkologianbudet-avgjores-lmi-kommenterer/ 2022-11-21T10:08:50+00:00 https://www.lmi.no/2022/11/21/nordic-nanovector-vil-gjennomga-fusjonsforslaget-med-aksjonaerene-krever-abonnement/ 2022-11-21T11:10:00+00:00 https://www.lmi.no/2022/11/21/beslutningsforum-patentutlop-pa-abirateron-gir-handlingsrom/ 2022-11-21T11:10:45+00:00 https://www.lmi.no/2022/11/21/cathrine-thomassen-fra-ge-healthcare-er-nytt-styremedlem/ 2022-11-21T12:12:45+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Cathrine-Thomassen.jpg https://www.lmi.no/wp-content/uploads/2022/11/ge-cathrine-1.png https://www.lmi.no/wp-content/uploads/2022/11/Strategisamling-LR-scaled.jpg https://www.lmi.no/2022/11/21/ny-ceo-i-link-medical/ 2022-11-21T14:15:52+00:00 https://www.lmi.no/2022/11/16/legemiddelpodden-20-svensken-som-reddet-norge-under-pandemien/ 2022-11-22T14:11:05+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Richard-Bergstrom-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Richard-Bergstrom-scaled.jpg https://www.lmi.no/2022/11/22/nortrials-har-fatt-egne-nettsider/ 2022-11-22T15:07:46+00:00 https://www.lmi.no/wp-content/uploads/2022/11/nortrials-nettside.png https://www.lmi.no/wp-content/uploads/2022/11/nortrials-nettside.png https://www.lmi.no/wp-content/uploads/2022/09/Signe-Oien-Fretland-HIGHRES-scaled.jpg https://www.lmi.no/2022/11/23/alzheimermedisin-feiler-i-studier/ 2022-11-23T10:08:17+00:00 https://www.lmi.no/2022/11/23/boehringer-sjef-om-nedbemanning-trist-a-si-farvel-til-sa-mange/ 2022-11-23T10:09:15+00:00 https://www.lmi.no/2022/11/23/eli-lilly-vedgar-behov-for-lavere-insulinpriser/ 2022-11-23T10:10:29+00:00 https://www.lmi.no/2022/11/23/msd-lykkes-med-fase-3-studie-pa-mage-og-spiserorskreft/ 2022-11-23T10:11:35+00:00 https://www.lmi.no/2022/11/24/slv-utlyser-lederstillinger/ 2022-11-24T10:37:34+00:00 https://www.lmi.no/wp-content/uploads/2017/08/SLV-1.png https://www.lmi.no/2022/11/24/livsvitenskapskonferansen-2023-fra-forskning-til-helsenaering/ 2022-11-24T12:51:32+00:00 https://www.lmi.no/wp-content/uploads/2022/11/kollage_1000_farger_2.png https://www.lmi.no/wp-content/uploads/2022/11/kollage_1000_farger_2.png https://www.lmi.no/2022/11/25/rennes-ned-av-pasienter-pa-jakt-etter-medisinen/ 2022-11-25T09:49:00+00:00 https://www.lmi.no/2022/11/25/ny-als-medisin-glenn-skal-do-nytt-hap/ 2022-11-25T09:51:01+00:00 https://www.lmi.no/2022/11/25/slik-bor-anbudspiloten-evalueres/ 2022-11-25T09:52:01+00:00 https://www.lmi.no/2022/11/25/diabetesmedisin-tar-av-som-slankemetode-pa-sosiale-medier-ingen-quick-fix/ 2022-11-25T09:52:50+00:00 https://www.lmi.no/2022/11/25/nordic-nanovector-om-hastemotet-med-aksjonaerene-blir-kjempevanskelig-krever-abonnement/ 2022-11-25T11:13:40+00:00 https://www.lmi.no/2022/11/28/hypotesen-om-at-vaksinen-pavirker-menstruasjonen-er-styrket/ 2022-11-28T08:47:29+00:00 https://www.lmi.no/2022/11/28/den-forste-genterapien-mot-hemofili-b-er-godkjent-i-usa/ 2022-11-28T08:52:39+00:00 https://www.lmi.no/2022/11/28/ny-als-medisin-kan-gi-ti-maneder-lenger-levetid-2/ 2022-11-28T08:54:48+00:00 https://www.lmi.no/2022/11/28/ny-studie-bekrefter-sammenheng-mellom-helvetesild-og-slag/ 2022-11-28T08:55:57+00:00 https://www.lmi.no/2022/11/28/internasjonale-forskere-foreslar-ny-definisjon-av-sykdommen-ms/ 2022-11-28T08:59:27+00:00 https://www.lmi.no/2022/11/28/bakteriegener-i-avforingen-kan-avslore-tidlig-kreft-i-tarmen/ 2022-11-28T09:05:17+00:00 https://www.lmi.no/2022/11/28/lmis-innspill-til-forskrift-om-nasjonal-losning-for-tilgjengeliggjoring-av-helsedata/ 2022-11-28T10:30:35+00:00 https://www.lmi.no/wp-content/uploads/2016/12/helsedata.jpg https://www.lmi.no/2022/11/28/velkommen-til-mote-om-tilgang-til-kritisk-viktige-antibiotika/ 2022-11-28T10:35:38+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Antibtioka-apotek-legemidler-Adobe-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/11/Antibtioka-apotek-legemidler-Adobe-scaled.jpeg https://www.lmi.no/2022/11/29/i-et-okonomisk-perspektiv-burde-jeg-vaert-abortert/ 2022-11-29T09:42:13+00:00 https://www.lmi.no/2022/11/29/skyrizi-godkjent-for-behandling-av-crohns-sykdom/ 2022-11-29T09:56:58+00:00 https://www.lmi.no/2022/11/29/sterk-okning-i-bruk-av-bredspektrede-antibiotika-i-sykehusene/ 2022-11-29T10:00:32+00:00 https://www.lmi.no/2022/11/29/viktige-forskningsfunn-om-delirium/ 2022-11-29T10:02:54+00:00 https://www.lmi.no/2022/11/29/australske-apotekfarmasoyter-skal-rekvirere-medisiner-og-vaksiner/ 2022-11-29T10:07:26+00:00 https://www.lmi.no/2022/11/30/fodsler-forebygger-livmorkreft/ 2022-11-30T08:41:04+00:00 https://www.lmi.no/2022/11/30/immunterapi-godkjent-for-a-behandle-livmorhalskreft/ 2022-11-30T08:45:54+00:00 https://www.lmi.no/2022/11/30/professor-med-klar-vaksineadvarsel-alt-peker-i-en-retning/ 2022-11-30T08:47:15+00:00 https://www.lmi.no/2022/11/30/takedas-dengue-vaksine-hurtigbehandles-av-fda/ 2022-11-30T08:48:29+00:00 https://www.lmi.no/2022/11/30/siw-hadde-13-svulster-i-hjernen-na-har-familien-vunnet-kampen-for-a-fa-medisinen-godkjent/ 2022-11-30T08:49:50+00:00 https://www.lmi.no/2022/11/30/vi-ma-kunne-redde-bade-oss-selv-og-andre/ 2022-11-30T08:52:46+00:00 https://www.lmi.no/2022/11/30/astrazeneca-kjoper-biotek-selskap-med-celleterapi-mot-kreft/ 2022-11-30T08:55:45+00:00 https://www.lmi.no/2022/11/30/roche-trekker-blaerekreft-indikasjon-i-usa/ 2022-11-30T08:56:30+00:00 https://www.lmi.no/2022/11/30/zimbabwe-med-enda-et-viktig-skritt-i-kampen-mot-hiv/ 2022-11-30T08:58:39+00:00 https://www.lmi.no/2022/11/30/gratulerer-med-program-for-voksenvaksinering-sverige/ 2022-11-30T11:08:33+00:00 https://www.lmi.no/2022/11/30/naeringslivet-krever-beredskap-for-neste-krise/ 2022-11-30T12:26:40+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen-beredskapskonferanse.-Foto-Norsk-Industri-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/IMG_5282-kopi-scaled.jpg https://www.lmi.no/2022/12/01/catherine-capdeville-ny-naeringspolitisk-direktor-i-melanor/ 2022-12-01T09:17:28+00:00 https://www.lmi.no/2022/12/01/samarbeid-for-a-hjelpe-oppstartsbedrifter-innen-livsvitenskap/ 2022-12-01T09:19:58+00:00 https://www.lmi.no/2022/12/01/onsker-flere-legemidler-pa-lager/ 2022-12-01T09:22:41+00:00 https://www.lmi.no/2022/12/01/forsker-tror-norge-kan-fa-alzheimers-medisin-i-2023/ 2022-12-01T09:38:01+00:00 https://www.lmi.no/2022/12/01/banebrytende-legemiddel-mot-irritabel-tarm-er-godkjent/ 2022-12-01T09:38:39+00:00 https://www.lmi.no/2022/12/01/positive-data-for-sanofi-medisin-mot-sovesyke/ 2022-12-01T09:39:45+00:00 https://www.lmi.no/2022/12/01/overvektige-sluker-andres-medisin/ 2022-12-01T09:44:50+00:00 https://www.lmi.no/2022/12/02/nodvendig-a-investere-i-medisinsk-utstyr/ 2022-12-02T09:07:11+00:00 https://www.lmi.no/2022/12/02/revidert-merkingsveiledning-for-legemiddelpakninger/ 2022-12-02T09:08:48+00:00 https://www.lmi.no/2022/12/02/onkologianbudet-er-gyldig-en-viktig-kjennelse-for-pasientene/ 2022-12-02T09:11:00+00:00 https://www.lmi.no/2022/12/02/apotekene-utsolgt-for-hormonplaster-i-verste-fall-far-du-overgangsplagene-tilbake/ 2022-12-02T09:17:40+00:00 https://www.lmi.no/2022/12/02/legemiddelberedskap-hoy-risiko-for-at-noe-kan-ga-galt/ 2022-12-02T09:21:33+00:00 https://www.lmi.no/2022/12/02/norge-fremdeles-ikke-signert-avtale-om-legemiddelkriminalitet/ 2022-12-02T09:24:02+00:00 https://www.lmi.no/2022/12/02/faktisk-no-nei-barnedodeligheten-er-ikke-attedoblet-etter-at-vaksinene-ble-rullet-ut/ 2022-12-02T09:30:16+00:00 https://www.lmi.no/2022/12/02/roche-dropper-utvikling-av-alzheimer-kandidat/ 2022-12-02T09:31:37+00:00 https://www.lmi.no/2022/12/02/coronamedisin-snart-tilgjengelig-pa-apotekene/ 2022-12-02T09:46:52+00:00 https://www.lmi.no/2022/12/05/her-lages-livsviktige-medisiner-nar-det-er-krise/ 2022-12-05T08:48:39+00:00 https://www.lmi.no/2022/12/05/kofa-unn-har-ikke-foretatt-ulovlige-anskaffelser/ 2022-12-05T08:49:34+00:00 https://www.lmi.no/2022/12/05/ny-medissin-knekker-kolesterol/ 2022-12-05T08:51:18+00:00 https://www.lmi.no/2022/12/05/forsker-tror-norge-kan-fa-alzheimers-medisin-i-2023-2/ 2022-12-05T08:52:38+00:00 https://www.lmi.no/2022/12/06/felles-budskap-mange-mal/ 2022-12-06T08:38:01+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Leif-Rune-og-Frode-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/Leif-Rune-cluster-innlegg-scaled.jpg https://www.lmi.no/2022/12/06/husk-a-melde-deg-pa-antibiotikamotet-8-desember/ 2022-12-06T11:24:44+00:00 https://www.lmi.no/wp-content/uploads/2022/12/nakstad-troen.png https://www.lmi.no/wp-content/uploads/2022/12/Espen-Rostrup-Nakstad-kred-Helsedirektoratet.jpg https://www.lmi.no/wp-content/uploads/2022/12/Tone-Troen.jpg https://www.lmi.no/wp-content/uploads/2022/12/Truls-Vasvik.jpg https://www.lmi.no/2022/12/06/ma-vi-ha-en-konflikt-om-menneskeverd-og-samfunnsnytte/ 2022-12-06T11:43:28+00:00 https://www.lmi.no/2022/12/01/sykehusinnkjop-fikk-medhold-i-retten/ 2022-12-08T10:34:04+00:00 https://www.lmi.no/wp-content/uploads/2016/08/loverregler_mindre_LMI-lilla-bl%C3%A5.jpg https://www.lmi.no/2022/12/09/bergstrom-tildelt-kongelig-fortenesteorden-av-norge/ 2022-12-09T11:57:12+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Store_-Kjerkol-og-Bergstrom-til-nett.jpg https://www.lmi.no/wp-content/uploads/2022/12/Store_-Kjerkol-og-Bergstrom-til-nett.jpg https://www.lmi.no/2022/12/09/180-dagersfristen-brutt-i-vurdering-av-hjertesvikt-medisin-saken-er-hoyt-prioritert/ 2022-12-09T12:41:30+00:00 https://www.lmi.no/2022/12/09/efpia-med-pa-storsatsing-pa-sjeldne-sykdommer/ 2022-12-09T13:05:46+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Rare-disease-plakat.jpg https://www.lmi.no/wp-content/uploads/2022/12/Rare-disease-plakat.jpg https://www.lmi.no/2022/08/31/siste-dag-i-lmi-for-karita-bekkemellem/ 2022-12-11T20:36:07+00:00 https://www.lmi.no/wp-content/uploads/2020/11/karita-play-4-scaled.jpg https://www.lmi.no/wp-content/uploads/2020/11/karita-play-4-scaled.jpg https://www.lmi.no/2022/12/12/referat-fra-kontaktmote-med-hod-3/ 2022-12-12T09:08:09+00:00 https://www.lmi.no/wp-content/uploads/2022/11/LMI-foran-HOD-november-2022-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/LMI-foran-HOD-november-2022-scaled.jpg https://www.lmi.no/2019/11/21/helseministerens-vaklende-system/ 2022-12-12T09:10:54+00:00 https://www.lmi.no/wp-content/uploads/2019/12/DSC_8459.jpg https://www.lmi.no/2022/12/09/stor-interesse-for-regulatory-og-pharmacovigilance/ 2022-12-12T09:29:39+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Faggruppen-for-regulatory-og-pharmacovigilance-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/Faggruppen-for-regulatory-og-pharmacovigilance-scaled.jpg https://www.lmi.no/2022/12/12/styret-i-nordic-nanovector-gar-av-og-administrerende-direktor-trekker-seg/ 2022-12-12T09:56:46+00:00 https://www.lmi.no/2022/12/12/anne-bee-hegge-farmasoyt-med-full-innsats-etter-innfallsmetoden/ 2022-12-12T09:57:33+00:00 https://www.lmi.no/2022/12/12/dette-er-de-viktigste-terapiformene-pa-hematologikonferanse-i-usa/ 2022-12-12T09:58:30+00:00 https://www.lmi.no/2022/12/12/healthtalk-statens-legemiddelverk-har-brutt-blareseptfristen-pa-viktig-hjertemedisin/ 2022-12-12T09:59:38+00:00 https://www.lmi.no/2022/12/12/nytt-verktoy-skal-hjelpe-leger-med-riktig-forskriving-av-koronamedisin/ 2022-12-12T10:00:32+00:00 https://www.lmi.no/2022/12/12/beslutningsforum-sier-ja-til-fem-nye-behandlinger-forhandlingene-om-sma-legemiddel-fortsetter/ 2022-12-12T11:06:26+00:00 https://www.lmi.no/2022/12/12/arbeidsprogram-2023-for-eu4health-er-klart/ 2022-12-12T11:47:31+00:00 https://www.lmi.no/wp-content/uploads/2022/12/EU4.jpg https://www.lmi.no/wp-content/uploads/2022/12/EU4.jpg https://www.lmi.no/2022/12/12/hege-edvardsen-slutter-i-lmi/ 2022-12-12T14:06:58+00:00 https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/12/hege-edvardsen-scaled.jpg https://www.lmi.no/2022/12/12/jenni-nordborg-ny-sjef-for-internasjonale-relasjoner-i-lif/ 2022-12-12T14:17:49+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Jenni-Nordborg-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/Jenni-Nordborg-scaled.jpg https://www.lmi.no/2022/12/13/hege-edvardsen-forlater-lmi-skal-lede-kreftteam-i-gsk/ 2022-12-13T10:34:27+00:00 https://www.lmi.no/2022/12/13/amgen-skal-kjope-horizon-therapeutics-for-280-milliarder-kroner/ 2022-12-13T10:35:15+00:00 https://www.lmi.no/2022/12/13/jente-13-ble-kurert-for-uhelbredelig-kreft-med-revolusjonerende-metode/ 2022-12-13T10:35:57+00:00 https://www.lmi.no/2022/12/13/vistin-pharma-sikret-seg-langsiktig-stromavtale-gir-mulighet-for-utvikling-og-videre-vekst-krever-abonnement/ 2022-12-13T10:36:46+00:00 https://www.lmi.no/2022/12/13/ema-disse-covid-19-medisinene-kan-ha-null-effekt-mot-nye-varianter-av-viruset/ 2022-12-13T10:44:34+00:00 https://www.lmi.no/2022/12/13/apner-for-alternativ-prisavtale-for-sma-medisiner/ 2022-12-13T10:45:23+00:00 https://www.lmi.no/2022/12/13/begynner-a-ga-tomme-for-penicillin-mikstur-etter-bakterieutbrudd/ 2022-12-13T11:49:52+00:00 https://www.lmi.no/2022/12/14/diskuterte-naering-og-beredskap-i-porsgrunn/ 2022-12-14T08:18:24+00:00 https://www.lmi.no/wp-content/uploads/2022/12/porsgunnmote.jpg https://www.lmi.no/wp-content/uploads/2022/12/porsgunnmote.jpg https://www.lmi.no/2022/12/14/modernas-mrna-vaksine-og-msds-keytruda-reduserte-floflekkreft-tilbakefall-med-44-prosent/ 2022-12-14T11:00:50+00:00 https://www.lmi.no/2022/12/14/dyr-og-avansert-kreftpille-er-mer-kostnadseffektiv-enn-billig-kjemoterapi/ 2022-12-14T11:01:37+00:00 https://www.lmi.no/2022/12/14/vi-ma-samarbeid-om-miljokrav/ 2022-12-14T11:41:01+00:00 https://www.lmi.no/wp-content/uploads/2021/01/karoline-knutsen.jpg https://www.lmi.no/2022/12/14/lmi-fronter-helseindustrisatsing/ 2022-12-14T13:09:57+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Veronika-oppsummerer-styrem%C3%B8te-2.-desember.png https://www.lmi.no/wp-content/uploads/2019/12/Veronika-oppsummerer-styrem%C3%B8te-2.-desember.png https://www.lmi.no/2022/12/14/okt-industrisamarbeid-ved-st-olavs-hospital/ 2022-12-14T13:11:04+00:00 https://www.lmi.no/wp-content/uploads/2022/12/skjermdum-fra-stolav-video.png https://www.lmi.no/2022/12/15/velkommen-til-drug-safety-forum-2023/ 2022-12-15T08:37:12+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Tar-medisin-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/11/Tar-medisin-scaled.jpeg https://www.lmi.no/2022/12/15/ny-innsikt-i-hvordan-utbredt-adhd-medisin-fungerer-i-hjernen-til-barn/ 2022-12-15T08:58:01+00:00 https://www.lmi.no/2022/12/15/grundere-vil-bekjempe-alvorlig-kreftsykdom-med-ny-nanomedisin/ 2022-12-15T08:58:58+00:00 https://www.lmi.no/2022/12/15/dette-regnes-som-en-revolusjon/ 2022-12-15T09:01:49+00:00 https://www.lmi.no/2022/12/15/metodevurdering-slv-har-halvert-koen-siden-juni/ 2022-12-15T09:02:48+00:00 https://www.lmi.no/2022/12/15/ge-healthcare-inngar-langtidsavtale-med-statkraft/ 2022-12-15T09:03:35+00:00 https://www.lmi.no/2022/12/15/targovax-starter-samarbeid-med-agenus-for-a-teste-vaksine-mot-bukspyttkjertelkreft/ 2022-12-15T09:04:35+00:00 https://www.lmi.no/2022/12/19/pillen-skulle-bli-redningen-titusenvis-kan-ikke-bruke-den/ 2022-12-19T08:36:32+00:00 https://www.lmi.no/2022/12/19/godkjenning-av-kreftlegemiddel-ble-tre-ar-forsinket/ 2022-12-19T08:38:28+00:00 https://www.lmi.no/2022/12/19/lege-bekymra-for-penicillinmangel-mener-vi-bor-gjore-som-sverige/ 2022-12-19T08:39:25+00:00 https://www.lmi.no/2022/12/19/kunstig-intelligens-som-kan-skrive-kode-imponerer-i-konkurranse/ 2022-12-19T08:42:22+00:00 https://www.lmi.no/2022/12/19/trodde-du-norske-apotek-var-pa-norske-hender/ 2022-12-19T08:48:06+00:00 https://www.lmi.no/2022/12/19/smertemedisin-ulovlig-markedsfort-felleskatalogen-kommenterer/ 2022-12-19T09:12:44+00:00 https://www.lmi.no/2022/12/19/en-moteplass-som-bygger-tillitt-og-forstaelse/ 2022-12-19T09:18:03+00:00 https://www.lmi.no/wp-content/uploads/2022/12/access-kurs-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/access-kurs-scaled.jpg https://www.lmi.no/2022/12/20/lmi-padriver-for-helseindustriinnspill/ 2022-12-20T08:52:53+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/wp-content/uploads/2022/12/Skjermbilde_20221220_095101.png https://www.lmi.no/2022/12/20/210-000-har-tatt-influensavaksinen-i-apotek/ 2022-12-20T09:34:49+00:00 https://www.lmi.no/2022/12/20/vil-lage-smittesporingsprogram-for-antibiotikaresistens/ 2022-12-20T09:37:54+00:00 https://www.lmi.no/2022/12/20/psoriasislegemiddel-med-effekt-pa-svettekjertelbetennelse/ 2022-12-20T09:41:24+00:00 https://www.lmi.no/2022/12/20/astrazenecas-imfinzi-nadde-ikke-opp-i-fase-3-studie-pa-lungekreft/ 2022-12-20T09:46:02+00:00 https://www.lmi.no/2022/12/20/st-olavs-hospital-bekymret-for-krevende-arbeidssituasjon/ 2022-12-20T09:46:29+00:00 https://www.lmi.no/2022/12/20/litt-faerre-laks-vaksinert-i-november/ 2022-12-20T09:49:21+00:00 https://www.lmi.no/2022/12/20/stor-ettersporsel-etter-kursing-i-fiskehelse/ 2022-12-20T09:50:14+00:00 https://www.lmi.no/2022/12/20/medlemsmote-utvalgspresentasjon/ 2022-12-20T12:26:54+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Teams-mote.png https://www.lmi.no/wp-content/uploads/2022/12/Teams-mote.png https://www.lmi.no/2022/12/21/legene-slo-alarm-om-sykehusmonopol-men-private-kunne-ha-forskrevet-medisinen/ 2022-12-21T08:29:17+00:00 https://www.lmi.no/2022/12/21/norge-rigger-seg-for-a-fa-eu-penger-til-a-bekjempe-kreft/ 2022-12-21T08:37:19+00:00 https://www.lmi.no/2022/12/21/ny-antistoffbehandling-til-immun-trombocytopeni-kan-vaere-pa-vei/ 2022-12-21T08:56:03+00:00 https://www.lmi.no/2022/12/21/oker-egenandelene-du-betaler-pa-apoteket-medisinene-blir-dyrere-fra-nyttar/ 2022-12-21T08:58:13+00:00 https://www.lmi.no/2022/12/21/rsv-vaksine-like-rundt-hjornet/ 2022-12-21T09:02:14+00:00 https://www.lmi.no/2022/12/21/horingssvar-legemiddelberedskapslager-for-primaerhelsetjenesten/ 2022-12-21T11:16:10+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2022/12/21/ultimovacs-bytter-ut-sjekkpunkthemmer-i-lungekreftstudie-etter-beslutningsforum-vedtak/ 2022-12-21T11:17:29+00:00 https://www.lmi.no/2022/12/21/selskapene-solgte-livreddende-medisin-for-milliarder-staten-mener-selskapenes-pris-er-for-hoy/ 2022-12-21T11:22:54+00:00 https://www.lmi.no/2022/12/21/vaksinerad-er-helse/ 2022-12-21T11:24:40+00:00 https://www.lmi.no/2022/12/21/horingssvar-forslag-til-plan-for-digitalisering-pa-legemiddelomradet-2023-2026/ 2022-12-21T14:47:45+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2022/12/22/pa-tide-a-tenke-nytt-om-alzheimers-sykdom/ 2022-12-22T08:43:27+00:00 https://www.lmi.no/2022/12/22/nortrials-hjertesenter-i-gang-pa-ahus/ 2022-12-22T08:44:52+00:00 https://www.lmi.no/2022/12/22/apoteket-overtar-koronavaksineringen-for-kommunen/ 2022-12-22T08:49:29+00:00 https://www.lmi.no/2022/12/22/legemiddelsok-manglende-og-eller-utdaterte-preparatomtaler-for-sentralt-godkjente-veterinaere-legemidler/ 2022-12-22T08:51:31+00:00 https://www.lmi.no/2022/12/22/julebrev-2022-aret-som-har-gatt/ 2022-12-22T08:52:02+00:00 https://www.lmi.no/wp-content/uploads/2022/12/julebrev-forside-2022.png https://www.lmi.no/wp-content/uploads/2022/12/julebrev-forside-2022.png https://www.lmi.no/wp-content/uploads/2022/02/Karita_podkastporrtrett-5-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen_portrett-halvnaert-scaled.jpg https://www.lmi.no/2022/12/22/brukere-av-billige-legemidler-kan-fa-okte-utgifter-fra-arsskifte/ 2022-12-22T08:53:43+00:00 https://www.lmi.no/2022/12/22/norge-knyttes-til-eu-losning-for-helseinformasjon/ 2022-12-22T08:55:25+00:00 https://www.lmi.no/2022/12/22/immunterapi-oker-overlevelsen-ved-avansert-eller-tilbakevendende-livmorkreft/ 2022-12-22T08:56:31+00:00 https://www.lmi.no/2022/12/22/pfizer-kjoper-rsv-kandidat-fra-kinesisk-selskap/ 2022-12-22T09:01:18+00:00 https://www.lmi.no/2022/12/22/jacob-lund-blir-global-pressesjef-i-astrazeneca/ 2022-12-22T09:06:11+00:00 https://www.lmi.no/2022/12/22/ny-medisinsk-direktor-i-direktoratet-for-e-helse/ 2022-12-22T09:08:20+00:00 https://www.lmi.no/2022/12/22/monica-larsen-diskuterte-eksport-pa-stortinget/ 2022-12-22T10:57:03+00:00 https://www.lmi.no/wp-content/uploads/2017/03/Stortinget.jpg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen.jpg https://www.lmi.no/2023/01/02/ny-slankemedisin-i-norge-revolusjonerende-krever-abonnement/ 2023-01-02T08:52:25+00:00 https://www.lmi.no/2023/01/02/malrettet-radioaktivt-legemiddel-godkjent-i-eu/ 2023-01-02T08:53:07+00:00 https://www.lmi.no/2022/12/02/salgstall-fra-farmastat-for-november-2022/ 2023-01-03T08:31:09+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/01/03/salgstall-fra-farmastat-for-desember-2022/ 2023-01-03T08:34:41+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/01/03/farmasoyt-blir-omradedirektor-i-forskningsradet/ 2023-01-03T10:32:17+00:00 https://www.lmi.no/2023/01/03/mirakelmedisin-tilgjengelig-i-norge-loser-pa-ingen-mate-problemet/ 2023-01-03T10:33:39+00:00 https://www.lmi.no/2023/01/03/to-nye-radgivere-pa-plass-i-lmi/ 2023-01-03T14:57:35+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Hausken-og-Haugen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Hausken-og-Haugen-scaled.jpg https://www.lmi.no/2023/01/04/thermo-fisher-lanserer-norsk-utviklet-instrument-for-celleterapi/ 2023-01-04T08:04:06+00:00 https://www.lmi.no/wp-content/uploads/2023/01/dynacollect1.jpg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/2023/01/04/north-energy-kapitulerte-ag-nanovector-valgte-nytt-styre-i-nordic-nanovector/ 2023-01-04T11:04:21+00:00 https://www.lmi.no/2023/01/05/vi-ma-bli-mer-selvforsynt-enn-vi-er-i-dag/ 2023-01-05T08:59:54+00:00 https://www.lmi.no/wp-content/uploads/2023/01/skymoen-nho-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/skymoen-nho-scaled.jpg https://www.lmi.no/2023/01/05/sa-mye-brukte-staten-pa-nye-migrenemedisiner-i-2022/ 2023-01-05T10:13:37+00:00 https://www.lmi.no/2023/01/05/rektoratbloggen-fra-forskning-til-helsenaering/ 2023-01-05T10:13:59+00:00 https://www.lmi.no/2023/01/06/omsetningen-i-industrien-oker/ 2023-01-06T10:14:18+00:00 https://www.lmi.no/2023/01/06/leger-kan-skrive-ut-slankemedisin-til-barn/ 2023-01-06T10:16:03+00:00 https://www.lmi.no/2023/01/06/aleris-dr-dropin-og-volvat-melder-seg-inn-i-nho-geneo/ 2023-01-06T10:17:14+00:00 https://www.lmi.no/2023/01/06/frp-hoksrud-om-cgrp-hemmere-innstramningene-var-urimelige/ 2023-01-06T10:18:08+00:00 https://www.lmi.no/2023/01/06/ge-healthcare-er-na-pa-borsen/ 2023-01-06T10:18:57+00:00 https://www.lmi.no/2023/01/06/hubro-henter-finansdirektor-fra-thermo-fisher/ 2023-01-06T10:21:08+00:00 https://www.lmi.no/2023/01/06/barrabes-hemmelige-priser-er-vinn-eller-forsvinn-for-mange-selskaper-krever-abonnement/ 2023-01-06T11:48:07+00:00 https://www.lmi.no/2023/01/06/medlemsmote-utvalgspresentasjon-2/ 2023-01-06T13:51:39+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Teams-mote.png https://www.lmi.no/2023/01/06/hun-leder-na-et-selvstendig-ge-healthcare-jeg-er-veldig-glad-i-bedriften-min/ 2023-01-06T14:10:58+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Cathrine-Thomassen_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Dreamteam-1-scaled.jpg https://www.lmi.no/2023/01/06/legeforeningen-inviterte-til-debatt-om-konfidensielle-priser/ 2023-01-09T07:51:50+00:00 https://www.lmi.no/wp-content/uploads/2023/01/panel-pris-legenes-hus-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/panel-pris-legenes-hus_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/veronika-pris-legenes-hus-scaled.jpg https://www.lmi.no/2023/01/09/mee-eline-41-blir-fagdirektor-i-helse-og-velferdsbransjen/ 2023-01-09T08:40:04+00:00 https://www.lmi.no/2023/01/09/fda-vil-hurtigbehandle-roche-sitt-bispesifikke-antistoff-glofitamab/ 2023-01-09T08:57:15+00:00 https://www.lmi.no/2023/01/09/godkjenner-verdens-forste-vaksine-for-honningbier/ 2023-01-09T09:04:17+00:00 https://www.lmi.no/2023/01/09/ny-alzheimer-medisin-gir-hap/ 2023-01-09T09:10:07+00:00 https://www.lmi.no/2023/01/09/uenighet-om-hemmelige-priser-apenhet-gir-ikke-billigere-legemidler/ 2023-01-09T09:13:26+00:00 https://www.lmi.no/2023/01/09/medikamentene-gjor-mer-skade-enn-nytte/ 2023-01-09T09:16:54+00:00 https://www.lmi.no/2023/01/06/sykehusinnkjop-vil-ta-konkrete-grep-for-a-sikre-konfidensialitet-av-legemiddelpriser/ 2023-01-09T09:59:57+00:00 https://www.lmi.no/wp-content/uploads/2020/06/logo-sykehusinnkj%C3%B8p.jpg https://www.lmi.no/wp-content/uploads/2016/11/BenteHayes.jpg https://www.lmi.no/2023/01/09/fhi-gratis-vaksine-kunne-ha-fort-til-faerre-innleggelser/ 2023-01-09T10:21:48+00:00 https://www.lmi.no/2023/01/10/uhelbredelig-kreft-fjernet-med-revolusjonerende-ny-crispr-metode/ 2023-01-10T08:41:38+00:00 https://www.lmi.no/2023/01/10/abbvie-og-immunome-inngar-strategisk-samarbeid-skal-finne-nye-kreftmal/ 2023-01-10T08:46:49+00:00 https://www.lmi.no/2023/01/10/astrazeneca-kjoper-biotek-selskap-for-opp-mot-18-milliarder-kroner-for-a-sikre-seg-hjertemedisin/ 2023-01-10T08:53:18+00:00 https://www.lmi.no/2023/01/10/1923-aret-da-banting-fikk-nobelprisen-og-forste-nordmann-fikk-insulin/ 2023-01-10T09:58:24+00:00 https://www.lmi.no/2023/01/11/andreas-forsker-pa-omstridt-depresjonsbehandling-den-forste-randomiserte-studien-i-norge/ 2023-01-11T08:23:11+00:00 https://www.lmi.no/2023/01/11/overlege-om-nye-data-pa-medisin-mot-sjelden-leversykdom-spennende-studie/ 2023-01-11T08:32:05+00:00 https://www.lmi.no/2023/01/11/prisen-pa-eisai-og-biogens-alzheimerlegemiddel-vil-neppe-dempe-ettersporselen-sier-analytikere/ 2023-01-11T08:33:36+00:00 https://www.lmi.no/2023/01/11/ge-healthcare-utvider-vil-ha-mer-plass-og-bredere-vei/ 2023-01-11T08:45:48+00:00 https://www.lmi.no/2023/01/11/underforbruk-av-paxlovid/ 2023-01-11T08:49:58+00:00 https://www.lmi.no/2023/01/12/dette-er-den-nye-ledergruppen-i-novartis-norge-etter-omstruktureringen/ 2023-01-12T09:28:41+00:00 https://www.lmi.no/2023/01/12/rekordstor-legemiddelmangel-i-2022/ 2023-01-12T09:36:01+00:00 https://www.lmi.no/2023/01/12/positive-tall-i-videreutviklingen-av-nye-metoder/ 2023-01-12T09:38:35+00:00 https://www.lmi.no/2023/01/12/helseplattformen-en-it-skandale-i-midt-norge/ 2023-01-12T09:52:41+00:00 https://www.lmi.no/2023/01/12/eisai-soker-om-tillatelse-til-a-selge-alzheimers-medisin-i-europa/ 2023-01-12T09:54:33+00:00 https://www.lmi.no/2023/01/12/hun-er-astrazenecas-nye-medisinske-onkologi-direktor-for-26-europeiske-land/ 2023-01-12T09:59:18+00:00 https://www.lmi.no/2023/01/12/konkurranseloven-pa-1-2-3/ 2023-01-12T11:43:55+00:00 https://www.lmi.no/wp-content/uploads/2023/01/konkurranseloven-pa-123.png https://www.lmi.no/2023/01/13/lmi-grossistene-bor-dele-lagerstatus-for-beredskapslagring-av-medisiner/ 2023-01-13T09:36:32+00:00 https://www.lmi.no/2023/01/13/samlet-helsemiljo-presenterte-hvorfor-helseindustri-bor-bli-en-av-norges-nye-eksportsatsinger/ 2023-01-13T09:38:35+00:00 https://www.lmi.no/2023/01/13/eu-ja-til-roche-medisin-mot-influensa-for-barn-over-ett-ar/ 2023-01-13T09:47:59+00:00 https://www.lmi.no/2023/01/13/livreddende-datadeling/ 2023-01-13T09:49:44+00:00 https://www.lmi.no/2023/01/13/store-kutt-i-danske-leo-pharma-ingen-oppsigelser-i-norge/ 2023-01-13T09:51:23+00:00 https://www.lmi.no/2023/01/12/hod-presenterer-revidert-strategi-for-persontilpasset-medisin/ 2023-01-13T10:06:14+00:00 https://www.lmi.no/wp-content/uploads/2023/01/persontilpasset-medisin-kvadratisk.png https://www.lmi.no/wp-content/uploads/2023/01/Persontilpasset-medisin-avlangt.png https://www.lmi.no/2022/11/07/mangedoblet-antall-gastrostudier-etter-nortrials-etableringen/ 2023-01-16T10:01:46+00:00 https://www.lmi.no/wp-content/uploads/2022/11/skjermdump-nortrials-unn.png https://www.lmi.no/2023/01/16/vedum-vil-gjore-norge-mindre-avhengig-av-kina-pa-helseberedskap-varsler-okt-pengebruk-pa-legemiddelproduksjon/ 2023-01-16T10:01:47+00:00 https://www.lmi.no/2023/01/16/medisin-mot-barnesykdom-er-ofte-mangelvare-det-er-en-fare-for-pasientsikkerheten/ 2023-01-16T10:01:51+00:00 https://www.lmi.no/2023/01/16/et-kraftsenter-for-kreftbehandling/ 2023-01-16T10:02:08+00:00 https://www.lmi.no/wp-content/uploads/2023/01/NorTrials_radiumhospitalet-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/NorTrials_radiumhospitalet-scaled.jpg https://www.lmi.no/2023/01/16/grossistene-om-betalingsniva-for-beredskapslagring-ikke-akseptabelt/ 2023-01-16T10:02:28+00:00 https://www.lmi.no/2023/01/16/ny-effektiv-slankemedisin-%e2%88%92-dramatisk-effekt/ 2023-01-16T10:03:09+00:00 https://www.lmi.no/2023/01/16/vi-ma-etablere-en-norsk-helsenaering/ 2023-01-16T10:11:45+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Veronika1a.jpg https://www.lmi.no/2023/01/17/sykehustalen-2023-kjerkol-strammer-toylene/ 2023-01-17T12:55:56+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Sykehustalen-2023-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Sykehustalen-2023-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/sykehustalen-2023-1-scaled.jpg https://www.lmi.no/2023/01/17/lmi-legemiddelberedskap-er-ikke-en-byrde/ 2023-01-17T13:12:46+00:00 https://www.lmi.no/2023/01/17/ny-strategi-for-persontilpasset-medisin-lansert-i-dag/ 2023-01-17T17:28:26+00:00 https://www.lmi.no/wp-content/uploads/2023/01/kjerkol-legger-frem-pm-strategi-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/kjerkol-legger-frem-pm-strategi-scaled.jpg https://www.lmi.no/2023/01/18/helseministeren-persontilpasset-medisin-skal-bli-en-naturlig-del-av-pasientbehandlingen/ 2023-01-18T10:05:55+00:00 https://www.lmi.no/2023/01/18/lmi-mener-ny-strategi-for-persontilpasset-medisin-kunne-vaert-enda-mer-ambisios/ 2023-01-18T10:07:10+00:00 https://www.lmi.no/2023/01/18/en-svaert-god-strategi-som-likevel-kunne-vaert-enda-mer-ambisios/ 2023-01-18T14:15:40+00:00 https://www.lmi.no/wp-content/uploads/2023/01/nicolas-og-kjerkol-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/nicolas-og-kjerkol-scaled.jpg https://www.lmi.no/2023/01/19/bristol-myers-squibb-og-karolinska-universitetssjukhuset-vil-utvikle-innovative-kreftbehandlinger/ 2023-01-19T12:59:50+00:00 https://www.lmi.no/2023/01/19/pfizer-tilbyr-flere-lavpris-legemidler/ 2023-01-19T13:00:25+00:00 https://www.lmi.no/2023/01/20/slankemedisinen-wegovy-innvilges-ikke-bla-resept/ 2023-01-20T08:45:41+00:00 https://www.lmi.no/2023/01/20/sa-mye-er-solgt-av-omdiskutert-slankemedisin/ 2023-01-20T08:46:17+00:00 https://www.lmi.no/2023/01/20/slv-i-disse-tilfellene-kan-legen-hindre-medisinbytte/ 2023-01-20T08:47:09+00:00 https://www.lmi.no/2023/01/20/beslutningsforum-skal-vurdere-to-kreftlegemidler/ 2023-01-20T08:47:45+00:00 https://www.lmi.no/2023/01/19/var-industri-er-et-utpekt-satsingsomrade/ 2023-01-20T09:06:07+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Skymoen-helseogfremtid.jpg https://www.lmi.no/wp-content/uploads/2023/01/Skymoen-helseogfremtid.jpg https://www.lmi.no/wp-content/uploads/2023/01/vb-helseogfremtid.jpg https://www.lmi.no/2023/01/23/farmasiet-utomatiserer-lageret/ 2023-01-23T09:47:18+00:00 https://www.lmi.no/2023/01/23/nye-sentre-skal-gi-flere-kliniske-studier-i-norge/ 2023-01-23T09:48:05+00:00 https://www.lmi.no/2023/01/23/halvor-sorbye-star-bak-millioninvestering-i-nytt-legemiddel-han-har-vaert-uvurderlig-for-oss/ 2023-01-23T09:48:57+00:00 https://www.lmi.no/2023/01/23/regjeringen-lover-enklere-tilgang-til-helsedata/ 2023-01-23T09:49:43+00:00 https://www.lmi.no/2023/01/23/ber-erna-skjerpe-seg-bloffer/ 2023-01-23T09:50:28+00:00 https://www.lmi.no/2023/01/23/dette-ble-dommen-etter-beslutningsforums-januarmote/ 2023-01-23T09:58:53+00:00 https://www.lmi.no/2023/01/23/pamelding-til-partnership-4-life-og-mote-om-kliniske-studier/ 2023-01-23T10:13:02+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Nettbanner_1000x563_norsk-1.png https://www.lmi.no/2023/01/24/eli-lilly-far-nei-fra-fda-pa-soknaden-om-tidlig-godkjennelse-for-alzheimers-middel/ 2023-01-24T08:43:00+00:00 https://www.lmi.no/2023/01/24/ultimovacs-har-fullfort-ny-rekruttering-gar-inn-i-en-veldig-spennende-periode/ 2023-01-24T08:43:45+00:00 https://www.lmi.no/2023/01/24/dr-dropin-betaler-5000-kroner-i-bot-daglig-for-ulovlig-reklamering/ 2023-01-24T08:44:33+00:00 https://www.lmi.no/2023/01/24/kaja-og-thea-kan-juble-ikkje-alle-er-like-heldige/ 2023-01-24T08:45:27+00:00 https://www.lmi.no/2023/01/24/beslutningsforum-innforer-behandling-for-livmorkreft-og-svaert-sjeldent-syndrom/ 2023-01-24T08:46:14+00:00 https://www.lmi.no/2023/01/24/anbud-er-ikke-egnet-for-fremtidens-behandlinger/ 2023-01-24T12:08:22+00:00 https://www.lmi.no/wp-content/uploads/2023/01/VB_DM-Arena1.jpg https://www.lmi.no/wp-content/uploads/2023/01/VB_DM-Arena1.jpg https://www.lmi.no/2023/01/25/fedmeekspert-harreisende-at-pasienter-ikke-far-dekket-ny-slankemedisin/ 2023-01-25T09:40:52+00:00 https://www.lmi.no/2023/01/25/nytt-system-for-kliniske-studier-i-eu-slik-har-industri-og-akademia-forberedt-seg-lmi-kommenterer/ 2023-01-25T09:45:36+00:00 https://www.lmi.no/2023/01/25/54681/ 2023-01-25T09:47:04+00:00 https://www.lmi.no/2023/01/25/2023-mindre-til-sykehusene-mer-til-legemidler/ 2023-01-25T09:47:57+00:00 https://www.lmi.no/2023/01/25/medlemsmotet-se-opptaket/ 2023-01-25T12:15:54+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Utvalgsmotet-2501-1.jpg https://www.lmi.no/wp-content/uploads/2023/01/Utvalgsmotet-2501-1.jpg https://www.lmi.no/2023/01/12/presenterte-helseindustri-for-nasjonalt-eksportrad/ 2023-01-25T18:19:03+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/2023/01/26/msd-stanser-fase-3-studie-pa-prostatakreft/ 2023-01-26T09:07:44+00:00 https://www.lmi.no/2023/01/26/novo-nordisk-investerer-milliardbelop-i-fransk-fabrikk/ 2023-01-26T09:08:30+00:00 https://www.lmi.no/2023/01/26/prioritering-med-bremsene-pa/ 2023-01-26T09:09:22+00:00 https://www.lmi.no/2023/01/27/ernaeringsprofessor-om-helsedirektoratets-fedmemiddel-begrensning-respektlost/ 2023-01-27T13:37:26+00:00 https://www.lmi.no/2023/01/30/den-nye-astrazeneca-sjefen-alle-pasienter-er-forskjellige/ 2023-01-30T08:00:00+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Guro-Bjontegaard-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Guro-Bjontegaard-scaled.jpg https://www.lmi.no/2023/01/29/nytt-cra-kurs-i-oktober/ 2023-01-29T22:32:04+00:00 https://www.lmi.no/wp-content/uploads/2023/01/CRA-kurs-2023.jpg https://www.lmi.no/wp-content/uploads/2023/01/CRA-kurs-2023.jpg https://www.lmi.no/2023/01/30/kritisk-til-ous-handteringav-ekspertpanel-henvisninger/ 2023-01-30T08:35:59+00:00 https://www.lmi.no/2023/01/30/flere-er-bekymret-for-fremtiden-etter-at-effektiv-slankemedisin-falt-ut-av-bla-resept-ordningen/ 2023-01-30T08:38:10+00:00 https://www.lmi.no/2023/01/30/forsker-advarer-om-feilmedisinering-et-okende-problem/ 2023-01-30T08:41:57+00:00 https://www.lmi.no/2023/01/30/flere-kvinner-har-sokt-erstatning-etter-vaksinen-vi-vet-for-lite-om-menstruasjon-mener-forsker/ 2023-01-30T08:44:36+00:00 https://www.lmi.no/2023/01/30/kreftpasienter-kan-fa-en-ny-sjanse-med-t-celle-terapi/ 2023-01-30T08:46:36+00:00 https://www.lmi.no/2023/01/06/innspill-til-styrekandidater-i-lmi-3/ 2023-01-30T12:45:31+00:00 https://www.lmi.no/wp-content/uploads/2016/05/Utvalgsm%C3%B8te.jpg https://www.lmi.no/2023/01/30/solid-okning-i-kliniske-studier-i-2022/ 2023-01-30T14:32:25+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Kliniske-studier-sokt-i-2022.png https://www.lmi.no/wp-content/uploads/2023/01/Kliniske-studier-sokt-i-2022.png https://www.lmi.no/wp-content/uploads/2021/02/hege-edvardsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/01/Nicolas_1.jpg https://www.lmi.no/2023/01/31/ola-borten-moe-onsker-mer-satsing-pa-farmasi/ 2023-01-31T08:12:04+00:00 https://www.lmi.no/2023/01/31/regjeringen-no-stor-okning-i-antall-sokte-kliniske-studier-i-2022/ 2023-01-31T08:18:28+00:00 https://www.lmi.no/2023/01/31/selv-5-minutters-smerte-endrer-genene-dine-kanskje-for-alltid/ 2023-01-31T08:20:06+00:00 https://www.lmi.no/2023/01/31/ge-healthcare-omsatte-for-naer-fem-milliarder-dollar-i-det-fjerde-kvartalet/ 2023-01-31T08:23:41+00:00 https://www.lmi.no/2023/01/31/hod-vi-ma-innrette-helsetjenesten-til-a-vaere-i-stand-til-a-ta-imot-produktene-dere-leverer/ 2023-01-31T17:12:17+00:00 https://www.lmi.no/wp-content/uploads/2023/01/hod-presenterer-rev-strategi.png https://www.lmi.no/wp-content/uploads/2023/01/hod-presenterer-rev-strategi.png https://www.lmi.no/2023/02/01/apoteklovutvalget-behov-for-okt-konkurranse-i-apotekmarkedet/ 2023-02-01T10:42:28+00:00 https://www.lmi.no/2023/02/01/apotekutvalget-vil-styrke-apotek-som-faghandel/ 2023-02-01T10:44:19+00:00 https://www.lmi.no/2023/02/01/dette-var-de-storste-legemiddelselskapene-og-de-storste-legemidlene-i-2022/ 2023-02-01T10:45:16+00:00 https://www.lmi.no/2023/02/01/fiskehelse-patogen-apner-bakteriologilab/ 2023-02-01T10:46:48+00:00 https://www.lmi.no/2023/02/01/nytt-medikament-for-migrenepasienter-potensielt-livsendrende/ 2023-02-01T10:51:10+00:00 https://www.lmi.no/2023/02/01/moren-ble-forgiftet-pa-sykehjemmet-sa-skjer-feilen-igjen/ 2023-02-01T10:55:28+00:00 https://www.lmi.no/2023/02/01/disse-legemidlene-vil-ema-ha-godkjent-i-eu/ 2023-02-01T10:57:19+00:00 https://www.lmi.no/2023/02/01/pfizer-ser-svakere-enn-ventet-salg-av-covid-produkter/ 2023-02-01T10:59:17+00:00 https://www.lmi.no/2023/02/01/oljefondet-fikk-en-avkastning-pa-minus-1637-mrd/ 2023-02-01T11:01:26+00:00 https://www.lmi.no/2023/02/01/overvektige-fortviler-jeg-er-livredd/ 2023-02-01T11:18:06+00:00 https://www.lmi.no/2023/01/31/kronikk-om-fremtidens-apotek-ny-teknologi-og-innovasjon-ma-tas-i-bruk/ 2023-02-01T11:53:55+00:00 https://www.lmi.no/wp-content/uploads/2021/01/Katrine-bilde.jpg https://www.lmi.no/2023/02/01/fatt-gjennomslag-i-viktige-saker-for-industrien/ 2023-02-01T11:54:57+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Bryne-og-Kjerkol-cropped1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Bryne-og-Kjerkol-cropped1-scaled.jpg https://www.lmi.no/2023/02/02/salgstall-fra-farmastat-for-januar-2023/ 2023-02-02T08:18:12+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/02/02/dnb-spar-nykode-vaksine-pa-markedet-i-2027/ 2023-02-02T09:50:42+00:00 https://www.lmi.no/2023/02/03/far-og-sonn-westen-satset-alt-pa-en-ny-hjertemedisin-na-sover-jeg-veldig-godt-igjen/ 2023-02-03T07:41:59+00:00 https://www.lmi.no/2023/02/03/helseminister-kjerkol-%e2%88%92-det-er-tid-for-felles-handling/ 2023-02-03T07:47:17+00:00 https://www.lmi.no/2023/02/03/farmasoyter-er-ikke-losningen-for-helsepersonellkommisjonen/ 2023-02-03T07:55:57+00:00 https://www.lmi.no/2023/02/03/gsk-medisin-far-spesiell-status-i-usa-utvikles-mot-sjelden-autoimmun-sykdom/ 2023-02-03T07:57:15+00:00 https://www.lmi.no/2023/02/02/store-fremskritt-i-behandling-av-lungekreft%ef%bf%bc/ 2023-02-03T08:06:17+00:00 https://www.lmi.no/2023/02/03/sykepleierforbundet-sykepleiere-kan-slippe-a-brette-klaer-og-vaske-oppkast/ 2023-02-03T08:09:15+00:00 https://www.lmi.no/2023/02/03/helsepersonellkommisjonen-en-situasjon-vi-ikke-kan-betale-oss-ut-av/ 2023-02-03T08:11:21+00:00 https://www.lmi.no/2023/02/03/novo-nordisk-gir-ansatte-milliardgave/ 2023-02-03T08:12:28+00:00 https://www.lmi.no/2023/01/27/full-sal-pa-drug-safety-forum-2023/ 2023-02-03T12:57:35+00:00 https://www.lmi.no/wp-content/uploads/2023/01/DSF-2023-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Drug-Safety-Forum-2023-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Bente-DSF-23-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Linn-Camilla-DSF23.jpg https://www.lmi.no/2023/02/06/kan-ny-strategi-for-persontilpasset-medisin-innfores-nar-alle-budsjetter-kuttes/ 2023-02-06T08:47:54+00:00 https://www.lmi.no/2023/02/06/farmastat-sjef-novo-nordisk-er-i-realiteten-storst-i-norge/ 2023-02-06T08:48:31+00:00 https://www.lmi.no/2023/02/06/ber-regjeringen-nedsette-nytt-prioriteringsutvalg/ 2023-02-06T08:49:18+00:00 https://www.lmi.no/2023/02/06/frist-for-innspill-til-atmp-delavtale/ 2023-02-06T10:31:12+00:00 https://www.lmi.no/wp-content/uploads/2018/10/Avtale.gif https://www.lmi.no/2023/02/07/helseministeren-naeringslivet-har-en-plass-i-samarbeidet-om-persontilpasset-medisin/ 2023-02-07T10:23:00+00:00 https://www.lmi.no/2023/02/07/apotek-nou-apotekforeningen-misfornoyd-lmi-fornoyd-farmasiet-gledelig-fornoyd/ 2023-02-07T10:23:38+00:00 https://www.lmi.no/2023/02/07/kobenhavn-ecco-kongressen-presenterer-norge-som-studieland/ 2023-02-07T10:23:51+00:00 https://www.lmi.no/wp-content/uploads/2022/09/Signe-Oien-Fretland-HIGHRES-scaled.jpg https://www.lmi.no/wp-content/uploads/2020/11/Kliniske-studier-i-norge-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/Signe-Oien-Fretland-HIGHRES-scaled.jpg https://www.lmi.no/2023/02/08/novo-nordisk-onsker-a-rulle-ut-fedmemiddel-til-flere-europeiske-land-i-lopet-av-2023/ 2023-02-08T09:13:46+00:00 https://www.lmi.no/2023/02/08/disse-teknologiske-gjennombruddene-tror-vi-pa/ 2023-02-08T09:14:31+00:00 https://www.lmi.no/2023/02/08/sykehusinnkjop-vil-apne-for-bytte-av-kreftlegemidler-i-nytt-anbud-msd-bekymret/ 2023-02-08T09:15:11+00:00 https://www.lmi.no/2023/02/08/tar-i-bruk-skanningskontroll-for-a-oke-pasientsikkerheten/ 2023-02-08T09:15:43+00:00 https://www.lmi.no/2023/02/08/disse-ti-nye-legemidlene-kan-bli-framtidens-melkekuer/ 2023-02-08T09:16:22+00:00 https://www.lmi.no/2023/02/08/slv-disse-legemidlene-kan-koste-staten-unodvendig-mye-penger/ 2023-02-08T09:17:22+00:00 https://www.lmi.no/2023/02/07/meld-deg-pa-varens-reklamekurs-2/ 2023-02-08T10:30:14+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Reklame_Dig_Nov-2019.jpg https://www.lmi.no/2023/02/08/video-nominer-styrekandidater-innen-24-februar/ 2023-02-08T11:21:28+00:00 https://www.lmi.no/wp-content/uploads/2023/02/Per-AA.jpg https://www.lmi.no/2023/02/09/arctic-bioscience-med-betydelig-salgsvekst/ 2023-02-09T09:19:43+00:00 https://www.lmi.no/2023/02/09/debatt-legg-listen-hoyt-i-revisjonen-av-eus-legemiddellovgivning/ 2023-02-09T09:20:20+00:00 https://www.lmi.no/2023/02/09/beslutningsforum-skal-vurdere-ms-middel-for-tredje-gang/ 2023-02-09T09:22:44+00:00 https://www.lmi.no/2023/02/09/four-years-of-securing-europe-from-falsified-medicines-how-is-it-going-in-the-nordic-region/ 2023-02-09T11:26:36+00:00 https://www.lmi.no/wp-content/uploads/2023/02/Nordiske-ledere-2-1.jpg https://www.lmi.no/wp-content/uploads/2023/02/Nordiske-ledere-2-1.jpg https://www.lmi.no/2023/02/09/vil-gjore-celleterapi-mer-tilgjengelig/ 2023-02-09T12:06:11+00:00 https://www.lmi.no/wp-content/uploads/2023/02/IMG_5323-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5323-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/2023/02/13/helsenaering-ma-bli-en-nasjonal-strategisk-eksportnaering/ 2023-02-13T08:38:46+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen_portrett-halvnaert-scaled.jpg https://www.lmi.no/2023/02/13/immunterapi-pluss-kjemoterapi-bedre-enn-kjemoterapi-i-forstelinje-livmorkreft/ 2023-02-13T08:46:19+00:00 https://www.lmi.no/2023/02/13/astrazeneca-pa-vei-med-15-nye-medisiner-det-neste-tiaret/ 2023-02-13T08:48:09+00:00 https://www.lmi.no/2023/02/13/leo-pharma-nar-malene-i-handeksem-studie/ 2023-02-13T08:49:00+00:00 https://www.lmi.no/2023/02/13/sykehusinnkjop-taus-om-eget-kreftanbud-forslag/ 2023-02-13T08:50:05+00:00 https://www.lmi.no/2023/02/14/skymoen-tror-pa-tredobling-av-eksporten-av-helsenaeringen-de-neste-ti-arene/ 2023-02-14T10:13:41+00:00 https://www.lmi.no/2023/02/14/mannsdominert-legemiddelindustri-ser-kvinnehelse-som-nisje/ 2023-02-14T10:14:35+00:00 https://www.lmi.no/2023/02/14/naeringsministeren-om-norsk-helseindustri-vi-ma-vise-fram-vare-sterke-sider/ 2023-02-14T10:15:27+00:00 https://www.lmi.no/2023/02/14/novo-styreleder-dette-ma-norge-gjore-for-a-bli-store-innen-livsvitenskap/ 2023-02-14T10:16:06+00:00 https://www.lmi.no/2023/02/14/norway-life-science-skymoen-tror-norge-kan-bli-store/ 2023-02-14T10:16:53+00:00 https://www.lmi.no/2023/02/14/novartis-har-forhandlet-om-ms-middel-siden-2021-fortsatt-ikke-i-mal/ 2023-02-14T10:17:58+00:00 https://www.lmi.no/2023/02/14/lungekreft-behandling-far-midlertidig-ja/ 2023-02-14T10:18:44+00:00 https://www.lmi.no/2023/02/16/targovax-annonserer-finansiering-pa-inntil-300-millioner/ 2023-02-16T08:41:30+00:00 https://www.lmi.no/2023/02/16/britiske-medier-novo-nordisk-ventes-a-lansere-fedmemiddel-i-storbritannia/ 2023-02-16T08:42:25+00:00 https://www.lmi.no/2023/02/16/fersk-bcg-rapport-slik-kan-helsenaeringen-ta-igjen-sjomat-pa-eksport/ 2023-02-16T08:44:11+00:00 https://www.lmi.no/2023/02/16/seminar-om-etablering-av-desentraliserte-kliniske-studier-i-norge/ 2023-02-16T09:25:01+00:00 https://www.lmi.no/wp-content/uploads/2021/06/kliniske-studier-naeringsutvikling-scaled.jpeg https://www.lmi.no/2023/02/16/vi-ma-investere-i-life-science-og-ha-en-god-dialog-for-a-drive-prosjekter-sammen/ 2023-02-16T12:02:43+00:00 https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2889-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2889-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2406-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2412-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2436-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2452-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2579-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2630-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-2877-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-6013-scaled.jpg https://www.lmi.no/2023/02/17/setter-ned-foten-for-nytt-offentlig-utvalg-men-apner-for-a-innhente-ekspertrad/ 2023-02-17T11:18:41+00:00 https://www.lmi.no/2023/02/17/produktivt-fjerdekvartal-reddet-arsresultatet-til-vistin-pharma/ 2023-02-17T11:20:35+00:00 https://www.lmi.no/2023/02/17/ti-ar-etter-algeta-bragden-kan-de-gjore-det-igjen/ 2023-02-17T11:21:25+00:00 https://www.lmi.no/2023/02/16/horing-fremtidens-apotek-fleksibelt-og-forsvarlig/ 2023-02-17T14:56:36+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/02/20/gjor-medikamentell-behandling-mot-fedme-tilgjengelig-pa-blaresept/ 2023-02-20T09:44:28+00:00 https://www.lmi.no/2023/02/20/ny-vaksine-beskytter-eldre-mot-rs-virus/ 2023-02-20T09:45:13+00:00 https://www.lmi.no/2023/02/20/debatt-norge-ma-gjore-det-lonnsomt-a-utvikle-nye-legemidler-mot-antibiotikaresistens/ 2023-02-20T09:45:53+00:00 https://www.lmi.no/2023/02/20/ms-medisin-far-ja-fantastiske-nyheter/ 2023-02-20T10:07:29+00:00 https://www.lmi.no/2023/02/20/horing-tid-for-handling-personellet-i-en-baerekraftig-helse-og-omsorgstjeneste/ 2023-02-20T10:20:05+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2023/02/21/slik-jobber-norske-byrakrater-for-a-fa-innpass-i-eus-helsesamarbeid/ 2023-02-21T08:35:20+00:00 https://www.lmi.no/2023/02/21/biontech-onsker-a-starte-kliniske-studier-pa-mrna-kreftvaksiner-i-2023/ 2023-02-21T08:37:08+00:00 https://www.lmi.no/2023/02/21/kronikk-norge-trenger-en-bred-prioriteringsdiskusjon/ 2023-02-21T09:18:32+00:00 https://www.lmi.no/wp-content/uploads/2023/02/48974317152_31063e182d_o-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/48974317152_31063e182d_o-scaled.jpg https://www.lmi.no/2023/02/22/targovax-legemiddelkandidat-pa-gmo-horing/ 2023-02-22T08:48:42+00:00 https://www.lmi.no/2023/02/22/ny-avtale-bedrer-norsk-helseberedskap/ 2023-02-22T08:49:21+00:00 https://www.lmi.no/2023/02/22/fda-skal-vurdere-om-pfizers-rsv-vaksine-kan-gis-til-gravide/ 2023-02-22T08:49:51+00:00 https://www.lmi.no/2023/02/22/asco-gu-redusert-risiko-for-tilbakefall-av-blaerekreft-med-photocures-blalys-cystoskopi/ 2023-02-22T08:50:25+00:00 https://www.lmi.no/2023/02/22/forste-genterapi-som-behandler-hemofili-b-er-godkjent-i-europa/ 2023-02-22T08:50:58+00:00 https://www.lmi.no/2023/02/22/adjuvant-immunterapi-fortsetter-a-gi-effekt-for-blaerekreftpasienter-etter-tre-ar/ 2023-02-22T08:51:30+00:00 https://www.lmi.no/2023/02/14/norge-har-bygget-store-industrier-for-og-na-har-vi-muligheten-til-a-bygge-en-sterk-norsk-helseindustri/ 2023-02-22T18:16:13+00:00 https://www.lmi.no/wp-content/uploads/2023/02/IMG_5431-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5431-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-0628-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-0560-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-0448-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-0420-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/NLS23_Foto_EvenKleppa_KleppaMedia-0399-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5459-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5454-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5448-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5444-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/image00001-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/02/image00011-scaled.jpeg https://www.lmi.no/2023/02/23/lanserer-vaksine-mot-kalvediare/ 2023-02-23T09:05:49+00:00 https://www.lmi.no/2023/02/23/tablettversjon-av-leukemi-medisin-fra-astrazeneca-eu-godkjent/ 2023-02-23T09:06:35+00:00 https://www.lmi.no/2023/02/23/ti-kliniske-studier-pa-legemidler-som-floppet-i-2022/ 2023-02-23T09:17:42+00:00 https://www.lmi.no/2023/02/24/kronikk-viktig-om-antibiotikautfordringer/ 2023-02-24T07:54:04+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen-beredskapskonferanse.-Foto-Norsk-Industri-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/LR_dag-og-tid.png https://www.lmi.no/2023/02/24/legemiddelverket-fortsatt-ikke-ferdig-med-vurdering-av-hjertesviktmedisin-er-fire-maneder-pa-overtid/ 2023-02-24T09:15:35+00:00 https://www.lmi.no/2023/02/24/naeringsministeren-lovte-veikart-for-helseindustrien-hva-betyr-det-slik-utdyper-han/ 2023-02-24T09:16:12+00:00 https://www.lmi.no/2023/02/27/curida-direktoren-blir-ny-styreleder-i-nadeno/ 2023-02-27T09:19:38+00:00 https://www.lmi.no/2023/02/27/meld-deg-pa-lmis-ordinaere-generalforsamling-28-mars/ 2023-02-27T09:47:33+00:00 https://www.lmi.no/wp-content/uploads/2023/02/mikael-kristenson-3aVlWP-7bg8-unsplash-scaled.jpg https://www.lmi.no/2023/02/27/en-hilsen-fra-lmis-patroppende-leder/ 2023-02-27T12:11:16+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen_portrett-2-halvnaert-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen_portrett-2-halvnaert-scaled.jpg https://www.lmi.no/2023/02/27/motte-studentene/ 2023-02-27T18:28:04+00:00 https://www.lmi.no/wp-content/uploads/2023/02/IMG_5589.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5584-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5589.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_5588-scaled.jpg https://www.lmi.no/2023/02/28/torbjorn-solsnaes-forlater-nho-service-og-handel-gar-til-legemiddelselskap/ 2023-02-28T11:01:50+00:00 https://www.lmi.no/2023/02/28/ema-vil-godkjenne-atte-nye-medisiner/ 2023-02-28T11:03:14+00:00 https://www.lmi.no/2023/02/28/forsterket-samarbeid-for-a-finne-nye-behandlinger-lmi-kommenterer/ 2023-02-28T11:03:53+00:00 https://www.lmi.no/2023/02/28/ble-nektet-samme-medisin-som-andre-na-oyner-han-hap/ 2023-02-28T11:07:01+00:00 https://www.lmi.no/2023/02/28/norge-kjopte-over-8000-koronapiller-na-vendes-tommelen-ned-for-markedsforingstillatelse/ 2023-02-28T11:08:05+00:00 https://www.lmi.no/2023/02/28/sanofi-om-data-pa-medisin-mot-pompes-sykdom-styrker-potensial-som-ny-standardbehandling/ 2023-02-28T11:12:30+00:00 https://www.lmi.no/2023/02/28/gonoresmitte-skyter-i-vaeret/ 2023-02-28T11:13:29+00:00 https://www.lmi.no/2023/02/28/helseministeren-konkluderer-for-legemiddelverket-sier-hjertesvikt-medisin-ma-godkjennes-av-stortinget/ 2023-02-28T11:16:49+00:00 https://www.lmi.no/2023/02/28/tid-for-en-sjelden-mulighet-i-helse-norge/ 2023-02-28T11:19:30+00:00 https://www.lmi.no/2023/02/28/vi-bruker-mer-legemidler-enn-noen-gang/ 2023-02-28T11:20:31+00:00 https://www.lmi.no/2023/02/28/horing-skjerpede-miljokrav-i-offentlige-anskaffelser/ 2023-02-28T12:51:42+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2023/02/Horing_crop.png https://www.lmi.no/2023/02/28/horingssvar-legemiddelgrunndata-analyse-av-behov-og-omfang/ 2023-02-28T13:44:27+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2023/02/Horing_crop.png https://www.lmi.no/2023/03/01/ous-forskningsgruppe-har-inngatt-avtale-med-roche/ 2023-03-01T08:07:45+00:00 https://www.lmi.no/2023/03/01/legemiddelverket-har-konkludert-om-hjertesviktmedisin-overstiger-fullmaktsgrensen/ 2023-03-01T08:11:00+00:00 https://www.lmi.no/2023/03/01/feil-pa-faksmaskin-forte-til-livstruende-feilmedisinering/ 2023-03-01T08:12:10+00:00 https://www.lmi.no/2023/03/01/na-skaffer-flere-seg-privat-helseforsikring-%e2%88%92-en-trygghet/ 2023-03-01T08:12:58+00:00 https://www.lmi.no/2023/03/01/ife-etablerer-agilera-pharma-as/ 2023-03-01T10:26:43+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Erik-Flatmark_dir-Agilera.jpg https://www.lmi.no/wp-content/uploads/2023/03/Dir-Nils-Morten-Huseby-IFE-Foto-IFE-Bo-Mathisen.jpg https://www.lmi.no/wp-content/uploads/2023/03/Erik-Flatmark_dir-Agilera.jpg https://www.lmi.no/2023/03/01/regjeringen-vil-forby-gentesting-av-barn/ 2023-03-01T10:32:39+00:00 https://www.lmi.no/2023/03/01/forste-dag-forste-medlemsmote/ 2023-03-01T12:29:35+00:00 https://www.lmi.no/wp-content/uploads/2023/03/LR_Bayer4-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/LR_Bayer4-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/LR_Bayer1-scaled.jpg https://www.lmi.no/2023/03/02/asamedic-om-medieoppmerksomheten-veien-til-lansering-og-malet-om-europa-og-resten-av-verden/ 2023-03-02T08:24:10+00:00 https://www.lmi.no/wp-content/uploads/2023/02/IMG_1402-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/IMG_1402-scaled.jpg https://www.lmi.no/2023/03/02/salgstall-fra-farmastat-for-februar-2023/ 2023-03-02T08:37:58+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/03/02/mange-leger-forskriver-uregistrerte-legemidler-dette-gjor-slv-for-a-bremse-utviklingen/ 2023-03-02T08:53:41+00:00 https://www.lmi.no/2023/03/02/eli-lilly-kutter-prisen-pa-insulin-med-70-prosent-i-usa/ 2023-03-02T08:56:41+00:00 https://www.lmi.no/2023/03/02/vil-ha-en-milliard-til-kvinnehelse/ 2023-03-02T09:55:08+00:00 https://www.lmi.no/2023/03/02/gsk-et-steg-naermere-godkjenning-av-rsv-vaksine-for-voksne/ 2023-03-02T09:56:16+00:00 https://www.lmi.no/2023/03/02/keytruda-skuffer-msd-skroter-sin-fjerde-prostatakreftstudie/ 2023-03-02T09:57:07+00:00 https://www.lmi.no/2023/03/02/almirall-lanserer-psoriasis-medisin-i-norge-satser-med-ny-organisasjon-i-norden/ 2023-03-02T09:58:02+00:00 https://www.lmi.no/2023/03/03/antidepressiva-mot-kroniske-smerter-er-det-effektivt/ 2023-03-03T07:52:50+00:00 https://www.lmi.no/2023/03/03/bruk-av-acetylsalisylsyre-ved-mistanke-om-hjerteinfarkt/ 2023-03-03T08:01:36+00:00 https://www.lmi.no/2023/03/03/novo-nordisk-ansetter-200-i-boston-ekspansjon/ 2023-03-03T08:08:29+00:00 https://www.lmi.no/2023/03/03/janssen-onsker-midlertidig-avtale-om-kreftmedisin-felles-forstaelse-av-merverdien-et-sentralt-premiss-for-enighet/ 2023-03-03T08:13:41+00:00 https://www.lmi.no/2023/03/06/pfizer-inngar-produksjonsavtale-med-samsung-biologics-hva-som-skal-produseres-holdes-hemmelig/ 2023-03-06T09:32:17+00:00 https://www.lmi.no/2023/03/06/mener-kvinnehelseutvalget-burde-anbefalt-endring-i-pakningsvedlegg/ 2023-03-06T09:32:49+00:00 https://www.lmi.no/2023/03/06/uambisiost-om-persontilpasset-medisin/ 2023-03-06T09:33:21+00:00 https://www.lmi.no/2023/03/06/boehringer-ingelheim-synd-at-saken-ma-gjennom-stortinget-pa-grunn-av-18-millioner-kroner/ 2023-03-06T09:33:57+00:00 https://www.lmi.no/2023/03/06/norge-gir-minst-til-forskning-og-utvikling-i-norden/ 2023-03-06T09:34:46+00:00 https://www.lmi.no/2023/03/06/legene-sa-urovekkende-vekttrend-pa-naert-hold-na-satser-de-pa-ny-medisin/ 2023-03-06T09:35:25+00:00 https://www.lmi.no/2023/03/06/teknologi-fra-vaksiner-skal-lure-kreften/ 2023-03-06T09:35:57+00:00 https://www.lmi.no/2023/03/06/industri-og-klinikere-mottes-i-kobenhavn-pa-nortrials-mote-ved-den-norske-ambassaden/ 2023-03-06T10:43:18+00:00 https://www.lmi.no/wp-content/uploads/2023/03/23.jpg https://www.lmi.no/wp-content/uploads/2023/03/23.jpg https://www.lmi.no/wp-content/uploads/2023/03/image00010-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/image00054-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/image00007-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/image00037-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/image00014-scaled.jpeg https://www.lmi.no/2023/03/06/ina-dahslveen-er-ny-seniorradgiver-i-lmi/ 2023-03-06T12:55:48+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Dalsveen-Ina.jpg https://www.lmi.no/wp-content/uploads/2023/03/Dalsveen-Ina.jpg https://www.lmi.no/2023/03/07/novo-nordisk-sjefen-frykter-konsekvensene-av-ny-eu-lovgivning/ 2023-03-07T10:52:12+00:00 https://www.lmi.no/2023/03/07/positive-fase-2-data-for-astrazeneca-og-daiichi-sankyos-kreftlegemiddel/ 2023-03-07T10:52:32+00:00 https://www.lmi.no/2023/03/07/to-nye-omradedirektorer-i-legemiddelverket/ 2023-03-07T10:53:28+00:00 https://www.lmi.no/2023/03/07/kraftig-okning-i-industristudier-pa-legemidler-marsjordren-har-fungert/ 2023-03-07T10:54:59+00:00 https://www.lmi.no/2023/03/07/fem-ar-siden-den-siste-papirutgaven-av-felleskatalogen/ 2023-03-07T11:05:02+00:00 https://www.lmi.no/wp-content/uploads/2023/03/IMG_1694-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_1694-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/FK-gjengen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Mingling3-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/SLV-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Sveinung-Stensland-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Trond-Viggo-med-FK-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Veronika-Barrabes1-scaled.jpg https://www.lmi.no/2023/03/09/ge-healthcare-i-finalen-til-eksportprisen/ 2023-03-09T09:14:56+00:00 https://www.lmi.no/2023/03/09/bms-har-fatt-ny-eu-godkjenning-av-medisin-for-voksne-med-arvelig-blodsykdom/ 2023-03-09T09:15:41+00:00 https://www.lmi.no/2023/03/09/sak-om-sma-medisin-ikke-klar-til-beslutningsforums-mars-mote/ 2023-03-09T09:16:19+00:00 https://www.lmi.no/2023/03/09/taushetsbelagte-dokumenter-fra-npe-kommer-na-i-altinn/ 2023-03-09T09:20:38+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Hemmelige-dokumenter-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/Hemmelige-dokumenter-scaled.jpeg https://www.lmi.no/2023/03/09/horingssvar-skjerpede-miljokrav-i-offentlige-anskaffelser/ 2023-03-09T10:24:13+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/03/09/ny-prioriteringsmelding-lmi-har-startet-et-storre-arbeid/ 2023-03-09T11:27:27+00:00 https://www.lmi.no/wp-content/uploads/2022/10/KK-cropped-ny.jpg https://www.lmi.no/wp-content/uploads/2022/06/KKBeskjaert.jpg https://www.lmi.no/2023/03/10/moderna-far-vaksinekonkurranse-fra-msd/ 2023-03-10T08:52:56+00:00 https://www.lmi.no/2023/03/10/15-millioner-til-forskningsprosjekt-bare-starten-pa-et-kjempestort-kapittel-innen-kreftbehandling/ 2023-03-10T08:53:34+00:00 https://www.lmi.no/2023/03/10/bergenbio-har-dosert-forste-pasient-i-forstelinje-lungekreftsstudie/ 2023-03-10T08:54:08+00:00 https://www.lmi.no/2023/03/10/eli-lilly-feilet-i-alzheimer-studie-med-solanezumab-satser-videre-pa-andre-kandidater/ 2023-03-10T08:54:40+00:00 https://www.lmi.no/2023/03/10/utlysning-utvalgsmedlem-ihi/ 2023-03-10T09:58:10+00:00 https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/2023/03/10/lmis-medlemmer-pa-sjomatkongress/ 2023-03-10T10:17:52+00:00 https://www.lmi.no/wp-content/uploads/2023/03/IMG_5624-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_5628-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_5624-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_5633-scaled.jpg https://www.lmi.no/2023/03/10/podkast-ny-lmi-sjef-om-satsingen-pa-helsenaering/ 2023-03-10T12:47:00+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Podcast-Healthtalk-LR.png https://www.lmi.no/wp-content/uploads/2023/03/Podcast-Healthtalk-LR.png https://www.lmi.no/2023/03/13/moderna-far-vaksinekonkurranse-fra-msd-2/ 2023-03-13T11:30:19+00:00 https://www.lmi.no/2023/03/13/slik-vil-targovax-unnga-a-havne-i-en-dodsspiral-bak-betalingsmur/ 2023-03-13T11:31:03+00:00 https://www.lmi.no/2023/03/13/utsetter-sma-vedtak-veldig-overraskende-og-utrolig-leit-for-pasientene/ 2023-03-13T11:32:00+00:00 https://www.lmi.no/2023/03/13/lege-om-tilgang-til-ny-kreftmedisin-dette-vil-strupe-ordningen/ 2023-03-13T11:33:08+00:00 https://www.lmi.no/2023/03/13/lmi-direktoren-det-er-historisk-god-politisk-vilje-til-a-satse-pa-var-naering-na/ 2023-03-13T11:36:48+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen_portrett-halvnaert-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen_portrett-halvnaert-scaled.jpg https://www.lmi.no/2023/03/13/ge-healthcare-i-innovasjon-norges-eksportprisfinale/ 2023-03-13T13:20:55+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Cathrine-Thomassen_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Cathrine-Thomassen_crop-scaled.jpg https://www.lmi.no/2023/03/14/pfizer-kjoper-seagen-i-kjempeavtale/ 2023-03-14T08:21:50+00:00 https://www.lmi.no/2023/03/14/sanofi-kjoper-amerikansk-diabetes-selskap/ 2023-03-14T08:23:02+00:00 https://www.lmi.no/2023/03/14/legemiddel-for-oyesykdom-fikk-ja-i-beslutningsforum/ 2023-03-14T08:23:58+00:00 https://www.lmi.no/2023/03/14/miljokrav-horingen-viktig-a-ikke-begrense-tilgang-til-legemidler-lmi-kommenterer-krever-abonnement/ 2023-03-14T08:25:09+00:00 https://www.lmi.no/2023/03/14/hvorfor-kjore-langt-nar-du-kan-bli-hjemme/ 2023-03-15T08:13:43+00:00 https://www.lmi.no/wp-content/uploads/2023/03/DCT_programkomiteen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Sam-Novartis-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/DCT_Bergen_salen3-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/DCT_Bengtsson-slide-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/DCT_LEgemiddelverket-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Ina-Dahlsveen-1-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/DCT_panelet-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/DCT_programkomiteen-scaled.jpg https://www.lmi.no/2023/03/15/nortrials-mener-desentraliserte-studier-kan-bli-en-fordel-for-norge/ 2023-03-15T12:35:34+00:00 https://www.lmi.no/2023/03/15/per-harald-aabakken-er-ny-daglig-leder-i-sanofi-norge/ 2023-03-15T12:36:05+00:00 https://www.lmi.no/2023/03/15/fedmemiddel-fikk-nei-i-norge-britiske-helsemyndigheter-sier-ja/ 2023-03-15T12:36:37+00:00 https://www.lmi.no/2023/03/15/targovax-har-dosert-forste-pasient-med-kreftvaksine-i-usa/ 2023-03-15T12:37:08+00:00 https://www.lmi.no/2023/03/15/migrene-nesespray-er-godkjent-i-usa-veldig-effektiv-behandling-av-migreneanfall/ 2023-03-15T12:37:39+00:00 https://www.lmi.no/2023/03/15/beslutningsforumsjefen-legemiddelselskapene-ma-ta-sin-del-av-ansvaret-for-tidsbruken/ 2023-03-15T12:43:22+00:00 https://www.lmi.no/2023/03/16/nedgang-i-legemiddelbruken-i-norsk-fiskeoppdrett/ 2023-03-16T08:44:33+00:00 https://www.lmi.no/2023/03/16/slik-skal-norge-lykkes-med-desentraliserte-kliniske-studier/ 2023-03-16T08:46:05+00:00 https://www.lmi.no/2023/03/16/skymoen-svarer-om-tidsbruk-i-medwatch/ 2023-03-16T08:56:47+00:00 https://www.lmi.no/wp-content/uploads/2023/03/LR-kroinikk-medwatch.png https://www.lmi.no/2023/03/16/lmi-holdt-innlegg-og-deltok-i-debatt-pa-mote-om-avanserte-terapier-for-sjeldne-sykdommer/ 2023-03-16T11:57:37+00:00 https://www.lmi.no/wp-content/uploads/2023/03/image00093-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/image00093-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/VG.jpg https://www.lmi.no/wp-content/uploads/2023/03/debatten-scaled.jpg https://www.lmi.no/2023/03/16/fk-foredrag-i-paris-om-elektronisk-produktinformasjon/ 2023-03-16T13:01:27+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Bente.jpg https://www.lmi.no/wp-content/uploads/2023/03/Bente.jpg https://www.lmi.no/wp-content/uploads/2023/03/image0.jpeg https://www.lmi.no/2023/03/17/skymoen-pa-leverandorseminar-vi-ma-sta-sammen-om-a-lose-oppgavene-vi-star-overfor/ 2023-03-17T08:36:11+00:00 https://www.lmi.no/wp-content/uploads/2023/03/IMG_18811.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_18811.jpg https://www.lmi.no/2023/03/17/desentraliserte-kliniske-studiar/ 2023-03-17T08:41:10+00:00 https://www.lmi.no/2023/03/17/direktoratet-for-e-helse-har-na-vedtaksmyndighet-over-11-helseregistre-en-milepael-i-helsedata-arbeidet/ 2023-03-17T08:42:00+00:00 https://www.lmi.no/2023/03/17/astellas-og-den-danske-ambassaden-med-tilgangs-mote/ 2023-03-19T14:11:09+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Ambassademote-om-tilgang-Koben-mars-23-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Ambassademote-om-tilgang-Koben-mars-23-scaled.jpg https://www.lmi.no/2023/03/20/cathrine-lofthus-til-lmis-generalforsamling/ 2023-03-20T06:37:02+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Cathrine-Lofthus-portrettfoto-front.jpg https://www.lmi.no/wp-content/uploads/2023/03/Cathrine-Lofthus-portrettfoto.jpg https://www.lmi.no/2023/03/20/vedums-sykdom-har-lenge-vaert-et-mysterium-finnes-det-noe-hap-for-en-ms-kur/ 2023-03-20T12:38:50+00:00 https://www.lmi.no/2023/03/20/authera-har-inngatt-avtale-med-internasjonalt-legemiddelselskap/ 2023-03-20T12:41:29+00:00 https://www.lmi.no/2023/03/20/novo-nordisk-suspendert-fra-britisk-bransjeforening-for-alvorlige-brudd/ 2023-03-20T12:43:22+00:00 https://www.lmi.no/2023/03/20/9-av-10-nordmenn-har-ikke-hort-om-den-livsviktige-medisinen/ 2023-03-20T12:46:16+00:00 https://www.lmi.no/2023/03/20/sauebondene-ventar-spent-pa-vaksinen-som-skal-berge-lamma/ 2023-03-20T12:47:34+00:00 https://www.lmi.no/2023/03/20/forskere-pa-sikt-kan-en-vaksine-utrydde-ms/ 2023-03-20T12:49:01+00:00 https://www.lmi.no/2023/03/22/svensk-regjeringsutvalg-ser-til-norske-nortrials-foreslar-nasjonalt-partnerskap-for-kliniske-studier/ 2023-03-22T07:43:41+00:00 https://www.lmi.no/2023/03/22/bra-gjenapning-av-kina-forte-til-hundretusener-av-covid-dodsfall/ 2023-03-22T07:44:57+00:00 https://www.lmi.no/2023/03/22/gilead-sikrer-rettighetene-til-potensiell-leddgikt-medisin-fra-nurix/ 2023-03-22T07:48:24+00:00 https://www.lmi.no/2023/03/22/flere-avslag-pa-ekspertrad-om-utprovende-behandling-kan-skyldes-sykehusokonomien/ 2023-03-22T07:50:07+00:00 https://www.lmi.no/2023/03/22/jemperli-fikk-ja-i-beslutningsforum-et-stort-fremskritt/ 2023-03-22T07:51:18+00:00 https://www.lmi.no/2023/03/22/na-kan-danske-pasienter-med-foflekkreft-fa-behandling-med-t-celleterapi-ikke-aktuelt-i-norge/ 2023-03-22T07:53:26+00:00 https://www.lmi.no/2023/03/22/mistanke-om-bivirkninger-fra-medisinen-din-sjekk-enkelt-her/ 2023-03-22T07:55:56+00:00 https://www.lmi.no/2023/03/22/utlysning-utvalgsmedlem-ihi-2/ 2023-03-22T09:20:50+00:00 https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/wp-content/uploads/2017/07/utvalgillustrasjon.jpg https://www.lmi.no/2023/03/21/lmi-arrangerer-halvdagsmote-om-prioritering-i-helsesektoren-27-mars-meld-deg-pa-her/ 2023-03-22T14:37:51+00:00 https://www.lmi.no/wp-content/uploads/2021/08/KK.png https://www.lmi.no/2023/03/23/hjertemedisinen-selger-over-all-forventning-11-000-doser-gikk-ut-i-lopet-av-to-uker-krever-abonnement/ 2023-03-23T09:55:36+00:00 https://www.lmi.no/2023/03/23/fleire-jenter-enn-gutar-over-16-ar-bruker-antidepressiva-sovemiddel-og-antipsykotika/ 2023-03-23T09:56:17+00:00 https://www.lmi.no/2023/03/23/dette-vet-vi-na-om-bivirkningene-av-covid-19-vaksinen/ 2023-03-23T09:57:25+00:00 https://www.lmi.no/2023/03/23/uio-satser-tungt-pa-kjerneforskning-og-kunnskap-om-radioaktivitet/ 2023-03-23T09:58:07+00:00 https://www.lmi.no/2023/03/24/regjeringen-styrker-offentlig-privat-forskningssamarbeid/ 2023-03-24T08:54:56+00:00 https://www.lmi.no/wp-content/uploads/2023/03/hodbygget_315x177-1.webp https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen.jpg https://www.lmi.no/2023/03/24/karsten-bruins-slot-om-ny-jobb-i-lytix-far-mer-ansvar-i-den-kliniske-utviklingen/ 2023-03-24T09:11:30+00:00 https://www.lmi.no/2023/03/24/helge-lund-gjenvalgt-som-styreleder-i-novo-nordisk-veldig-fornoyd-med-selskapets-resultater/ 2023-03-24T09:12:32+00:00 https://www.lmi.no/2023/03/24/flere-jenter-enn-gutter-bruker-antidepressiver-sovemedisin-og-antipsykotika/ 2023-03-24T09:16:23+00:00